CEL SCI CORP
8-K, 1997-12-24
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CEL SCI CORP, 10-K, 1997-12-24
Next: INVESCO STRATEGIC PORTFOLIOS INC, 485APOS, 1997-12-24





                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

                        Date of Report: December 22, 1997

                               CEL-SCI CORPORATION
             (Exact name of registrant as specified in its charter)

             COLORADO                     0-11503           84-0916344
    (State or other jurisdiction of    Commission            (I.R.S. Employer
     incorporation or organization)    File Number          Identification No.)

         66 Canal Center Plaza, Suite 510
            Alexandria, Virginia                            22314
   (Address of principal executive offices)               (Zip Code)

        Registrant's telephone number, including area code: (703) 549-5293

                                            Not Applicable
        Former Name or Former Address, If Changed Since Last Report





<PAGE>


ITEM 5.  OTHER INFORMATION

     On  December  22,  1997,  the Company  sold  10,000  shares of its Series D
Preferred Stock, 550,000 Series A Warrants and 550,000 Series B Warrants, to ten
institutional  investors for  $10,000,000.  The Series D Preferred Shares may be
converted into shares of the Company's Common Stock. Prior to September 19, 1998
(or such earlier date as the market price of the Company's Common Stock is $3.45
or less for five  consecutive  trading days) the number of shares  issuable upon
the conversion of each Series D Preferred  Share is to be determined by dividing
$1,000 by $8.28.  On or after  September 19, 1998 the number of shares  issuable
upon the  conversion  of each Series D Preferred  Share is to be  determined  by
dividing  $1,000 by the lower of (i)  $8.28,  or (ii) the  average  price of the
Company's  common  stock for any two trading  days  during the ten trading  days
preceeding  the  conversion  date.  Each  Series A Warrant  allows the holder to
purchase one share of the Company's  common stock for $8.62 at any time prior to
December 22, 2001. Each Series B Warrant allows the holder to purchase one share
of the Company's Common Stock for $9.31 at any time prior to December 22, 2001.

     The Company has agreed to file a registration statement with the Securities
and Exchange  Commission covering the sale of the common stock issuable upon the
conversion  of the Series D Preferred  Stock and/or the exercise of the Series A
and Series B Warrants.









<PAGE>


ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS

         (c)  Exhibits

              Exhibit             Exhibit
              Number               Name

              4.1                 Securities Purchase    Agreement    (without
                                  Exhibits and Schedules)

              4.2                 Certificate of Designations  Preferences  and
                                  Rights of Series D Preferred Stock.

              4.3                 Form of Common Stock Purchase Warrant;

              4.4                 Registration Rights Agreement;

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.



                                            CEL-SCI CORPORATION


Date: December 24, 1997                     By /s/ Geert R. Kersten
                                              Geert R. Kersten
                                              Chief Executive Officer




    
                          SECURITIES PURCHASE AGREEMENT


     This  SECURITIES  PURCHASE  AGREEMENT  ("Agreement")  is entered into as of
December 22, 1997, by and between Cel-Sci  Corporation,  a Colorado  corporation
(the "Company"),  with headquarters located at 66 Canal Center Plaza, Suite 510,
Alexandria,  Virginia, 22314 and the purchasers  ("Purchasers") set forth on the
schedule of Purchasers attached hereto, with regard to the following:

                                    RECITALS

     A. The Company and Purchasers  are executing and delivering  this Agreement
in reliance  upon the exemption  from  securities  registration  afforded by the
provisions of Regulation D ("Regulation D"), as promulgated by the United States
Securities and Exchange Commission (the "SEC") under the Securities Act of 1933,
as amended (the "Securities Act").

     B. Purchasers desire (a) to purchase,  upon the terms and conditions stated
in this Agreement,  Ten Million U.S. Dollars face amount of the Company's Series
D Preferred  Stock (the  "Preferred  Shares"),  in the form  attached  hereto as
Exhibit A,  convertible  into shares of the Company's  Common Shares,  par value
$0.01 per share (the "Common Stock"),  and (b) to receive,  in consideration for
such purchase,  Stock Purchase Warrants (the  "Warrants"),  in the form attached
hereto as  Exhibit B, to acquire  shares of Common  Stock.  The shares of Common
Stock  issuable  upon  exercise of or  otherwise  pursuant to the  Warrants  are
referred to herein as "Warrant Shares".  The shares of Common Stock to be issued
to the Purchasers upon conversion of the Preferred Shares are referred to herein
as the "Common Shares." The Preferred Shares,  the Common Shares,  the Warrants,
and the Warrant Shares are collectively referred to herein as the "Securities."

     C. Contemporaneously with the execution and delivery of this Agreement, the
parties hereto are executing and delivering a Registration  Rights  Agreement in
the form attached  hereto as Exhibit C (the  "Registration  Rights  Agreement"),
pursuant to which the Company has agreed to provide certain  registration rights
under the Securities Act, the rules and regulations  promulgated  thereunder and
applicable state securities laws.

                                   AGREEMENTS

     NOW,  THEREFORE,  in consideration of their respective  promises  contained
herein and other good and valuable consideration, the receipt and sufficiency of
which are  hereby  acknowledged,  the  Company  and  Purchaser  hereby  agree as
follows:



                                    ARTICLE I
                      PURCHASE AND SALE OF PREFERRED SHARES


     1.1 Purchase of Preferred  Shares.  Subject to the terms and  conditions of
this Agreement, the issuance, sale and purchase of the Preferred Shares shall be
consummated  in a  "Closing".  On  the  date  of  the  Closing,  subject  to the
satisfaction  or waiver of the  conditions set forth in Articles VI and VII, the
Company  shall issue and sell to the  Purchasers,  and the  Purchasers  agree to
purchase from the Company,  Preferred Shares in the respective amounts set forth
opposite  each  Purchaser's  name on the Schedule of  Purchasers.  The per share
purchase  price (the "Purchase  Price") of the Preferred  Shares shall be $1,000
for an aggregate purchase price of Ten Million U.S. Dollars.


<PAGE>

     1.2 Form of Payment.  The  Purchaser  shall pay the Purchase  Price for the
Preferred  Shares by wire  transfer  to the account  designated  pursuant to the
Escrow  Agreement by and among the Company,  the  Purchaser and the escrow agent
("Escrow  Agent")  designated  therein in the form attached  hereto as Exhibit D
("Escrow  Agreement")  upon delivery to the Escrow Agent of the Preferred Shares
and the Warrants, all in accordance with the terms of the Escrow Agreement,  and
upon satisfaction of the other Closing conditions.

     1.3 Closing Date. Subject to the satisfaction (or waiver) of the conditions
set forth in  Articles VI and VII below,  and  further  subject to the terms and
conditions of the Escrow Agreement,  the date and time of the issuance, sale and
purchase of the Preferred  Shares  pursuant to this Agreement  shall be at 10:00
a.m. California time, on December 22, 1997, (the "Closing Date").

     1.4  Warrants.  In  consideration  of  the  purchase  by  Purchaser  of the
Preferred  Shares,  the  Company  shall at the Closing  issue to the  Purchasers
Warrants to acquire an aggregate of One Million One Hundred Thousand (1,100,000)
Common Shares.

                                   ARTICLE II
                         PURCHASER'S REPRESENTATIONS AND
                                   WARRANTIES

     Each Purchaser represents and warrants to the Company as of the date hereof
and as of the  Closing,  severally  and  solely  with  respect to itself and its
purchase  hereunder  and  not  with  respect  to any  other  Purchaser,  (and no
Purchaser  shall be deemed to make or have any liability for any  representation
or warranty made by any other Purchaser) as set forth in this Article II.

     2.1 Investment  Purpose.  Purchaser is purchasing the Preferred  Shares and
the Warrants for Purchaser's own account for investment only and not with a view
toward the public sale or  distribution  thereof in violation of the  applicable
securities laws. Purchaser will not, directly or indirectly, offer, sell, pledge
or otherwise  transfer the Preferred  Shares or Warrants or any interest therein
except  pursuant  to  transactions   that  are  exempt  from  the   registration
requirements of the Securities Act and/or sales  registered under the Securities
Act, the rules and regulations promulgated pursuant thereto and applicable state
securities  laws.  Purchaser  understands  that Purchaser must bear the economic
risk of this  investment  indefinitely,  unless the  Securities  are  registered
pursuant to the Securities Act and any applicable  state  securities  laws or an
exemption  from such  registration  is  available,  and that the  Company has no
present  intention of registering any such Securities other than as contemplated
by the Registration  Rights  Agreement.  By making the  representations  in this
Section 2.1, the Purchaser does not agree to hold the Securities for any minimum
or other  specific  term and reserves the right to dispose of the  Securities at
any time in  accordance  with or  pursuant  to a  registration  statement  or an
exemption from  registration  under the Securities Act and any applicable  state
securities laws.

     2.2 Accredited  Investor Status.  Purchaser is an "accredited  investor" as
that term is defined in Rule 501(a) of  Regulation D and Purchaser has indicated
on the Investor  Questionnaire and  Representation  Agreement attached hereto as
Exhibit E in which capacity that it so qualifies as an "accredited investor."

     2.3 Reliance on Exemptions. Purchaser understands that the Preferred Shares
and Warrants are being  offered and sold to Purchaser in reliance  upon specific
exemptions from the registration requirements of United States federal and state
securities  laws and that the Company is relying upon the truth and accuracy of,
and Purchaser's  compliance with, the representations,  warranties,  agreements,
acknowledgments  and  understandings  of Purchaser  set forth herein in order to
determine the  availability  of such exemptions and the eligibility of Purchaser
to acquire the Preferred Shares and Warrants.

     2.4 Information. Purchaser or its counsel have been furnished all materials
relating to the business, finances and operations of the Company and materials

<PAGE>

relating to the offer and sale of the  Securities  which have been  specifically
requested by Purchaser, including without limitation the Company's Annual Report
on Form 10-K/A for the Year ended September 30, 1996,  Quarterly Reports on Form
10-Q for the periods ended December 31, 1996,  March 31, 1997 and June 30, 1997,
Proxy  Statement  relating  to the  Company's  June 3, 1997  Annual  Meeting  of
Shareholders  (the "Proxy  Statement")  and Private  Offering  Memorandum  dated
December 15, 1997 (the "Offering Memorandum") (such documents collectively,  the
"SEC  Documents").  Purchaser has been afforded the opportunity to ask questions
of the Company  and has  received  what  Purchaser  believes to be complete  and
satisfactory answers to any such inquiries. Neither such inquiries nor any other
due diligence investigation conducted by Purchaser or any of its representatives
nor any other  disclosures or documents  (including  without  limitation the SEC
Documents)  shall  modify,  amend  or  affect  Purchaser's  right to rely on the
Company's  representations and warranties  contained in this Agreement or in any
Exhibit hereto or in any certificate issued in connection herewith or therewith.
Purchaser  understands that Purchaser's  investment in the Securities involves a
high degree of risk,  including  without  limitation the risks and uncertainties
disclosed in the SEC Documents. Subject to the foregoing, Purchaser acknowledges
the  disclosures  presented  under the caption  "Risk  Factors" in the  Offering
Memorandum, and the incorporation of those disclosures by reference herein.

     2.5  Governmental  Review.  Purchaser  understands  that no  United  States
federal  or state  agency or any other  government  or  governmental  agency has
passed upon or made any recommendation or endorsement of the Securities.

     2.6 Transfer or Resale.  Purchaser  understands that (i) except as provided
in the Registration  Rights Agreement,  the Securities have not been and are not
being  registered under the Securities Act or any state securities laws, and may
not be offered,  sold,  pledged or  otherwise  transferred  unless  subsequently
registered thereunder or an exemption from such registration is available (which
exemption the Company  expressly  agrees may be established as  contemplated  in
clauses (b) and (c) of Section 5.1 hereof); and (ii) neither the Company nor any
other  person is under any  obligation  to register  such  Securities  under the
Securities  Act or any state  securities  laws or to  comply  with the terms and
conditions of any  exemption  thereunder  (in each case,  other than pursuant to
this Agreement or the Registration Rights Agreement).

     2.7 Legends.  Purchaser  understands that, subject to Article V hereof, the
certificates  for the Preferred  Shares and Warrants and, until such time as the
resale of the Common Shares and Warrant  Shares have been  registered  under the
Securities Act as contemplated by the Registration Rights Agreement or otherwise
may be sold by Purchaser pursuant to Rule 144 (subject to and in accordance with
the procedures  specified in Article V hereof),  the certificates for the Common
Shares and Warrant  Shares,  will bear a  restrictive  legend (the  "Legend") in
substantially the following form:

      THE SECURITIES  REPRESENTED BY THIS  CERTIFICATE  HAVE NOT BEEN REGISTERED
      UNDER THE  SECURITIES ACT OF 1933, AS AMENDED,  OR THE SECURITIES  LAWS OF
      ANY STATE OF THE UNITED STATES. THE SECURITIES  REPRESENTED HEREBY MAY NOT
      BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE
      REGISTRATION STATEMENT FOR THE SECURITIES UNDER APPLICABLE SECURITIES LAWS
      OR UNLESS OFFERED,  SOLD OR TRANSFERRED PURSUANT TO AN AVAILABLE EXEMPTION
      FROM THE REGISTRATION REQUIREMENTS OF THOSE LAWS.

     2.8 Authorization:  Enforcement. This Agreement and the Registration Rights
Agreement  have been duly and validly  authorized,  executed  and  delivered  on
behalf  of  Purchaser  and  are  valid  and  binding   agreements  of  Purchaser
enforceable in accordance with their respective terms,  except (i) to the extent
that such  validity  or  enforceability  may be  subject to or  affected  by any
bankruptcy, insolvency, reorganization,  moratorium, liquidation or similar laws
relating to, or affecting  generally the  enforcement of,  creditors'  rights or
remedies of creditors  generally,  or by other  equitable  principles of general
application,  and  (ii) as  rights  to  indemnity  and  contribution  under  the
Registration  Rights  Agreement  may be limited  by Federal or state  securities
laws.


<PAGE>

     2.9 Residency.  Purchaser is a resident of the jurisdiction set forth under
Purchaser's name on the signature page hereto executed by Purchaser.


                                   ARTICLE III
                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

     The Company represents and warrants to the Purchasers as of the date hereof
and
as of the Closing as set forth in this Article III.

     3.1   Organization  and   Qualification.   Each  of  the  Company  and  its
subsidiaries is a corporation duly organized and existing in good standing under
the laws of the jurisdiction in which it is incorporated,  and has the requisite
corporate  power to own its properties and to carry on its business as now being
conducted.  The  Company and each of its  subsidiaries  is duly  qualified  as a
foreign corporation to do business and is in good standing in every jurisdiction
where the  failure so to qualify  or be in good  standing  would have a Material
Adverse Effect.  "Material Adverse Effect" means any effect which,  individually
or in the aggregate with all other effects,  is or reasonably  could be expected
to be materially  adverse to the  business,  operations,  properties,  financial
condition,  operating  results or prospects of the Company and its subsidiaries,
taken as a whole on a  consolidated  basis or on the  transactions  contemplated
hereby or on any of the Securities,  or any of the documents or agreements to be
entered into in connection herewith.

     3.2 Authorization: Enforcement. (a) The Company has the requisite corporate
power  and  authority  to  enter  into  and  perform  this   Agreement  and  the
Registration  Rights  Agreement,  and to issue, sell and perform its obligations
with respect to the Preferred  Shares and Warrants in accordance  with the terms
hereof  and the terms of the  Preferred  Shares and  Warrants,  and to issue the
Common Shares and Warrant  Shares upon  conversion  of the Preferred  Shares and
exercise  of the  Warrant,  respectively,  in  accordance  with  the  terms  and
conditions  of  the  Preferred  Shares  and  Warrants,   respectively;  (b)  the
execution,  delivery and  performance  of this  Agreement  and the  Registration
Rights  Agreement by the Company and the  consummation by it of the transactions
contemplated  hereby and thereby  (including  without limitation the issuance of
the Preferred  Shares and the  Warrants,  and the issuance and  reservation  for
issuance of the Common Shares and the Warrant  Shares) have been duly authorized
by all  necessary  corporate  action and,  except as set forth on  Schedule  3.2
hereof,  no  further  consent  or  authorization  of the  Company,  its board of
directors,  or its  stockholders  or any other  person,  body or agency,  and no
filing with any person,  body or agency,  is required with respect to any of the
transactions contemplated hereby or thereby (whether under rules of the American
Stock  Exchange  ("AMEX"),  the National  Association  of Securities  Dealers or
otherwise); (c) this Agreement, the Registration Rights Agreement,  certificates
for the Preferred Shares, and the Warrants have been duly executed and delivered
by the Company;  (d) this Agreement,  the  Registration  Rights  Agreement,  the
Preferred  Shares,  and  the  Warrants   constitute  legal,  valid  and  binding
obligations of the Company  enforceable  against the Company in accordance  with
their  respective  terms,  except  (i) to  the  extent  that  such  validity  or
enforceability  may be subject to or  affected  by any  bankruptcy,  insolvency,
reorganization,   moratorium,  liquidation  or  similar  laws  relating  to,  or
affecting  generally  the  enforcement  of,  creditors'  rights or  remedies  of
creditors  generally,  or by other equitable  principles of general application,
and (ii) as rights to indemnity and contribution  under the Registration  Rights
Agreement may be limited by Federal or state  securities  laws; and (e) prior to
the Closing Date,  the  Certificate  of Designation in the form of Exhibit F has
been filed with the Secretary of State of Colorado and will be in full force and
effect, enforceable against the Company in accordance with its terms.

     3.3  Capitalization.  The  capitalization  of the  Company  as of the  date
hereof,  including the authorized capital stock, the number of shares issued and
outstanding,  the  number  of  shares  reserved  for  issuance  pursuant  to the
Company's stock option plans, the number of shares reserved for issuance

<PAGE>

pursuant  to  securities  (other  than the  Preferred  Shares  or the  Warrants)
exercisable  for, or convertible  into or exchangeable  for any shares of Common
Stock and the number of shares to be reserved for issuance  upon  conversion  of
the Preferred  Shares and exercise of the Warrants is set forth in the "Dilution
and  Comparative  Share Data"  Section of the Offering  Memorandum.  All of such
outstanding shares of capital stock have been, or upon issuance will be, validly
issued, fully paid and nonassessable.  No shares of capital stock of the Company
(including  the Common  Shares and the Warrant  Shares)  are, and no such shares
will be,  subject  to  preemptive  rights  or any  other  similar  rights of the
stockholders  of the  Company  or of any other  person or entity or any liens or
encumbrances.  Except as disclosed in the "Dilution and Comparative  Share Data"
Section of the Offering Memorandum,  as of the date of this Agreement, (i) there
are no outstanding options,  warrants,  scrip, rights to subscribe for, calls or
commitments  of any  character  whatsoever  relating to, or securities or rights
convertible into or exercisable or exchangeable for, any shares of capital stock
of  the  Company  or  any  of  its  subsidiaries,  or  contracts,   commitments,
understandings  or arrangements by which the Company or any of its  subsidiaries
is or may  become  bound to issue  additional  shares  of  capital  stock of the
Company or any of its subsidiaries, and (ii) issuance of the Securities will not
trigger  antidilution  or  similar  rights  for  any  other  present  or  future
outstanding  or  authorized  securities  of  the  Company,  (iii)  there  are no
agreements or arrangements under which the Company or any of its subsidiaries is
obligated  to  register  the sale of any of its or their  securities  under  the
Securities Act (except the Registration Rights Agreement), and (iv) there are no
outstanding  debt  securities.  The Company has furnished to Purchaser  true and
correct copies of the Company's Certificate of Incorporation as in effect on the
date hereof  ("Certificate of  Incorporation"),  and the Company's By-laws as in
effect on the date hereof (the  "By-laws").  The Company has set forth on in the
"Dilution and  Comparative  Share Data" Section of the Offering  Memorandum  all
instruments  and agreements  (other than the  Certificate of  Incorporation  and
By-laws) governing or concerning  securities  convertible into or exercisable or
exchangeable  for Common Shares of the Company (and the Company shall provide to
Purchaser copies thereof upon the request of Purchaser).

     3.4  Issuance  of Shares.  The Common  Shares and  Warrant  Shares are duly
authorized  and reserved for  issuance,  and,  upon  conversion of the Preferred
Shares and the Warrants,  in accordance  with the terms thereof,  as applicable,
will be validly issued, fully paid and non-assessable,  and free from all taxes,
liens, claims and encumbrances directly or indirectly imposed or suffered by the
Company  or any  of its  subsidiaries,  will  be  entitled  to  all  rights  and
preferences accorded to a holder of Common Stock, shall be entitled to be traded
on the same  markets and  exchanges  as the other  shares of Common Stock of the
Company  are  traded,  and will not be  subject  to  preemptive  rights or other
similar rights of  stockholders of the Company or of any other person or entity.
The Preferred Shares and Warrants are duly authorized and validly issued,  fully
paid  and  nonassessable,  and free  from all  liens,  claims  and  encumbrances
directly  or  indirectly  imposed  or  suffered  by  the  Company  or any of its
subsidiaries or affiliates and will not be subject to preemptive rights or other
similar rights of stockholders of the Company or of any other person or entity.

     3.5  No  Conflicts.  The  execution,   delivery  and  performance  of  this
Agreement,  the  Preferred  Shares,  the  Warrants and the  Registration  Rights
Agreement by the Company,  and the  consummation  by the Company of transactions
contemplated hereby and thereby (including, without limitation, the issuance and
reservation for issuance, as applicable, of the Preferred Shares, Common Shares,
Warrants,  and  Warrant  Shares)  will  not (a)  result  in a  violation  of the
Certificate  of  Incorporation  or By-laws or (b) conflict with, or constitute a
default (or an event  which with notice or lapse of time or both would  become a
default)  under,  or  give to  others  any  rights  of  termination,  amendment,
acceleration or cancellation of, any agreement, indenture or instrument to which
the Company or any of its  subsidiaries  is a party, or result in a violation of
any law, rule, regulation, order, judgment or decree (including U.S. federal and
state  securities  laws and  regulations  and the rules and regulations of AMEX)
applicable to the Company or any of its  subsidiaries,  or by which any property
or asset of the Company or any of its subsidiaries, is bound or affected (except

<PAGE>

for such possible conflicts, defaults, terminations,  amendments, accelerations,
cancellations  and  violations as would not,  individually  or in the aggregate,
have a Material Adverse Effect.  Neither the Company nor any of its subsidiaries
is in violation of its  Certificate  of  Incorporation  or other  organizational
documents,  and neither the  Company nor any of its  subsidiaries  is in default
(and no event has occurred which has not been waived which, with notice or lapse
of time or both,  would put the Company or any of its  subsidiaries  in default)
under,  nor has there  occurred any event giving others (with notice or lapse of
time or both) any rights of termination, amendment, acceleration or cancellation
of, any  agreement,  indenture or  instrument to which the Company or any of its
subsidiaries is a party, except for possible  violations,  defaults or rights as
would not, individually or in the aggregate, have a Material Adverse Effect. The
businesses  of the Company and its  subsidiaries  are not being  conducted,  and
shall  not be  conducted  so  long  as  Purchaser  (or any  direct  or  indirect
transferee, assignee or participant of Purchaser or of such transferee, assignee
or  participant in a transaction of the type referred to in Section 5.1(b) below
("Purchaser  Transferee")) owns any of the Securities,  in violation of any law,
ordinance  or  regulation  of  any  governmental  entity,  except  for  possible
violations the sanctions for which either individually or in the aggregate would
not have a Material  Adverse  Effect.  Except as set forth on  Schedule  3.5, or
except (A) such as may be required under the  Securities Act in connection  with
the  performance  of the Company's  obligations  under the  Registration  Rights
Agreement,  (B)  filing of a Form D with the SEC,  and (C)  compliance  with the
state  securities or Blue Sky laws of applicable  jurisdictions,  the Company is
not  required  to obtain  any  consent,  authorization  or order of, or make any
filing or registration with, any court or governmental  agency or any regulatory
or self-regulatory agency in order for it to execute,  deliver or perform any of
its obligations under this Agreement,  the Preferred Shares, the Warrants or the
Registration  Rights  Agreement or to perform its obligations in accordance with
the terms  hereof or  thereof.  The Company is not in  violation  of the listing
requirements  of AMEX,  does not know of or anticipate  any event which could be
grounds for such  delisting and does not reasonably  anticipate  that the Common
Stock (including the Common Shares) will be delisted by AMEX for the foreseeable
future.

     3.6 SEC Documents. Except as disclosed in Schedule 3.6, since September 30,
1996, the Company has timely filed all reports, schedules, forms, statements and
other  documents  required  to be  filed  by it  with  the SEC  pursuant  to the
reporting  requirements of the Securities  Exchange Act of 1934, as amended (the
"Exchange  Act").  The Company has delivered to each Purchaser true and complete
copies of the SEC  Documents,  except for exhibits,  schedules and  incorporated
documents.  As of their  respective  dates,  the SEC  Documents  complied in all
material  respects with the  requirements  of the Exchange Act and the rules and
regulations of the SEC promulgated  thereunder  applicable to the SEC Documents,
and  none of the SEC  Documents,  at the  time  they  were  filed  with the SEC,
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated  therein or necessary in order to make the statements
therein,  in  light  of the  circumstances  under  which  they  were  made,  not
misleading.  None of the  statements  made in any  such SEC  Documents  which is
required to be updated or amended under  applicable  law has not been so updated
or  amended.  The  financial  statements  of the  Company  included  in the  SEC
Documents  have  been  prepared  in  accordance  with  U.S.  generally  accepted
accounting  principles,  consistently  applied, and the rules and regulations of
the SEC during the periods involved (except (i) as may be otherwise indicated in
such financial statements or the notes thereto, or (ii) in the case of unaudited
interim statements, to the extent they do not include footnotes or are condensed
or  summary  statements)  and,  fairly  present  in all  material  respects  the
consolidated financial position of the Company and its consolidated subsidiaries
as of the dates thereof and the  consolidated  results of their  operations  and
cash  flows  for the  periods  then  ended  (subject,  in the case of  unaudited
statements,  to normal,  immaterial year-end audit  adjustments).  Except as set
forth in the financial  statements or the notes thereto of the Company  included
in the SEC Documents,  the Company has no liabilities,  contingent or otherwise,
other  than  (i)  liabilities  incurred  in  the  ordinary  course  of  business
consistent  with  past  practice  subsequent  to  the  date  of  such  financial
statements and (ii) obligations under contracts and commitments  incurred in the
ordinary course of business consistent with past practice and not required under

<PAGE>

generally  accepted  accounting  principles  to be reflected  in such  financial
statements,  in each case of clause (i) and (ii) next above which,  individually
or in the  aggregate,  are not material to the  financial  condition,  business,
operations,  properties,  operating  results or prospects of the Company and its
subsidiaries or to the transactions contemplated hereby or to the Securities. To
the  extent  required  by the  rules  of the  SEC  applicable  thereto,  the SEC
Documents  contain a complete  and accurate  list of all  material  undischarged
written or oral contracts,  agreements,  leases or other instruments existing as
of the respective date of each such SEC Document (or such other date required by
the rules of the SEC) to which the  Company or any  subsidiary  is a party or by
which the Company or any  subsidiary is bound or to which any of the  properties
or assets of the  Company  or any  subsidiary  is subject  (each a  "Contract").
Except as set forth in Schedule 3.6, none of the Company,  its  subsidiaries or,
to the best knowledge of the Company,  any of the other parties  thereto,  is in
breach or violation  of any  Contract,  which  breach or violation  would have a
Material Adverse Effect.  No event,  occurrence or condition exists which,  with
the lapse of time, the giving of notice,  or both, would become a default by the
Company or its  subsidiaries  thereunder  which  would  have a Material  Adverse
Effect.

     3.7 Absence of Certain Changes. Since September 30, 1996, there has been no
material  adverse  change and no material  adverse  development in the business,
properties,  operations, financial condition, results of operations or prospects
of the Company, except as disclosed in Schedule 3.7.

     3.8 Absence of Litigation. Except as disclosed in Schedule 3.8, there is no
action,  suit,  proceeding,  inquiry  or  investigation  before or by any court,
public board, government agency, or self-regulatory organization or body pending
or, to the  knowledge  of the  Company  or any of its  subsidiaries,  threatened
against or  affecting  the  Company,  any of its  subsidiaries,  or any of their
respective directors or officers in their capacities as such, which if adversely
determined  could have a Material  Adverse Effect or would adversely  affect the
transactions contemplated by this Agreement or any of the documents contemplated
hereby or which would adversely affect the validity or enforceability of, or the
authority  or ability of the  Company to perform  its  obligations  under,  this
Agreement  or any of such  other  documents.  There  are no  facts  known to the
Company which, if known by a potential claimant or governmental authority, could
reasonably be expected to give rise to a claim or proceeding  which, if asserted
or conducted with results unfavorable to the Company or any of its subsidiaries,
could reasonably be expected to have a Material Adverse Effect.

     3.9 Disclosure. No information,  statement or representation relating to or
concerning the Company or any of its subsidiaries set forth in this Agreement or
provided to a Purchaser in connection with the transactions  contemplated hereby
contains an untrue  statement of a material fact. No information  relating to or
concerning  the Company or any of its  subsidiaries  set forth in any of the SEC
Documents  contains a statement of material  fact that was untrue as of the date
such SEC Document was filed with the SEC. The Company has not omitted to state a
material fact necessary in order to make the statements and representations made
herein or therein, in light of the circumstances under which they were made, not
misleading.  Except for the  execution and  performance  of this  Agreement,  no
material fact (within the meaning of the federal  securities  laws of the United
States and of  applicable  state  securities  laws)  exists with  respect to the
Company or any of its subsidiaries which has not been publicly disclosed.

     3.10 Acknowledgment  Regarding Purchaser's Purchase of the Securities.  The
Company  acknowledges  and agrees  that  Purchaser  is not acting as a financial
advisor  or  fiduciary  of the  Company  or any of its  subsidiaries  (or in any
similar   capacity)  with  respect  to  this   Agreement  or  the   transactions
contemplated  hereby,  that  this  Agreement  and the  transaction  contemplated
hereby,  and  the  relationship  between  the  Purchaser  and the  Company,  are
"arms-length",  and that any statement made by Purchaser (except as set forth in
Article II), or any of its  representatives  or agents,  in connection with this
Agreement  and  the  transactions   contemplated  hereby  is  not  advice  or  a
recommendation,  is merely incidental to Purchaser's  purchase of the Securities
and has not been relied upon as such in any way by the Company,  its officers or
directors.  The Company  further  represents  to  Purchaser  that the  Company's
decision to enter into this Agreement and the transactions  contemplated  hereby
have been based  solely on an  independent  evaluation  by the  Company  and its
representatives.

     3.11 S-3  Registration.  The Company is currently  eligible to register the
resale of its Common  Stock on a  registration  statement  on Form S-3 under the
Securities  Act.  The  Company  acknowledges  that once the resale of the Common
Stock and  Warrant  Shares  have been  registered  under the  Securities  Act or
otherwise may be sold by a Purchaser  pursuant to Rule 144, the Common Stock and
Warrant Shares will not contain the legend set forth in Section 2.7.


<PAGE>

     3.12 No General  Solicitation.  Neither  the  Company  nor any  distributor
participating on the Company's behalf in the  transactions  contemplated  hereby
(if any) nor any person  acting for the Company,  or any such  distributor,  has
conducted  any  "general  solicitation,"  as  described  in  Rule  502(c)  under
Regulation D, with respect to any of the Securities being offered hereby.

     3.13  No  Integrated  Offering.   Neither  the  Company,  nor  any  of  its
affiliates,  nor any  person  acting on its or their  behalf,  has  directly  or
indirectly  made any offers or sales of any security or solicited  any offers to
buy any security under  circumstances that would either require  registration of
any of the  Securities  under  the  Act  or  prevent  the  parties  hereto  from
consummating,  or delay or interfere with the  consummation of, the transactions
contemplated  hereby  pursuant to an exemption from the  registration  under the
Securities  Act pursuant to the  provisions of  Regulation  D. The  transactions
contemplated  hereby  are  exempt  from  the  registration  requirements  of the
Securities  Act,  assuming  the  accuracy of the  relevant  representations  and
warranties   herein  contained  of  the  Purchaser  and  of  Shoreline   Pacific
Institutional  Finance,  the  Institutional  Division  of  Financial  West Group
("Shoreline")  in their  letter to the Company  dated as of December 22, 1997 (a
copy of which is attached as Schedule  3.13  hereto) to the extent  relevant for
such  determination.  To  the  Company's  knowledge,  such  representations  and
warranties of Shoreline are accurate.

     3.14 No Brokers.  The Company has taken no action,  directly or indirectly,
which  would  give rise to any claim by any person  for  brokerage  commissions,
finder's fees or similar payments by Purchaser relating to this Agreement or the
transactions contemplated hereby, except for dealings with Shoreline the fees of
which shall be paid in full by the  Company.  The  Company  will  indemnify  the
Purchaser from and against any fees and expenses  (including  without limitation
reasonable attorneys fees and expenses) sought or other claims made by Shoreline
with respect to its brokerage commission.

     3.15  Intellectual  Property.  The Company owns or has  obtained  valid and
enforceable  licenses for the US,  Japanese and  European  patents,  trademarks,
trademark registrations,  service marks, service mark registrations, trade names
and, copyright  registrations  described in Schedule 3.15 as being owned or used
by or licensed to it or necessary for the conduct of its business  (collectively
with any other patents, patent applications,  inventions, technology, copyrights
and trade secrets, the "Intellectual Property"). Except as set forth in Schedule
3.15 (i) there are no rights of third parties of any such Intellectual Property;
(ii) to the Company's knowledge there is no infringement by third parties of any
such  Intellectual  Property;  (iii)  there is no pending  or, to the  Company's
knowledge,  threatened action,  suit,  proceeding or claim by others challenging
the Company's rights in or to any such Intellectual property, and the Company is
unaware of any facts  which  would form a  reasonable  basis for any such claim;
(iv) there is no pending  or, to the  Company's  knowledge,  threatened  action,
suit,  proceeding  or claim by others  challenging  the validity or scope of any
such Intellectual  Property, and the Company is unaware of any facts which would
form a reasonable  basis for any such claim;  (v) there is no pending or, to the
Company's knowledge, threatened action, suit, proceeding or claim by others that
the Company infringes or otherwise  violates any patent,  trademark,  copyright,
trade secret or other proprietary  rights of others,  and the Company is unaware
of any facts which would form a reasonable basis for any such claim; (vi) to the
Company's  knowledge  there is no patent or patent  application  which  contains
claims that dominate or may dominate any Intellectual  Property described in the
Schedule  3.15 as being owned by or licensed to the Company or that is necessary
for the  conduct of its  business or that  interferes  with the issue or pending
claims of any such  Intellectual  Property,  and (vii)  there is no prior art of
which the Company is aware that may render any patent held by or licensed to the
Company invalid or any patent application held by the Company unpatentable which
has not been disclosed to the U.S. Patent and Trademark Office.

     3.16 Key  Employees.  Each Key  Employee  (as defined  below) is  currently
serving the Company in the  capacity  disclosed in the Proxy  Statement.  No Key
Employee, to the best of the knowledge of the Company and its subsidiaries,  is,
or is now expected to be, in violation of any material term of any employment

<PAGE>

contract,  confidentiality,  disclosure or  proprietary  information  agreement,
non-competition agreement, or any other contract or agreement or any restrictive
covenant, and the continued employment of each Key Employee does not subject the
Company or any of its  subsidiaries  to any liability with respect to any of the
foregoing  matters.  No Key  Employee  has, to the best of the  knowledge of the
Company and its subsidiaries, any intention to terminate his employment with, or
services  to, the  Company or any of its  subsidiaries,  and the  Company has no
intention to terminate  the  employment  or services of any Key  Employee.  "Key
Employee" means each of the Executive  Officers  listed in the Proxy  Statement.
Neither the Company nor any  subsidiary  is involved in any union labor  dispute
and none of  their  employees  is a  member  of a  union.  The  Company  and its
subsidiaries believe their employee relations are good.

     3.17 The  Company has in effect a  shareholders  rights  plan.  None of the
Purchaser's Preferred Shares, Warrants, Common Shares and Warrant Shares will be
deemed to trigger such plan.

     3.18 Dilution.  The number of Common Shares and Warrant Shares may increase
substantially in certain  circumstances,  including the circumstances  where the
trading price of the Company's Common Stock declines.  The Company  acknowledges
that its obligation to issue Common Shares and Warrant Shares upon conversion of
the  Preferred  Shares  (to the  extent of the "AMEX  Limit,"  as defined in the
Registration  Rights  Agreement  as it relates to the  Common  Share  Limit (the
"Common Share Limit"),  as defined in the  Certificate  of Designation  attached
hereto as Exhibit F and exercise of the Warrants is absolute and  unconditional,
regardless of the dilution that such issuance may have on other  shareholders of
the Company.

     3.19 Certain Transactions.  Except as disclosed in Schedule 3.19 and except
for arm's length transactions pursuant to which the Company or any of its direct
or indirect  subsidiaries makes payments in the ordinary course of business upon
terms no less  favorable  than the  Company  or any of its  direct  or  indirect
subsidiaries could obtain from third parties,  none of the officers,  directors,
or  employees of the company is  presently a party to any  transaction  with the
Company or any of its direct or indirect  subsidiaries  (other than for services
as employees,  officers and  directors),  including  any contract,  agreement or
other  arrangement  providing for the furnishing of services to or by, providing
for rental of real or  personal  property  to or from,  or  otherwise  requiring
payments to or from any officer,  director or such  employee or to the knowledge
of the Company, any corporation, partnership, trust or other entity in which any
officer,  director,  or any such  employee has a  substantial  interest or is an
officer, director, trustee or partner.

     3.20 Permits;  Compliance.  The Company and each of its direct and indirect
subsidiaries  is  in  possession  of  all  franchises,  grants,  authorizations,
licenses, permits, easements,  variances,  exemptions,  consents,  certificates,
approvals and orders  necessary to own,  lease and operate its properties and to
carry on its business as it is now being conducted  (collectively,  the "Company
Permits"),  and there is no action  pending or, to the knowledge of the Company,
threatened  regarding  suspension or  cancellation of any of the Company Permits
except  for such  Company  Permits  the  failure  of which  to  possess,  or the
cancellation  or  suspension  of  which,  would  not,  individually  or  in  the
aggregate,  have a Material  Adverse Effect.  Neither the Company nor any of its
direct or indirect  subsidiaries is in conflict with, or in default or violation
of, any of the  Company  Permits,  except for any such  conflicts,  defaults  or
violations  which,  individually  or in the  aggregate,  could not reasonably be
expected to have a Material Adverse Effect.  Since January 1, 1995,  neither the
Company  nor  any of its  direct  or  indirect  Subsidiaries  has  received  any
notification  with  respect to possible  conflicts,  defaults or  violations  of
applicable laws, except for notices relating to possible conflicts,  defaults or
violations,  which  conflicts,  defaults or violations would not have a Material
Adverse Effect.

     3.21   Insurance.   The  Company  and  each  of  its  direct  and  indirect
subsidiaries  are  insured by insurers of  recognized  financial  responsibility
against such losses and risks and in such amounts as  management  of the Company
believes to be prudent and customary in the  businesses in which the Company and
its direct and indirect subsidiaries are engaged. Neither the Company nor any

<PAGE>

such direct or indirect subsidiary has any reason to believe that it will not be
able to renew its existing  insurance coverage as and when such coverage expires
or to obtain  similar  coverage  from  similar  insurers as may be  necessary to
continue its business at a cost that would not have a Material Adverse Effect.

     3.22 Title. The Company and its subsidiaries have good and marketable title
in fee simple to all real property and good and marketable title to all personal
property  owned by them which is material to the business of the Company and its
subsidiaries, in each case free and clear of all liens, encumbrances and defects
except  such as are  described  in  Schedule  3.22 or such as do not  materially
affect the value of such  property  and do not  interfere  with the use made and
proposed to be made of such  property by the Company and its  subsidiaries.  Any
real  property  and  facilities   held  under  lease  by  the  Company  and  its
subsidiaries  are held by them under valid,  subsisting and  enforceable  leases
with such  exceptions as are not material and do not interfere with the use made
and proposed to be made of such  property  and  buildings by the Company and its
subsidiaries.

     3.23 Environmental.  The Company and its subsidiaries are (i) in compliance
with  any  and all  applicable  foreign,  federal,  state  and  local  laws  and
regulations  relating  to  the  protection  of  human  health  and  safety,  the
environment  or  hazardous  or  toxic   substances  or  wastes,   pollutants  or
contaminants ("Environmental Laws"), (ii) have received all permits, licenses or
other approvals required of them under applicable  Environmental Laws to conduct
their  respective  businesses  and  (iii) are in  compliance  with all terms and
conditions of any such permit, license or approval.

     3.24 Tax Status. Except as set forth on Schedule 3.24, the Company and each
of its subsidiaries has made or filed all federal and state income and all other
tax returns,  reports and declarations  required by any jurisdiction to which it
is subject  (unless  and only to the  extent  that the  Company  and each of its
subsidiaries has set aside on its books provisions  reasonably  adequate for the
payment  of all unpaid  and  unreported  taxes) and has paid all taxes and other
governmental  assessments  and charges  that are  material  in amount,  shown or
determined to be due on such  returns,  reports and  declarations,  except those
being  contested  in good  faith  and  has  set  aside  on its  books  provision
reasonably  adequate for the payment of all taxes for periods  subsequent to the
periods  to which such  returns,  reports or  declarations  apply.  There are no
unpaid taxes in any material amount claimed to be due by the taxing authority of
any jurisdiction,  and the officers of the Company know of no basis for any such
claim.

     3.25 Investment  Company Act. The Company is not, and as result of the sale
of the  Securities  to the  Purchasers  and  application  of  the  net  proceeds
therefrom as described in Section 4.9, will not become, an "investment  company"
or any entity  controlled by an "investment  company," as such terms are defined
in the Investment Company Act of 1940, as amended.



                                   ARTICLE IV
                                    COVENANTS

     4.1 Best  Efforts.  The  parties  shall use their  best  efforts  to timely
satisfy  each  of the  conditions  described  in  Articles  VI and  VII of  this
Agreement.

     4.2  Securities  Laws.  The  Company  agrees to  timely  file a Form D with
respect to the  Securities  with the SEC as required  under  Regulation D and to
provide a copy thereof to each Purchaser promptly after such filing. The Company
agrees to file a press release disclosing the transactions  contemplated  hereby
with the SEC within one (1))  business day  following the date of Closing and to
file an 8-K disclosing this Agreement and the transactions  contemplated  hereby
with the SEC within five (5) business days following the date of Closing. The

<PAGE>

Company  shall,  on or prior to the date of  Closing,  take  such  action  as is
necessary to qualify the Securities for sale to the Purchaser in compliance with
applicable  securities  laws  of the  states  of the  United  States  or  obtain
exemption  therefrom,  and shall provide evidence of any such action so taken to
the Purchaser on or prior to the date of the Closing.

     4.3 Reporting  Status.  So long as the Purchaser or a Purchaser  Transferee
beneficially  owns any of the Securities,  (a) the Company shall timely file all
reports  required to be filed with the SEC pursuant to the Exchange Act, and the
Company  shall not  terminate  its status as an issuer  required to file reports
under the Exchange  Act even if the  Exchange  Act or the rules and  regulations
thereunder would permit such termination,  and (b) the Company will maintain its
ability and eligibility to register its Common Shares on Form S-3.

     4.4  Information.  The Company agrees to send the following  reports to the
Purchaser  and  Purchaser's  Transferee  until  the  Purchaser  and  Purchaser's
Transferee transfers,  assigns or sells all of its Securities in transactions in
which the transferee is (unless such  transferee is an affiliate) not subject to
securities law resale restrictions: (a) within three (3) business days after the
filing with the SEC, a copy of its Annual  Report on Form 10-KSB,  its Quarterly
Reports on Form 10-QSB,  any proxy  statements  and any Current  Reports on Form
8-K;  and (b) within one (1)  business  day after  release,  copies of all press
releases issued by the Company or any of its  subsidiaries.  The Company further
agrees to promptly  provide to the  Purchaser  and  Purchaser's  Transferee  any
information  with respect to the  Company,  its  properties,  or its business or
Purchaser's   investment  as  the  Purchaser  and  Purchaser's   Transferee  may
reasonably request; provided, however, that the Company shall not be required to
give the  Purchaser  any  material  nonpublic  information.  If any  information
requested  by  the  Purchaser  from  the  Company  contains  material  nonpublic
information,  the  Company  shall  inform  the  Purchaser  in  writing  that the
information  requested contains material  nonpublic  information and shall in no
event provide such information to Purchaser  without the express written consent
of the Purchaser after being so informed.

     4.5  Listing.  The Company  shall  continue the  uninterrupted  listing and
trading of its  Common  Stock and the Common  Shares and  Warrant  Shares on the
AMEX, the Nasdaq  National  Market,  the Nasdaq Small Cap Market or the New York
Stock  Exchange;  and  comply  in  all  material  respects  with  the  Company's
reporting,  filing and other  obligations  under the  By-laws  and rules of such
Exchange or Nasdaq,  as  applicable  (including  without  limitation,  filing an
Additional  Listing  Application with AMEX for the Common Shares and the Warrant
Shares not later than ten (10) days after the date of Closing).  During a period
of two years from the date of  Closing,  if and so long as the Common  Stock and
the Common Shares and Warrant  Shares are not listed on one of such Exchanges or
Nasdaq,  as partial  compensation for the added liquidity risk of such delisting
the Company  shall be obligated to make the following  additional  cash payments
(the "Delisting Payments").  The Delisting Payments will be equal to two percent
(2%) of the Purchase Price (plus accrued but unpaid interest) of any outstanding
Preferred Shares for each month (or part thereof)  following the date the Common
Stock is delisted (the "Delisting Date") continuing  through the date the Common
Stock is listed on one of such  Exchanges  or Nasdaq  (the "New  Listing").  The
Delisting  Payments will be paid to the holder of the  Preferred  Shares in cash
within five (5) business days following the earlier of (i) the end of each month
following  the Delisting  Date,  or (ii) the effective  date of the New Listing.
Nothing  herein shall limit the Preferred  Share holder's right to pursue actual
damages for the  Company's  failure to maintain its listing on such  Exchange or
Nasdaq.

     4.6 Prospectus  Delivery  Requirement.  The Purchaser  understands that the
Securities  Act may  require  delivery  of a  prospectus  relating to the Common
Shares in connection with any sale thereof pursuant to a registration  statement
under the  Securities  Act  covering  the resale by the  Purchaser of the Common
Shares being sold, and the Purchaser shall comply with the applicable prospectus
delivery requirements of the Securities Act in connection with any such sale.

     4.7 Corporate Existence. So long as any Preferred Shares or Warrants remain
outstanding,  the Company shall not directly or indirectly  (i)  consummate  any
merger, reorganization, restructuring, consolidation or similar transaction by

<PAGE>

or involving the Company except a merger or  consolidation  where the Company is
the survivor, (ii) consummate any sale of all or substantially all of the assets
of the Company or of all of its material subsidiaries or any similar transaction
or  related  transactions  which  effectively  results  in  a  sale  of  all  or
substantially all of the assets of the Company and/or its subsidiaries, or (iii)
fail to continue to own, directly or indirectly, all of the capital stock of all
of its material subsidiaries (other than due to a merger or consolidation of any
subsidiary  into the Company or a wholly-owned  subsidiary of the Company,  or a
public or private Offering of Viral Technologies, Inc. ("VTI") where the Company
owns at least 50% of the voting control and 50% of the economic  interest in VTI
following such offering).

     4.8 Cash  Maintenance  Requirement.  As of November 13, 1997, the Company's
balance sheet  reflects cash and cash  equivalents  equal to  approximately  Six
Million Seven Hundred Thousand U.S. Dollars ($6,700,000).  From the Closing Date
through  September  30, 1998,  the Company  agrees to maintain not less than Six
Million Dollars  ($6,000,000)  in cash or cash  equivalents (as reflected in the
Company's quarterly financial statements). The Company does not presently intend
to  declare  or  distribute  dividends  on  any  of its  outstanding  shares  or
distribute any of its assets to stockholders, or to incur any liabilities not in
the ordinary course of its business.

     4.9 Use of Proceeds. The Company will use the proceeds from the sale of the
Preferred Shares for working capital and general corporate matters.

     4.10 Reservation of Shares.  The company shall take all action necessary to
at all times have authorized,  and reserved for the purpose of issuance, no less
than  3,343,782  or such  greater  number of shares  of Common  Stock  needed to
provide for the issuance of the Common Shares and the Warrants Shares.

     4.11  Additional  Financing;   Right  of  First  Refusal.  Subject  to  the
exceptions  described below, the Company agrees that during the period beginning
on the date hereof and ending one year  following the Closing Date (the "Lock-Up
Period"),  the Company and its subsidiaries shall not negotiate or contract with
any party for any equity financing  (including any debt financing with an equity
component) or issue any equity  securities  of the Company or any  subsidiary or
securities  convertible  or  exchangeable  into or for equity  securities of the
Company or any subsidiary  (including debt securities with an equity  component)
in any form ("Future  Offerings")  unless it shall have first  delivered to each
Purchaser or a designee  appointed by such Purchaser written notice (the "Future
Offering Notice")  describing the proposed Future Offering,  including the terms
and conditions thereof, and providing each Purchaser an option to purchase up to
its Aggregate  Percentage (as defined below),  as of the date of delivery of the
Future Offering Notice,  in the Future Offering (the limitations  referred to in
this and the  preceding  sentence are  collectively  referred to as the "Capital
Raising Limitation").  For purposes of this Section 4.11, "Aggregate Percentage"
at any time with respect to any Purchaser shall mean the percentage  obtained by
dividing (i) the aggregate  number of Common Shares issued or issuable,  as if a
conversion  occurred  on such date,  upon  conversion  of the  Preferred  Shares
initially owned by such Purchaser by (ii) the aggregate  number of Common Shares
issued or issuable, as if a conversion occurred on such date, upon conversion of
the Preferred Shares initially owned by all Purchasers. A Purchaser can exercise
its option to  participate  in a Future  Offering by delivering  written  notice
thereof to  participate to the Company within three (3) business days of receipt
of a Future Offering Notice, which notice shall state the quantity of securities
being offered in the Future  Offering that such Purchaser  will purchase,  up to
its  Aggregate  Percentage,  and that  number of  securities  it is  willing  to
purchase in excess of its Aggregate Percentage. In the event the Purchasers fail
to elect to fully participate in the Future Offering within the periods

<PAGE>

described  in this  Section  4.11,  the  Company  shall  have  sixty  (60)  days
thereafter to sell the securities of the Future Offering  respecting  which such
Purchaser's  rights  were not  exercised,  upon  terms and  conditions,  no more
favorable  to the  purchasers  thereof  than  specified  in the Future  Offering
Notice.  In the event the  Company  has not sold such  securities  of the Future
Offering  within such sixty (60) day period,  the Company  shall not  thereafter
issue or sell such  securities  without first  offering  such  securities to the
Purchasers  in the manner  provided in this Section  4.11.  The Capital  Raising
Limitations  shall  not  apply to (i) a loan from a  commercial  bank,  (ii) any
transaction  involving the Company's  issuances of securities in connection with
(A) a merger, consolidation or purchase of assets, (B) any strategic partnership
or joint venture (the primary purpose of which is not to raise equity  capital),
or (C) the  acquisition  of a business,  product,  technology  or license by the
Company,  (iii) the issuance of Common Stock in a firm commitment,  underwritten
public offering,  (iv) the issuance of securities upon exercise or conversion of
the company's options,  warrants or other convertible  securities outstanding as
of the date hereof, or (v) the grant of additional  options or warrants,  or the
issuance of additional securities,  under any Company stock option or restricted
stock plan for the benefit of the Company's employees, directors or consultants.

     4.12  Restriction on Certain  Issuances of Securities.  (a) For a period of
one year  following  the Closing  Date,  the Company shall not issue or agree to
issue,  (except (i) to Purchasers  pursuant to this Agreement,  (ii) pursuant to
any  employee  stock  option,  stock  purchase or  restricted  stock plan of the
Company in effect on the date hereof,  (iii) pursuant to any existing  security,
option,  warrant,  scrip,  call or  commitment or right or; (iv) pursuant to any
grant or exercise of any warrants or options granted or awarded to any person as
compensation for services provided to the Company, in the reasonable  discretion
of the  Board of  Directors;  (v)  pursuant  to a  strategic  joint  venture  or
partnership entered into by the Company, undertaken at the reasonable discretion
of the Board of Directors of the Company, the primary purpose of which is not to
raise equity capital,  or (vi) the Additional  Financing  referred to in Section
4.11), any equity securities of the Company (or any security convertible into or
exercisable or exchangeable,  directly or indirectly,  for equity  securities of
the  Company)  if such  securities  are  issued  at a price  (or in the  case of
securities  convertible  into  or  exercisable  or  exchangeable,   directly  or
indirectly, for Common Stock such securities provide for a conversion,  exercise
or exchange  price) which is less than the  Applicable  Price (as defined in the
Certificate of Designation attached hereto as Exhibit F) for Common Stock on the
date of issuance of such security.

     4.13 Transaction  with Affiliates.  So long as Purchasers own any Preferred
Shares,  the Company shall not, and shall cause each of its subsidiaries not to,
enter into, amend, modify or supplement, or permit any subsidiary to enter into,
amend,  modify  or  supplement,  any  agreement,   transaction,   commitment  or
arrangement with any of its or any subsidiary's officers,  directors, person who
were  officers  or  directors  at  any  time  during  the  previous  two  years,
stockholders  who beneficially own 5% or more of the Common Stock, or affiliates
or with any  individual  related  by blood,  marriage  or  adoption  to any such
individual or with any entity in which any such entity or  individual  owns a 5%
or more beneficial  interest (each a "Related Party"),  except for (a) customary
employment  arrangements  and benefit  programs  on  reasonable  terms,  (b) any
agreement,  transaction,  commitment or  arrangement  on terms no less favorable
than  terms  which  would  have been  obtainable  from a person  other than such
Related  Party,  or (c) any  agreement,  transaction,  commitment or arrangement
which is approved by a majority of the  disinterested  directors of the Company.
For purposes  hereof,  any director who is also an officer of the Company or any
subsidiary of the Company shall not be a disinterested  director with respect to
any such  agreement,  transaction  commitment or  arrangement.  "Affiliate"  for
purposes hereof means,  with respect to any person or entity,  another person or
entity that,  directly or  indirectly,  (i) has a 5% or more equity  interest in
that person or entity,  (ii) has 5% or more common ownership with that person or
entity, (iii) controls that person or entity, or (iv) shares common control with
that person or entity.  "Control" or "controls" for purposes hereof means that a
person or entity has the  power,  direct or  indirect,  to conduct or govern the
policies of another person or entity.

     4.14  Indemnification.  In consideration of each Purchaser's  execution and
delivery  of this  Agreement  and  acquiring  the  Securities  hereunder  and in
addition to all of the Company's other  obligations  under this  Agreement,  the
Company shall defend,  protect,  indemnify and hold harmless each  Purchaser and
all of their  officers,  directors,  employees  and agents  (including,  without
limitation,  those retained in connection with the transactions  contemplated by
this Agreement)  (collectively,  the "Indemnitees") from and against any and all
actions,  causes of action,  suits,  claims,  losses,  costs,  penalties,  fees,
liabilities and damages, and expenses in connection therewith (irrespective of

<PAGE>

whether any such  Indemnitee is a party to the action for which  indemnification
hereunder is sought), and including reasonable attorneys' fees and disbursements
(the  "Indemnified  Liabilities"),  incurred by an Indemnitee as a result of, or
arising  out of,  or  relating  to (a) any  misrepresentation  or  breach of any
representation  or  warranty  made  by  the  Company  in  this  Agreement,   the
Certificate of Designation, the Warrants or the Registration Rights Agreement or
any other certificate, instrument or document contemplated hereby or thereby, or
(b) any breach of any covenant, agreement or obligation of the Company contained
in  this  Agreement,  the  Certificate  of  Designations,  the  Warrants  or the
Registration  Rights Agreement or any other certificate,  instrument or document
contemplated hereby or thereby or (c) any cause of action, suit or claim brought
or made  against  such  Indemnitee  and  arising  out of or  resulting  from the
execution,  delivery,  performance or enforcement of this Agreement or any other
instrument,  document  or  agreement  executed  pursuant  hereto  by  any of the
Indemnitees,  or the status of such  Purchaser or holder of the Securities as an
investor  in the  Company,  except for any such  Indemnified  Liabilities  which
directly  and  primarily  results  from the  particular  Indemnitee's  (i) gross
negligence or willful  misconduct,  and (ii) breach or default by the particular
Indemnitee of an agreement or contract  between the particular  Indemnitee and a
third party not related to, or arising out of, this  transaction.  To the extent
that the  foregoing  undertaking  by the  Company may be  unenforceable  for any
reason,  the  Company  shall make the  maximum  contribution  to the payment and
satisfaction of each of the Indemnified  Liabilities  which is permissible under
applicable law.

     4.15  Notification.  The Company  agrees to notify each holder within three
(3) business days of the Company becoming aware of the relevant facts,  that any
holder has (a) converted all of its Preferred Shares,  (b) requested  redemption
of its Preferred  Shares or (c) been issued a number of shares,  upon conversion
of Preferred Shares, which equals or exceeds such holder's portion of the Common
Share Limit.

                                    ARTICLE V
           LEGEND REMOVAL, TRANSFER, CERTAIN SALES, ADDITIONAL SHARES

     5.1 Removal of Legend.  The Legend  shall be removed and the Company  shall
issue,  or shall cause to be issued,  a  certificate  without such Legend to the
holder  of any  Security  upon  which it is  stamped,  and a  certificate  for a
security  shall be originally  issued  without the Legend,  if (a) the resale of
such Security is registered  under the Securities  Act, (b) such holder provides
the Company with an opinion of counsel,  in form,  substance and scope customary
for opinions of counsel in comparable  transactions and reasonably  satisfactory
to the Company and its counsel (the  reasonable  cost of which shall be borne by
the Company if neither an effective  registration statement under the Securities
Act or Rule 144 is available in connection  with such sale) to the effect that a
public sale or transfer of such Security may be made without  registration under
the Securities Act pursuant to an exemption from such registration  requirements
or (c) such Security can be sold  pursuant to Rule 144, the Holder  provides the
Company  with  reasonable  assurances  that the  Security can be so sold without
restriction,  or (d) such  Security can be sold  pursuant to Rule  144(k).  Each
Purchaser agrees to sell all registered Securities,  including those represented
by a  certificate(s)  from  which the  Legend  has been  removed,  or which were
originally  issued  without the Legend,  pursuant to an  effective  registration
statement,  in  accordance  with the manner of  distribution  described  in such
registration  statement and to deliver a prospectus in connection with such sale
or in compliance  with an exemption from the  registration  requirements  of the
Securities  Act.  In the event the Legend is removed  from any  Security  or any
Security  is issued  without  the Legend and the  Security  is to be disposed of
other than pursuant to the registration  statement or pursuant to Rule 144, then
prior to,  and as a  condition  to,  such  disposition  such  Security  shall be
relegended  as  provided  herein  in  connection  with  any  disposition  if the
subsequent  transfer thereof would be restricted under the Securities Act. Also,
in the event the Legend is removed  from any  Security or any Security is issued
without the Legend and thereafter the effectiveness of a registration  statement
covering the resale of such Security is suspended or the Company determines that
a supplement  or amendment  thereto is required by applicable  securities  laws,
then upon  reasonable  advance notice to Purchaser  holding such  Security,  the
Company may require that the Legend be placed on any such  Security  that cannot
then be sold pursuant to an effective registration statement or Rule 144 or with
respect to which the  opinion  referred to in clause (b) next above has not been
rendered,  which Legend shall be removed when such Security may be sold pursuant
to an effective  registration  statement or Rule 144 or such holder provides the
opinion with respect thereto described in clause (b) next above.


<PAGE>

     5.2 Transfer  Agent  Instructions.  The Company shall instruct its transfer
agent to issue  certificates,  registered  in the name of the  Purchaser  or its
nominee,  for the Common Shares and the Warrant Shares in such amounts specified
from time to time by the Purchaser upon  conversion or exercise of the Preferred
Shares and the Warrants,  respectively.  Such certificates shall bear the Legend
only to the extent provided by Section 5.1 above. The Company  covenants that no
instruction other than such instructions referred to in this Article V, and stop
transfer  instructions  to give  effect to Section 2.6 hereof in the case of the
Common Shares and Warrant Shares prior to  registration of the Common Shares and
Warrant Shares under the  Securities  Act or "black-out"  periods as provided in
the Registrations Rights Agreement between the Company and the Purchaser,  dated
of such date  herewith,  will be given by the Company to its transfer  agent and
that the  Securities  shall  otherwise be freely  transferable  on the books and
records of the  Company.  Nothing in this  Section  shall  affect in any way the
Purchaser's  obligations and agreement set forth in Section 5.1 hereof to resell
the Securities pursuant to an effective  registration statement and to deliver a
prospectus  as  required  in  Section  5.1 in  connection  with  such sale or in
compliance  with an exemption from the  registration  requirements of applicable
securities  laws. If (a) the  Purchaser  provides the Company with an opinion of
counsel,  which  opinion  of  counsel  shall be in  form,  substance  and  scope
customary  for opinions of counsel in  comparable  transactions  and  reasonably
satisfactory  to the Company and its counsel (the reasonable cost of which shall
be borne by the Company if neither an effective registration statement under the
Securities  Act  (beginning  after a  registration  statement  is required to be
declared  effective  pursuant  to the  Registration  Rights  Agreement  and with
respect to the Common Shares only) nor Rule 144 is available in connection  with
such sale),  to the effect that the Securities to be sold or transferred  may be
sold or  transferred  pursuant  to an  exemption  from  registration  or (b) the
Purchaser  transfers  Securities to an affiliate which is an accredited investor
(within the meaning of Regulation D under the Securities Act) and which delivers
to the  Company  in  written  form  the  same  representations,  warranties  and
covenants made by Purchaser hereunder or pursuant to Rule 144, the Company shall
permit the transfer,  and, in the case of the Common Shares and Warrant  Shares,
promptly  instruct its transfer agent to issue one or more  certificates in such
name and in such  denomination as specified by the Purchaser which shall contain
a legend if required by Section 5.1.


                                   ARTICLE VI
                 CONDITIONS TO THE COMPANY'S OBLIGATION TO SELL

     6.1 The obligation of the Company hereunder to issue and sell the Preferred
Shares  and  Warrants  to  the  Purchaser  at  the  Closing  is  subject  to the
satisfaction,  as of  the  date  of  the  Closing,  of  each  of  the  following
conditions,  provided that these  conditions  are for the Company's sole benefit
and may be waived by the Company at any time in its sole discretion:

     (i) The Purchaser shall have executed the signature page to this Agreement,
the  Registration  Rights  Agreement and the Escrow  Agreement and delivered the
same to the Company and Shoreline.

     (ii) The  Purchaser  shall  have wired to the  account of the Escrow  Agent
pursuant to the Escrow Agreement the Purchase Price.

     (iii) The representations and warranties of the Purchaser shall be true and
correct in all material  respects as of the date when made and as of the Closing
as though made at that time  (except for  representations  and  warranties  that
speak as of a specific date, which  representations and warranties shall be true
and correct as of such date), and the Purchaser shall have performed,  satisfied
and  complied  in all  material  respects  with the  covenants,  agreements  and
conditions  required by this  Agreement to be  performed,  satisfied or complied
with by the Purchaser at or prior to the Closing.


<PAGE>

     (iv) No statute,  rule,  regulation,  executive  order,  decree,  ruling or
injunction  shall have been  enacted,  entered,  promulgated  or endorsed by any
court or governmental authority of competent jurisdiction or any self-regulatory
organization  having  authority  over  the  matters  contemplated  hereby  which
restricts or prohibits the consummation of any of the transactions  contemplated
by this Agreement.

                                   ARTICLE VII
              CONDITIONS TO THE PURCHASER'S OBLIGATION TO PURCHASE

     7.1 The  obligation  of the  Purchaser  hereunder to purchase the Preferred
Shares and  Warrants to be purchased by it on the date of the Closing is subject
to the  satisfaction  as of the date of the  Closing,  of each of the  following
conditions,  provided that these conditions are for the Purchaser's sole benefit
and  may be  waived  by  the  Purchaser  at any  time  in the  Purchaser's  sole
discretion:

     (i) The Company shall have executed the signature  page to this  Agreement,
the  Registration  Rights  Agreement and the Escrow  Agreement and delivered the
same to Purchaser and Shoreline.

     (ii) The  Company  shall have  delivered  to the Escrow  Agent duly  issued
Preferred  Shares  being so  purchased by  Purchaser  and  certificates  for the
Warrants  being  issued to the  Purchaser  at the  Closing  in such  number  and
denominations as are reasonably requested by Purchaser.

     (iii) The  Common  Stock  shall be listed  on the AMEX and  trading  in the
Common Stock shall not have been  suspended or limited by the AMEX or the SEC or
other regulatory  authority,  and no such proceeding seeking suspension shall be
pending.

     (iv) The  representations  and  warranties of the Company shall be true and
correct in all material  respects as of the date when made and as of the Closing
as though made at that time and the Company shall have performed,  satisfied and
complied in all material respects with the covenants,  agreements and conditions
required by this  Agreement to be  performed,  satisfied or complied with by the
Company at or prior to the Closing. Purchaser shall have received a certificate,
executed  by the Chief  Executive  Officer  or Chief  Financial  Officer  of the
Company, dated as of the Closing to the foregoing effect.

     (v) No  statute,  rule,  regulation,  executive  order,  decree,  ruling or
injunction  shall have been  enacted,  entered,  promulgated  or endorsed by any
court or governmental authority of competent jurisdiction or any self-regulatory
organization  having  authority  over  the  matters  contemplated  hereby  which
prohibits  the  consummation  of any of the  transactions  contemplated  by this
Agreement.

     (vi) Purchaser shall have received opinions of Hart & Trinen, LLP, dated as
of the Closing, in the form attached hereto as Exhibit G.

     (vii)The  Certificate  of  Designations,  shall  have been  filed  with the
Secretary of State of the Sate of Colorado, and a copy thereof certified by such
Secretary of State shall have been delivered to such Purchaser.

     (viii)As  of Closing  Date,  the  Company  shall have  reserved  out of its
authorized  and  unissued  Common  Stock,  solely for purpose of  effecting  the
conversion  of the Preferred  Shares and the exercise of the Warrants,  at least
3,343,782 shares of Common Stock.

     (ix) The Irrevocable Transfer Agent Instructions,  in the form of Exhibit H
attached hereto, shall have been delivered to and acknowledged in writing by the
Company's transfer agent.


<PAGE>

     (x)  The  Company  shall  have  delivered  a  certificate   evidencing  the
incorporation  and good standing of the Company and each subsidiary in the state
of such corporation's state of incorporation  issued by the Secretary of Sate of
the state of incorporation as of a date within ten (10) days of the Closing.

     (xi) The Company shall have delivered  certified  copies of its charter and
bylaws, each as in effect at the Closing.


                                  ARTICLE VIII
                          GOVERNING LAW; MISCELLANEOUS

     8.1 Governing Law:  Jurisdiction.  This Agreement  shall be governed by and
construed in accordance with the Colorado  Business  Corporation Act (in respect
of matters of corporation law) and the laws of the State of New York (in respect
of all other  matters)  applicable to contracts  made and to be performed in the
State of New York. The parties hereto irrevocably consent to the jurisdiction of
the United  States  federal  courts and state  courts  located in the Borough of
Manhattan in the State of New York in any suit or proceeding based on or arising
under this Agreement or the  transactions  contemplated  hereby and  irrevocably
agree that all claims in respect of such suit or proceeding may be determined in
such courts. The Company and each Purchaser irrevocably waives the defense of an
inconvenient  forum to the maintenance of such suit or proceeding in such forum.
The Company and each  Purchaser  further agrees that service of process upon the
Company or such  Purchaser,  as  applicable,  mailed by the first  class mail in
accordance with Section 8.6 shall be deemed in every respect  effective  service
of process upon the Company or such Purchaser in any suit or proceeding  arising
hereunder. Nothing herein shall affect any Purchaser's right to serve process in
any other  manner  permitted  by law.  The  parties  hereto  agree  that a final
non-appealable  judgment in any such suit or proceeding  shall be conclusive and
may be enforced in other  jurisdictions by suit on such judgment or in any other
lawful manner.  The parties hereto  irrevocably waive any right to trial by jury
under applicable law.

     The Company and each  Purchaser  hereby  waive any and all rights to a jury
trial of any claim or cause of action based upon  arising out of this  Agreement
or the other  related  agreements  and  documents  or any  dealings  among  them
relating  to the  subject  matter  hereof  and the  relationship  that is  being
established.  The scope of this  waiver is  intended  to  encompass  any and all
disputes that may be filed in any court and that relate to the subject matter of
this Agreement,  including  without  limitation,  contract claims,  tort claims,
breach of duty  claims,  and all other  common  law and  statutory  claims.  The
parties  acknowledge  that this waiver is a material  inducement to enter into a
business relationship,  that each has already relied on the waiver and that each
will  continue  to rely on the  waiver in their  related  future  dealings.  The
Company and each Purchaser  hereby  warrants and represents that it has reviewed
this waiver with its legal counsel, and that it knowingly and voluntarily waives
its jury trial rights following  consultation with legal counsel. This waiver is
irrevocable, meaning that it shall apply to any subsequent amendments, renewals,
supplements or modifications to this Agreement or to any other related documents
or  agreements.  In the event of  litigation,  this  Agreement may be filed as a
written consent to a trial by the court.

     8.2   Counterparts.   This  Agreement  may  be  executed  in  two  or  more
counterparts,  including, without limitation, by facsimile transmission,  all of
which  counterparts  shall be  considered  one and the same  agreement and shall
become effective when  counterparts have been signed by each party and delivered
to the other party.  In the event any  signature  page is delivered by facsimile
transmission,  the party  using  such means of  delivery  shall  promptly  cause
additional  original  executed  signature  pages to be  delivered  to the  other
parties.

     8.3  Headings.  The  headings  of this  Agreement  are for  convenience  of
reference  and shall not form part of, or affect  the  interpretation  of,  this
Agreement.


<PAGE>

     8.4  Severability.  If any provision of this Agreement  shall be invalid or
unenforceable in any jurisdiction, such invalidity or unenforceability shall not
affect the validity or  enforceability of the remainder of this Agreement or the
validity or enforceability of this Agreement in any other jurisdiction.

     8.5  Entire  Agreement:  Amendments.  This  Agreement  and the  instruments
referenced  herein contain the entire  understanding of the parties with respect
to the maters covered herein and therein and, except as  specifically  set forth
herein  or  therein,   neither  the   Company  nor  the   Purchaser   makes  any
representation,  warranty, covenant or undertaking with respect to such matters.
No provision of this  Agreement  may be waived  other than by an  instrument  in
writing signed by the party to be charged with  enforcement  and no provision of
this  Agreement may be amended other than by an instrument in writing  signed by
the Company and the Purchaser.

     8.6 Notice. Any notice herein required or permitted to be given shall be in
writing  and may be  personally  served or  delivered  by  nationally-recognized
overnight  courier or by  facsimile  machine  confirmed  telecopy,  and shall be
deemed delivered at the time and date of receipt (which shall include  telephone
line facsimile transmission). The addresses for such communications shall be:

                  If to the Company:
                  Cel-Sci Corporation
                  66 Canal Center Plaza
                  Suite 510
                  Alexandria, VA 22314
                  Telecopy: (703) 549-6269
                  Attention:  Mr. Geert R. Kersten
                  with a copy to:

                  Hart & Trinen, LLP
                  1624 Washington Street
                  Denver, CO 80203
                  Telecopy: (303) 839-5414
                  Attention: Mr. Bill Hart, Esq.

                  If to Nelson Partners:

                  Nelson Partners
                  c/o Leeds Management Services
                  129 Front Street, 5th Floor
                  Hamilton HM 12
                  Bermuda
                  Telecopy: (441) 292-2239
                  Attention:  Ms. Anne Dupuy

                  with a copy to:

                  Citadel Investment Group, LLC
                  225 West Washington Street
                  9th Floor
                  Chicago, IL  60606
                  Telecopy: (312) 368-1347
                  Attention:  Mr. Michael J. Hughes and Mr. Kenneth C. Griffin

                  and with a copy to:


<PAGE>

                  Katten, Muchin, & Zavis
                  525 West Monroe Street
                  Suite 1700
                  Chicago, IL  60661-3693
                  Telecopy:  (312) 902-1061
                  Attention:  Steven G. Martin, Esq.

                  If to Olympus Securities, Ltd.:

                  Olympus Securities, Ltd.
                   c/o Leeds Management Services
                  129 Front Street, 5th Floor
                  Hamilton HM 12
                  Bermuda
                  Telecopy: (441) 292-2239
                  Attention:  Ms. Anne Dupuy

                  with a copy to:

                  Citadel Investment Group, LLC
                  225 West Washington Street
                  9th Floor
                  Chicago, IL  60606
                  Telecopy: (312) 368-1347
                  Attention: Mr. Michael J. Hughes and Mr. Kenneth C. Griffin

                  and with a copy to:

                  Katten, Muchin, & Zavis
                  525 West Monroe Street
                  Suite 1700
                  Chicago, IL  60661-3693
                  Telecopy:  (312) 902-1061
                  Attention:  Steven G. Martin, Esq.

                  If to KA Investments LDC:

                  KA Investments LDC
                  c/o Tarmachan Capital
                  1712 Hopkins Crossroads
                  Minnetonka, MN  55305
                  Telecopy: (612) 542-4253
                  Attention:  Ms. Ivana Bozjack

                  with a copy to:

                  Robinson Silverman Pearce Aronsohn & Berman LLP
                  1150 Avenue Of The Americas
                  @ 51st Street
                  New York, NY 10104
                  Telecopy: (212) 541-1432
                  Attention: Mr. Eric Louis Cohen, Esq.


<PAGE>

                  If to the following Purchasers:

                  Leonardo, L.P.
                  c/o Angelo, Gordon & Co., L.P.
                  245 Park Avenue, 26th Floor
                  New York, NY  10167
                  Telecopy:  (212) 692-6395
                  Attention:  Mr. Gary Wolf

                  GAM Arbitrage Investments, Inc.
                  11 Athol Street
                  Douglas, Isle of Man
                  British Isles, British Virgin Islands
                  Attention:  Mr. Michael L. Gordon

                  AG Super Fund International Partners, L.P.
                  Abbott Building
                  PO Box 3186
                  Road Town, Tortola
                  British Virgin Islands
                  Attention:  Mr. Michael L. Gordon

                  Raphael, L.P.
                  c/o Raphael Capital Management Limited
                  Abott Building
                  PO Box 3186 Main Street
                  Road Town, Tortola
                  British Virgin Islands
                  Attention:  Mr. Michael L. Gordon

                  Ramius Fund, Ltd.:
                  c/o Bank of Bermuda Building
                  6 Front Street
                  PO Box HM 1020
                  Hamilton, Bermuda HMDX
                  Attention:  Michael L. Gordon

                  Baldwin Enterprises, Inc.
                  529 East South Temple
                  Salt Lake City, Utah 84102
                  Attention:  Michael L. Gordon

                  and a copy to:

                  Angelo, Gordon & Co., L.P.
                  245 Park Avenue, 26th Floor
                  New York, NY  10167
                  Telecopy:  (212) 867-6395
                  Attention:  Mr. Gary Wolf


<PAGE>

                  in each case with a copy to:

                     Shoreline Pacific Institutional Finance
                            3 Harbor Drive, Suite 211
                  Sausalito, CA  94965
                  Telecopy: (415) 332-7800
                  Attention:  General Counsel

     Each  party  shall  provide  notice  to the  other  party of any  change in
address.  Failure of any party to give notice to  Shoreline  Pacific as provided
herein  shall not  invalidate  notice  given to any  other  party,  which  would
otherwise be a valid notice.

     8.7 Successors and Assigns.  This Agreement shall be binding upon and inure
to the benefit of the  parties and their  successors  and  assigns.  Neither the
Company  nor  the  Purchaser  shall  assign  this  Agreement  or any  rights  or
obligations   hereunder   without  the  prior  written  consent  of  the  other.
Notwithstanding  the foregoing,  the Purchaser may, subject to and in compliance
with  Section  5.2  hereof,  assign all or part of its  rights  and  obligations
hereunder  to any of its  "affiliates,"  as  that  term  is  defined  under  the
Securities Act,  without the consent of the Company so long as such affiliate is
an accredited  investor (within the meaning of Regulation D under the Securities
Act) and agrees in writing to be bound by this  Agreement.  This provision shall
not limit the Purchaser's right to transfer the Securities pursuant to the terms
of this  Agreement  or to assign the  Purchaser's  rights  hereunder to any such
transferee pursuant to the terms of this Agreement.

     8.8 Third Party  Beneficiaries.  This Agreement is intended for the benefit
of the parties hereto and their respective  permitted successors and assigns and
is not for the benefit  of, nor may any  provision  hereof be  enforced  by, any
other person.

     8.9 Survival.  The  representations  and  warranties of the Company and the
Purchaser  and the  agreements  and covenants set forth herein shall survive the
closing hereunder  notwithstanding any due diligence  investigation conducted by
or on behalf of the Company or any Purchaser as the case may be.

     8.10  Public  Filings:  Publicity.  As soon as  practicable  following  the
Closing (and not later than one (1) business days thereafter), the Company shall
issue a press release with respect to the transactions  contemplated hereby. The
Company and Citadel Investment Group, LLC on behalf of the Purchasers shall have
the right to approve before  issuance any press  releases,  SEC or AMEX or other
exchange   filings,   or  any  other  public  statements  with  respect  to  the
transactions  contemplated  hereby  (which  approval  shall not be  unreasonably
withheld or delayed).

     8.11 Further  Assurances.  Each party shall do and perform,  or cause to be
done and  performed,  all such  further acts and things,  and shall  execute and
deliver all such other agreements,  certificates,  instruments and documents, as
the other  party may  reasonably  request  in order to carry out the  intent and
accomplish  the  purposes  of  this  Agreement  and  the   consummation  of  the
transactions contemplated hereby.

     8.12 Remedies. No provision of this Agreement providing for any remedy to a
Purchaser  shall limit any remedy  which would  otherwise  be  available to such
Purchaser at law or in equity.  Nothing in this Agreement shall limit any rights
a Purchaser may have under any applicable  federal or state securities laws with
respect to the investment  contemplated  hereby.  The Company and each Purchaser
acknowledges  that a breach by it of its respective  obligations  hereunder will
cause  irreparable harm to each Purchaser,  in the case of the Company,  and the
Company, in the case of a Purchaser. Accordingly, the Company and each Purchaser
acknowledges that the remedy at law for a material breach of its respective

<PAGE>

obligations  under this Agreement will be inadequate and agrees, in the event of
a breach or threatened breach by the Company or a Purchaser, as the case may be,
of the  provisions of this  Agreement,  that a Purchaser or the Company,  as the
case may be, shall be entitled,  in addition to all other available remedies, to
an injunction restraining any breach and requiring immediate compliance, without
the necessity of showing  economic  loss and without any bond or other  security
being required.


            [THE REMAINDER OF THIS PAGE HAS BEEN INTENTIONALLY LEFT BLANK]

<PAGE>




     IN WITNESS WHEREOF, the undersigned  Purchasers and the Company have caused
this Agreement to be duly executed as of the date first above written.



CEL-SCI CORPORATION



By:
      Geert R. Kersten
      Chief Executive Officer


PURCHASER:


NELSON PARTNERS



By:
      Name:  Anne Dupuy
      Title:  Officer
      Residency: Bermuda


      Aggregate Subscription Amount

      Preferred Shares Purchased:
      Warrants Purchased:


OLYMPUS SECURITIES, LTD.



By:
      Name:  Anne Dupuy
      Title:  Officer
      Residency: Bermuda

      Aggregate Subscription Amount

      Preferred Shares Purchased:
      Warrants Purchased:




<PAGE>


KA INVESTMENTS LDC.



By:
      Name:
      Title: Secretary
      Residency:  Cayman Island


      Aggregate Subscription Amount

      Preferred Shares Purchased:
      Warrants Purchased:


LEONARDO, L.P.

By:  Angelo, Gordon & Co., L.P.
        General Partner


By:
      Name: Michael L. Gordon
      Title:      Chief Operating Officer
      Residency:  Cayman Islands

      Aggregate Subscription Amount

      Preferred Shares Purchased:
      Warrants Purchased:

GAM ARBITRAGE INVESTMENTS, INC.

By:  Angelo, Gordon & Co., L.P.
        Investment Advisor


By:
      Name: Michael L. Gordon
      Title:      Chief Operating Officer
      Residency:  British Virgin Islands

      Aggregate Subscription Amount

      Preferred Shares Purchased:
      Warrants Purchased:




<PAGE>


AG SUPER FUND INTERNATIONAL PARTNERS, L.P.

By:  Angelo, Gordon & Co., L.P.
        General Partner


By:
      Name: Michael L. Gordon
      Title:      Chief Operating Officer
      Residency:  Cayman Islands

      Aggregate Subscription Amount

      Preferred Shares Purchased:
      Warrants Purchased:

RAPHAEL, L.P.



By:
      Name: Michael L. Gordon
      Title:      Chief Operating Officer
      Residency:  Cayman Islands


      Aggregate Subscription Amount

      Preferred Shares Purchased:
      Warrants Purchased:

RAMIUS FUND, LTD.

By:  AG Ramius Partners, L.L.C.
        Investment Advisor


By:
      Name: Michael L. Gordon
      Title:      Managing Officer
      Residency:  Bermuda

      Aggregate Subscription Amount

      Preferred Shares Purchased:
      Warrants Purchased:




<PAGE>


BALDWIN ENTERPRISES, INC.

By:  AG Ramius Partners, L.L.C.
        Investment Advisor


By:
      Name: Michael L. Gordon
      Title:      Managing Officer
      Residency:  Colorado


      Aggregate Subscription Amount

      Preferred Shares Purchased:
      Warrants Purchased:




                CERTIFICATE OF DESIGNATIONS, PREFERENCES
           AND RIGHTS OF SERIES D CONVERTIBLE PREFERRED STOCK
                         OF CEL-SCI CORPORATION

      Cel-Sci Corporation (the "Company"),  a corporation organized and existing
under the Colorado  Corporation  Code,  does hereby  certify  that,  pursuant to
authority  conferred  upon  the  Board  of  Directors  of  the  Company  by  the
Certificate  of  Incorporation,  as amended,  of the  Company,  and  pursuant to
Section  7-106-102 of the Colorado  Corporation  Code, the Board of Directors of
the Company at a meeting duly held, adopted resolutions (i) authorizing a series
of the  Company's  previously  authorized  preferred  stock,  par value $.01 per
share,  and (ii)  providing  for the  designations,  preferences  and  relative,
participating, optional or other rights, and the qualifications,  limitations or
restrictions  thereof,  of Ten  Thousand  (10,000)  shares of Series D Preferred
Stock of the Company, as follows:

      RESOLVED,  that the Company is authorized  to issue Ten Thousand  (10,000)
shares of Series D Preferred Stock (the "Preferred Shares"),  par value $.01 per
share,  which shall have the following  powers,  designations,  preferences  and
other special rights:

      1.  Dividends.  The  Preferred  Shares  shall pay a dividend  equal to two
percent (2%) per month,  payable on the first day of each month with appropriate
proration for partial months. Such dividend shall only be payable if, and during
such time as, (i) the Registration  Statement has not been declared effective by
the SEC prior to the date  that is 120 days  after the  Closing  Date;  (ii) the
Registration Statement does not cover the resale of all of the Conversion Shares
or the Company gives notice that Common Stock issued or issuable upon conversion
of the Preferred Shares cannot be sold under the Registration  Statement for any
period of thirty (30) consecutive days after the date the Registration Statement
has been declared  effective by the SEC; (iii) the Common Stock is not listed on
the Nasdaq  National  Market,  the Nasdaq  Small Cap Market,  The New York Stock
Exchange,  Inc. or The American Stock Exchange, Inc. for a period of twenty (20)
consecutive trading days.

      2. Holder's  Conversion of Preferred  Shares. A holder of Preferred Shares
shall have the right, at such holder's  option,  to convert the Preferred Shares
into shares of the Company's common stock, $.01 par value per share (the "Common
Stock"), on the following terms and conditions:


            (a)  Conversion  Right.  At any time or times after the Closing Date
until 3 years after Closing, any holder of Preferred Shares shall be entitled to
convert any whole number of Preferred  Shares into fully paid and  nonassessable
shares  (rounded to the nearest  whole share in  accordance  with  Section  2(i)
below) of Common Stock,  at the Conversion  Rate (as defined  below);  provided,
however,  that in no event  shall any holder be  entitled  to convert  Preferred
Shares in excess of that number of Preferred Shares which, upon giving effect to
such  conversion,  would cause the  aggregate  number of shares of Common  Stock
beneficially  owned by the  holder  and its  affiliates  to  exceed  4.9% of the
outstanding  shares of the Common Stock following such conversion and,  provided
further,  a holder may elect,  upon sixty one (61) days prior written  notice to
the Company,  not to be bound by such  provision.  For purposes of the foregoing
proviso,  the aggregate number of shares of Common Stock  beneficially  owned by
the holder and its affiliates shall include the number of shares of Common Stock
issuable  upon  conversion  of the  Preferred  Shares with  respect to which the
determination of such proviso is being made, but shall exclude the

<PAGE>

number of shares of Common Stock which would be issuable upon (i)  conversion of
the remaining,  nonconverted  Preferred Shares  beneficially owned by the holder
and its  affiliates  and (ii)  exercise  or  conversion  of the  unexercised  or
unconverted portion of any other securities of the Company  (including,  without
limitation,  any  warrants)  subject to a limitation  on  conversion or exercise
analogous to the limitation  contained herein  beneficially  owned by the holder
and its affiliates.  Except as set forth in the preceding sentence, for purposes
of this paragraph,  beneficial  ownership shall be calculated in accordance with
Section 13(d) of the Securities Exchange Act of 1934, as amended.  Any Preferred
Shares  outstanding  on 3 year  anniversary  of Closing will be  converted  into
shares of Common Stock at the applicable Conversion Price (as defined below).

            (b) Conversion  Price. The number of shares of Common Stock issuable
upon conversion of each of the Preferred Shares shall be determined according to
the following formula (the "Conversion Rate"):

                                    1000
                            Conversion Price

                  (i) At any time or times on and prior to the Anniversary Date,
the "Conversion Price" means the Fixed Conversion
Price.

                  (ii) At any time or times on and  following  the  trading  day
following the  Anniversary  Date or upon occurrence of a Triggering  Event,  the
"Conversion  Price"  means the lesser of (a) the  Market  Price or (b) the Fixed
Conversion Price.

For purposes of this Certificate of Designations, the following terms shall have
the following meanings:

                        (1)   "Anniversary  Date"  means the  earlier of
(A) 270 days after the Closing Date, or the first trading day  thereafter or (B)
the trading day  immediately  following a period of 5  consecutive  trading days
during  which the Closing Bid Price (as  defined  below) of the Common  Stock is
equal to or less than 50% of the Closing Price.

                        (2)   "Fixed  Conversion  Price"  means  120% of
the Closing Price, subject to adjustment as provided herein;

                        (3)   "Market  Price"  means the  average of the
weighted  average prices on AMEX (as currently  shown by the ticker symbol HIV.A
as reported by  Bloomberg  Financial  Markets  ("Bloomberg"))  of the  Company's
Common Stock for any two consecutive  trading days, chosen by the holder, in the
ten trading  day period  ending on the day prior to a holder's  submission  of a
Conversion  Notice less one half of the difference  between the average  Closing
Ask Price and average  Closing Bid Price of the  Company's  Common  Stock during
such two trading days;

                        (4)   "Average   Market   Price"   means,   with
respect to any  security  for any period,  that price which shall be computed as
the  arithmetic  average of the Closing  Bid Prices (as defined  below) for such
security for each trading day in such period;

                        (5)   "Closing  Bid  Price" or  "Closing  Asked
Price"  means,  for any  security as of any date,  the last closing bid price or
asked price,  respectively,  for such  security on the American  Stock  Exchange
("AMEX") as reported  by  Bloomberg,  as  currently  shown by the ticker  symbol
HIV.A,  or, if the AMEX is not the principal  trading  market for such security,
the last closing bid price or asked price, respectively, of such security on the
principal securities exchange or trading market where such security is listed or
traded as reported by  Bloomberg,  or if the  foregoing  do not apply,  the last
closing  bid  price  or  asked  price,  respectively,  of such  security  in the
over-the-counter

<PAGE>

market  on the  electronic  bulletin  board for such  security  as  reported  by
Bloomberg, or, if no closing bid price or asked price, respectively, is reported
for such security by Bloomberg, the last closing trade price of such security as
reported by  Bloomberg,  or, if no last closing trade price is reported for such
security  by  Bloomberg,  the  average  of  the  bid  prices  or  asked  prices,
respectively,  of any market  makers for such  security as reported in the "pink
sheets" by the National  Quotation Bureau,  Inc. If the Closing Bid Price or the
Closing Asked Price cannot be  calculated  for such security on such date on any
of the  foregoing  bases,  the  Closing Bid Price or the  Closing  Asked  Price,
respectively,  of such  security on such date shall be the fair market  value as
mutually  determined by the Company and the holders of Preferred  Shares. If the
Company  and the holders of  Preferred  Shares are unable to agree upon the fair
market value of the Common Stock,  then such dispute shall be resolved  pursuant
to Section  2(e)(iii)  below with the term "Closing Bid Price" or "Closing Asked
Price,"  respectively,  being  substituted  for the term "Average Market Price."
(All such  determinations  to be appropriately  adjusted for any stock dividend,
stock, split or other similar transaction during such period).

                        (6)   "Closing  Price"  means the average of the
Closing  Bid  Price of the  Common  Stock  for  five  consecutive  trading  days
immediately proceeding the Closing Date; and

                        (7) "Closing Date" means the initial date of
issuance of the Preferred Shares.

                  (c)  Adjustment  to  Conversion  Price --  Dilution  and Other
Events.  In  order  to  prevent  dilution  of  the  rights  granted  under  this
Certificate of Designations,  the Conversion Price will be subject to adjustment
from time to time as provided in this Section 2(c).

                  (i)  Adjustment  of Fixed  Conversion  Price upon  Issuance of
Common Stock.  If and whenever on or after the date of issuance of the Preferred
Shares,  the Company  issues or sells,  or is deemed to have issued or sold, any
shares of Common  Stock  (other than shares of Common  Stock deemed to have been
issued by the  Company in  connection  with an  Approved  Stock Plan (as defined
below)) for a consideration per share less than the lesser of the Average Market
Price of the Common Stock for the previous five (5) consecutive  trading days or
the twenty (20) consecutive trading days immediately  preceding the date of such
issuance or sale (the "Applicable Price"),  then immediately after such issue or
sale,  the Fixed  Conversion  Price  shall be reduced to an amount  equal to the
product of (x) the Fixed  Conversion Price in effect  immediately  prior to such
issue or sale and (y) the quotient determined by dividing (1) the sum of (I) the
product derived by multiplying  the Applicable  Price by the number of shares of
Common Stock Deemed  Outstanding  (as defined below)  immediately  prior to such
issue or sale, and (II) the consideration,  if any, received by the Company upon
such issue or sale, by (2) the product derived by multiplying (I) the Applicable
Price  by  (II)  the  number  of  shares  of  Common  Stock  Deemed  Outstanding
immediately  after such issue or sale. For purposes of determining  the adjusted
Fixed  Conversion  Price under this  Section  2(c)(i),  the  following  shall be
applicable:

                        (A)   Issuance of Rights or Options.      If
the  Company in any manner  grants or sells any Option and the lowest  price per
share for which any one share of Common  Stock is issuable  upon the exercise of
any such Option,  or upon  conversion  or exchange of any  Convertible  Security
issuable upon exercise of any such Option, is less than the Applicable Price (as
defined  above)  in  effect  on the day  immediately  prior  to the  time of the
granting or sale of such Option, then such share of Common Stock shall be deemed
to be outstanding and to have been issued and sold by the Company at the time of
the  granting or sale of such Option for such price per share.  For  purposes of
this  paragraph,  the "lowest  price per share for which any one share of Common
Stock is issuable" shall be equal to the sum of the lowest

<PAGE>

amount of  consideration  (if any)  received or  receivable  by the Company with
respect  to any one  share of  Common  Stock  upon the  granting  or sale of the
Option,  upon  exercise  of the Option and upon  conversion  or  exchange of any
Convertible   Security  issuable  upon  exercise  of  such  Option.  No  further
adjustment of the Fixed  Conversion Price shall be made upon the actual issue of
such Common Stock or such Convertible Security upon the exercise of such Options
or upon the actual  issue of such Common  Stock upon  conversion  or exchange of
such Convertible Security.

                        (B)   Issuance of Convertible Securities. If
the  Company  in any manner  issues or sells any  Convertible  Security  and the
lowest price per share for which any one share of Common Stock is issuable  upon
conversion or exchange thereof,  calculated on the date of such issue or sale of
such convertible  security, is less than the Applicable Price (as defined above)
in effect on the day immediately prior to the time of such issue or sale of such
convertible  security,  then such  share of Common  Stock  shall be deemed to be
outstanding  and to have been  issued and sold by the Company at the time of the
issuance or sale of such  Convertible  Securities for such price per share.  For
the purposes of this  paragraph,  the "lowest  price per share for which any one
share of  Common  Stock  is  issuable"  shall be equal to the sum of the  lowest
amounts of  consideration  (if any)  received or  receivable by the Company with
respect  to any one  share of  Common  Stock  upon the  issuance  or sale of the
Convertible  Security and upon the  conversion  or exchange of such  Convertible
Security. No further adjustment of the Fixed Conversion Price shall be made upon
the  actual  issue of such  Common  Stock upon  conversion  or  exchange  of any
Convertible Security, and if any such issue or sale of such Convertible Security
is made upon  exercise of any Options for which  adjustments  of the  Conversion
Price had been or are to be made  pursuant to other  provisions  of this Section
2(c)(i),  no further  adjustment of the Conversion Price shall be made by reason
of such issue or sale.

                        (C)   Change in Option Price or Conversion Rate.
If the purchase price provided for in any Option,  the additional  consideration
(if any)  payable  upon the issue,  conversion  or exchange  of any  Convertible
Security or the rate at which any  Convertible  Security is convertible  into or
exchangeable for Common Stock changes at any time, the Fixed Conversion Price in
effect at the time of such  change  shall be adjusted  immediately  to the Fixed
Conversion Price which would have been in effect at such time had such Option or
Convertible  Security  originally  provided  for such  changed  purchase  price,
additional  consideration  or  conversion  rate, as the case may be, at the time
initially  granted,  issued or sold.  If the terms of any Option or  Convertible
Security which was  outstanding as of the Closing Date are changed in the manner
described in the immediately preceding sentence, then such Option or Convertible
Security and the Common Stock  deemed  issuable  upon  exercise,  conversion  or
exchange  thereof  shall be deemed  to have  been  issued as of the date of such
change;  provided  that no  such  change  shall  at any  time  cause  the  Fixed
Conversion  Price hereunder to be increased,  except that, in the event any such
Options or Convertible  Securities  expire,  the Fixed Conversion Price shall be
readjusted to remove the effect of such Options or Convertible Securities.

                        (D)   Certain   Definitions.   For  purposes  of
determining the adjusted Fixed Conversion Price under this Section 2(c)(i),  the
following terms have meanings set forth below:

                              (I)         "Options"  means  any  rights,
warrants  or  options  to  subscribe  for or  purchase  Common  Stock or
Convertible Securities.

                              (II)  "Convertible  Securities"  means any
stock or securities (other than Options) directly or indirectly convertible into
or exchangeable for Common Stock.

                              (III) "Approved  Stock  Plan"  shall  mean
any  contract,  plan or  agreement  which  has  been  approved  by the  Board of
Directors  of the Company,  pursuant to which the  Company's  securities  may be
issued to any employee, officer, director, consultant or other service provider.


<PAGE>

                              (IV)  "Common  Stock  Deemed  Outstanding"
means,  at any given  time,  the  number of  shares  of  Common  Stock  actually
outstanding at such time, plus the number of shares of Common Stock deemed to be
outstanding pursuant to Section 2(c)(i) hereof regardless of whether the Options
or Convertible  Securities are actually  exercisable at such time, but excluding
any shares of Common Stock issuable upon conversion of the Preferred Shares.


                        (E)   Effect  on  Fixed  Conversion  Price  of
Certain   Events.   For  purposes  of  determining  the  adjusted  Fixed
Conversion  Price under this Section  2(c)(i),  the  following  shall be
applicable:

                              (I)         Calculation of  Consideration
Received.  If any Common Stock, Options or Convertible  Securities are issued or
sold or deemed to have been issued or sold for cash, the consideration  received
therefor  will be deemed  to be the  amount  received  by the  Company  therefor
calculated  on the date of  issuance  or sale  without  giving  effect  to sales
commission or offering expenses,  if any, upon the sale,  conversion or exercise
of such securities.  In case any Common Stock, Options or Convertible Securities
are  issued or sold for a  consideration  other  than  cash,  the  amount of the
consideration  other than cash received by the Company will be the fair value of
such consideration,  except where such consideration consists of securities,  in
which case the  amount of  consideration  received  by the  Company  will be the
Average Market Price of such securities for the twenty (20) consecutive  trading
days  immediately  preceding  the date of  receipt.  In case any  Common  Stock,
Options or Convertible  Securities are issued to the owners of the non-surviving
entity in  connection  with any  merger in which the  Company  is the  surviving
entity the amount of consideration  therefor will be deemed to be the fair value
of such portion of the net assets and business of the non-surviving entity as is
attributable  to such Common Stock,  Options or Convertible  Securities,  as the
case may be. The fair value of any  consideration  other than cash or securities
will be  determined  jointly by the Company and the holders of a majority of the
Preferred Shares then outstanding. If such parties are unable to reach agreement
within ten (10) days after the occurrence of an event  requiring  valuation (the
"Valuation  Event"),  the fair value of such  consideration  will be  determined
within  forty-eight  (48) hours of the tenth (10th) day  following the Valuation
Event by an  independent,  reputable  appraiser  selected  by the  Company.  The
determination  of such appraiser shall be deemed binding upon all parties absent
manifest error.

                              (II)  Integrated  Transactions.   In  case
any Option is issued in connection with the issue or sale of other securities of
the Company, together comprising one integrated transaction in which no specific
consideration is allocated to such Options by the parties thereto, consideration
given upon the grant of such Option will be deemed to be $.01.

                              (III) Treasury   Shares.   The  number  of
shares of Common  Stock  outstanding  at any given time does not include  shares
owned or held by or for the account of the Company,  and the  disposition of any
shares so owned or held will be considered an issue or sale of Common Stock.

                              (IV)  Record  Date.  If the Company  takes
a record of the holders of Common Stock for the purpose of entitling them (1) to
receive a dividend or other distribution  payable in Common Stock, Options or in
Convertible Securities or (2) to subscribe for or purchase Common Stock, Options
or Convertible Securities, then such

<PAGE>

record  date will be deemed to be the date of the issue or sale of the shares of
Common  Stock  deemed to have been issued or sold upon the  declaration  of such
dividend or the making of such other distribution or the date of the granting of
such right of subscription or purchase, as the case may be.

                  (ii) Adjustment of Fixed  Conversion Price upon Subdivision or
Combination of Common Stock. If the Company at any time subdivides (by any stock
split, stock dividend, recapitalization or otherwise) one or more classes of its
outstanding  shares of Common Stock into a greater  number of shares,  the Fixed
Conversion  Price  in  effect  immediately  prior  to such  subdivision  will be
proportionately  reduced.  If the Company at any time combines (by  combination,
reverse stock split or otherwise) one or more classes of its outstanding  shares
of Common Stock into a smaller number of shares,  the Fixed  Conversion Price in
effect immediately prior to such combination will be proportionately increased.

                  (iii)  Adjustment of Market Price upon Issuance of Convertible
Securities.  If the Company in any manner issues or sells Convertible Securities
that are  convertible  into more than 500,000 shares of Common Stock (subject to
adjustment   for   stock   splits,    stock    dividends,    consolidation    or
recapitalizations)  at a price which  varies with the market price of the Common
Stock (the  formulation for such variable price being herein referred to as, the
"Variable  Price")  and such  Variable  Price is not  calculated  using the same
formula used to calculate  the Market Price in effect  immediately  prior to the
time of such issue or sale, the Company shall provide written notice thereof via
facsimile  and  overnight  courier  to  each  holder  of  the  Preferred  Shares
("Variable Notice") on the date of issuance of such Convertible  Securities.  If
the holders of Preferred  Shares  representing at least  two-thirds (2/3) of the
Preferred  Shares then  outstanding  provide  written  notice via  facsimile and
overnight  courier (the "Variable Price Election  Notice") to the Company within
five (5) business days of receiving a Variable  Notice that such holders  desire
to replace the Market Price then in effect with the Variable Price  described in
such  Variable  Notice,  the Company shall prepare and deliver to each holder of
the Preferred Shares via facsimile and overnight  courier a copy of an amendment
to this  Certificate of  Designations  (the  "Variable  Price  Amendment")  that
substitutes  the  Variable  Price  for the  Market  Price  (together  with  such
modifications  to this  Certificate of  Designations  as may be required to give
full effect to the  substitution  of the  Variable  Price for the Market  Price)
within five (5) business days after receipt of the requisite  number of Variable
Price  Election  Notices set forth above.  The Company  shall file such Variable
Price Amendment with the Secretary of State of the State of Colorado within five
(5) business days after delivery of the Variable Price  Amendment to the holders
of the Preferred Shares;  provided that in the event that the Company receives a
notice prior to the filing of the Variable  Price  Amendment from any holder who
has delivered a Variable Price Election  Notice in connection with such Variable
Price  Amendment  that such  holder  objects to the form of the  Variable  Price
Amendment,  the Company shall not file such Variable Price  Amendment until such
time  as the  Variable  Price  Amendment  has  been  revised  to the  reasonable
satisfaction  of such  holder and  approved  in  writing  by the  holders of the
Preferred Shares  representing at least two-thirds (2/3) of the Preferred Shares
then  outstanding.  Except as  provided  in the  preceding  proviso,  a holder's
delivery of a Variable Price Election Notice shall serve as the consent required
to amend this Certificate of Designations pursuant to Section 12 below.

                  (iv) Reorganization,  Reclassification,  Consolidation, Merger
or Sale. Any recapitalization,  reorganization, reclassification, consolidation,
merger,  sale of all or  substantially  all of the  Company's  assets to another
Person (as defined below) or other  transaction  which is effected in such a way
that holders of Common Stock are  entitled to receive  (either  directly or upon
subsequent  liquidation)  stock,  securities  or assets  with  respect  to or in
exchange  for Common Stock is referred to herein as "Organic  Change."  Prior to
the consummation of any Organic Change, the Company

<PAGE>

will make  appropriate  provision  (in form and  substance  satisfactory  to the
holders of a majority of the Preferred  Shares then  outstanding) to insure that
each of the holders of the Preferred  Shares will  thereafter  have the right to
acquire and receive in lieu of or addition to (as the case may be) the shares of
Common  Stock  immediately   theretofore  acquirable  and  receivable  upon  the
conversion of such holder's Preferred Shares,  such shares of stock,  securities
or assets as may be issued or payable  with  respect to or in  exchange  for the
number  of  shares  of  Common  Stock  immediately  theretofore  acquirable  and
receivable  upon the  conversion  of such  holder's  Preferred  Shares  had such
Organic  Change  not  taken  place.  In any such  case,  the  Company  will make
appropriate  provision (in form and substance  satisfactory  to the holders of a
majority of the Preferred Shares then outstanding) with respect to such holders'
rights and  interests  to insure that the  provisions  of this  Section 2(c) and
Section  2(d)  below will  thereafter  be  applicable  to the  Preferred  Shares
(including,  in the case of any such consolidation,  merger or sale in which the
successor  entity or purchasing  entity is other than the Company,  an immediate
adjustment  of the Fixed  Conversion  Price to the value  for the  Common  Stock
reflected by the terms of such  consolidation,  merger or sale,  if the value so
reflected is less than the Fixed Conversion Price in effect immediately prior to
such  consolidation,  merger or sale).  The  Company  will not  effect  any such
consolidation,  merger or sale,  unless prior to the consummation  thereof,  the
successor  entity (if other than the Company)  resulting from  consolidation  or
merger or the entity purchasing such assets assumes,  by written  instrument (in
form and  substance  satisfactory  to the holders of a majority of the Preferred
Shares then outstanding),  the obligation to deliver to each holder of Preferred
Shares such shares of stock,  securities  or assets as, in  accordance  with the
foregoing  provisions,  such holder may be entitled to acquire.  "Person"  shall
mean an individual, a limited liability company, a partnership, a joint venture,
a corporation,  a trust, an unincorporated  organization and a government or any
department or agency thereof.

                  (v)  Certain   Events.   If  any  event  occurs  of  the  type
contemplated  by the provisions of this Section 2(c) but not expressly  provided
for by such provisions  (including,  without  limitation,  the granting of stock
appreciation rights, phantom stock rights or other rights with equity features),
then the Company's Board of Directors will make an appropriate adjustment in the
Conversion  Price so as to protect  the rights of the  holders of the  Preferred
Shares;  provided that no such adjustment will increase the Conversion  Price as
otherwise determined pursuant to this Section 2(c).

                  (vi) Notices.

                        (A)   Immediately  upon  any  adjustment  of the
Conversion Price, the Company will give written notice thereof to each holder of
Preferred  Shares,  setting  forth  in  reasonable  detail  and  certifying  the
calculation of such adjustment.

                        (B)   The Company  will give  written  notice to
each holder of  Preferred  Shares at least twenty (20) days prior to the date on
which the  Company  closes its books or takes a record  (I) with  respect to any
dividend or  distribution  upon the Common  Stock,  (II) with respect to any pro
rata  subscription  offer to  holders of Common  Stock or (III) for  determining
rights to vote with respect to any Organic  Change,  dissolution or liquidation;
provided  that in no event shall such notice be provided to such holder prior to
such information being made known to the public.

                        (C) The Company will also give written notice
to each holder of  Preferred  Shares at least twenty (20) days prior to the date
on which any Organic Change, dissolution or liquidation will take place.

                  (vii)  Notwithstanding  the  above,  the  provisions  of  this
Section 2(c) shall not apply to (i) shares of Common Stock issued in  connection
with any  underwritten  public  offering  (ii)  any  transaction  involving  the
Company's issuance of securities in

<PAGE>

connection with any  partnership or joint venture,  the primary purpose of which
is not to raise equity capital,  (iii) issuance of securities by a subsidiary of
the Company, and (iv) any issuance of securities by the Company as consideration
for the acquisition of technology or rights to technology.

            (d)  Purchase  Rights.   In  addition  to  any  adjustments  of  the
Conversion  Price  pursuant to Section  2(c)  above,  if at any time the Company
grants,  issues  or sells  any  Options,  Convertible  Securities  or  rights to
purchase  stock,  warrants,  securities or other property pro rata to the record
holders of any class of Common Stock (the "Purchase  Rights"),  then the holders
of Preferred  Shares will be entitled to acquire,  upon the terms  applicable to
such Purchase Rights, the aggregate Purchase Rights which such holder could have
acquired if such holder had held the number of shares of Common Stock acquirable
upon complete  conversion of the Preferred Shares immediately before the date on
which a record is taken for the grant, issuance or sale of such Purchase Rights,
or, if no such  record is taken,  the date as of which  the  record  holders  of
Common Stock are to be determined for the grant,  issue or sale of such Purchase
Rights.

            (e) Mechanics of Conversion.  Subject to the Company's  inability to
fully satisfy its  obligations  under a Conversion  Notice (as defined below) as
provided for in Section 4 below:

                  (i)  Holder's  Delivery  Requirements.  To  convert  Preferred
Shares into full shares of Common Stock on any date (the "Conversion Date"), the
holder  thereof  shall (A) deliver or transmit by  facsimile,  for receipt on or
prior to 11:59  p.m.,  Central  Time on such  date,  a copy of a fully  executed
notice of conversion in the form attached  hereto as Exhibit I (the  "Conversion
Notice"),  to the  Company  along with a printout  from  Bloomberg  L.P.  of the
weighted  average  prices over the  relevant  ten  trading  day period,  and (B)
surrender to a common carrier for delivery to the Company as soon as practicable
following such date, the original certificates representing the Preferred Shares
being converted (or an  indemnification  undertaking with respect to such shares
in the  case  of  their  loss,  theft  or  destruction)  (the  "Preferred  Stock
Certificates") and the originally executed Conversion Notice.

                  (ii)  Company's  Response.  Upon  receipt by the  Company of a
facsimile  copy of a Conversion  Notice,  the Company shall use its best efforts
to, by the end of the following business day send, via facsimile, a confirmation
of receipt of such Conversion Notice to such holder. Upon receipt by the Company
of the Preferred  Stock  Certificates  to be converted  pursuant to a Conversion
Notice,  together with the originally  executed  Conversion  Notice, the Company
shall,  on the third  business  day  following  the date of receipt of the faxed
Conversion  Notice (or the fourth  business day following the date of receipt of
the faxed  Conversion  Notice if  received  after  11:00 a.m.  local time of the
Company), provided that the Company receives the original documents listed above
prior to such  issue  date,  (I) issue and  surrender  to a common  carrier  for
overnight  delivery to the address as  specified  in the  Conversion  Notice,  a
certificate,  registered  in the name of the  holder  or its  designee,  for the
number of shares of Common Stock to which the holder shall be entitled,  or (II)
credit such aggregate number of shares of Common Stock to which the holder shall
be  entitled  to the  holder's  or  its  designee's  balance  account  with  The
Depository Trust Company.  If the number of Preferred Shares  represented by the
Preferred  Stock  Certificate(s)  submitted  for  conversion is greater than the
number of Preferred Shares being converted,  then the Company or Transfer Agent,
as the case may be,  shall,  as soon as  practicable  and in no event later than
three (3) business days after receipt of the Preferred Stock  Certificate(s) and
at its  own  expense,  issue  and  send  to the  holder  a new  Preferred  Stock
Certificate representing the number of Preferred Shares not converted.

                  (iii) Dispute  Resolution.  In the case of a dispute as to the
determination  of the Average Market Price or the arithmetic  calculation of the
Conversion  Rate,  the Company shall  promptly issue to the holder the number of
shares of Common Stock that is not disputed

<PAGE>

the holder the number of shares of Common  Stock that is not  disputed and shall
submit the disputed  determinations or arithmetic calculations to the holder via
facsimile  within one (1)  business day of receipt of such  holder's  Conversion
Notice,  provided  that the holder has provided  the Company with the  Bloomberg
printout required in Section 2(e)(i).  If such holder and the Company are unable
to agree  upon the  determination  of the  Average  Market  Price or  arithmetic
calculation of the Conversion  Rate within one (1) business day of such disputed
determination or arithmetic  calculation being submitted to the holder, then the
Company  shall within one (1) business day submit via facsimile (A) the disputed
determination  of  the  Average  Market  Price  to  an  independent,   reputable
investment  bank or (B) the disputed  arithmetic  calculation  of the Conversion
Rate to its  independent,  outside  accountant.  The Company  shall use its best
efforts to cause the investment bank or the  accountant,  as the case may be, to
perform the determinations or calculations and notify the Company and the holder
of the  results no later than four (4)  business  days from the time it receives
the  disputed   determinations  or  calculations.   Such  investment  bank's  or
accountant's determination or calculation,  as the case may be, shall be binding
upon all parties absent manifest error.

                  (iv) Record Holder.  The person or persons entitled to receive
the shares of Common Stock issuable upon a conversion of Preferred  Shares shall
be treated for all  purposes  as the record  holder or holders of such shares of
Common Stock on the Conversion Date, provided the Company receives the Preferred
Stock Certificates within two (2) business days of the Conversion Notice.

                  (v) Company's Failure to Timely Convert.  If the Company shall
fail to issue and  deliver  to a courier  for  delivery  to a holder on a timely
basis as described in this Section  2(e)(ii),  a  certificate  for the number of
shares of Common  Stock to which  such  holder is  entitled  upon such  holder's
conversion of Preferred Shares or a new Preferred Stock Certificate representing
the number of shares of Common  Stock to which such holder is entitled  pursuant
to Section  2(e)(ii) except as provided in Section  4(a)(y),  in addition to all
other  available  remedies which such holder may pursue  hereunder and under the
Securities Purchase Agreement between the Company and the initial holders of the
Preferred   Shares   (the   "Securities    Purchase    Agreement")    (including
indemnification pursuant to Section 8 thereof), the Company shall pay additional
damages to such holder on each date such conversion is not timely effected in an
amount  equal to 1.0% of the product of (A) the number of shares of Common Stock
not issued to the holder on a timely  basis and to which such holder is entitled
and,  in the  event the  Company  has  failed to  deliver  the  Preferred  Stock
Certificate  to the holder on a timely basis pursuant to Section  2(e)(ii),  the
number of shares of Common  Stock  issuable  upon  conversion  of the  Preferred
Shares represented by such Preferred Stock Certificate,  and (B) the Closing Bid
Price of the Common Stock on the last possible date which the Company could have
issued such Common Stock and the Preferred  Stock  Certificate,  as the case may
be, to such holder without violating this Section 2(e).

            (f)  Taxes.  The  Company  shall pay any and all taxes  which may be
imposed  upon it with  respect to the issuance and delivery of Common Stock upon
the conversion of the Preferred Shares.

      (3)   Redemption at Option of Holders.

                   (a) Redemption Option Upon Major Transaction.  In addition to
all other rights of the holders of Preferred  Shares contained  herein,  after a
Major Transaction (as defined below), each holder of Preferred Shares shall have
the right,  at such holder's  option,  to require the Company to redeem all or a
portion of such holder's  Preferred  Shares at a price per Preferred Share equal
to

<PAGE>

greater of (i) $1,250 and (ii) the  product of (A) the  Conversion  Rate at such
time and (B) the  Closing  Bid Price on the date of the public  announcement  of
such Major Transaction or the next date on which the exchange or market on which
the Common Stock is traded is open if such public announcement is made (X) after
12:00  p.m.,  Central  Time,  time on such  date or (Y) on a date on  which  the
exchange  or  market  on which the  Common  Stock is  traded  is closed  ("Major
Transaction Redemption Price").

            (b)  Redemption  Option Upon  Triggering  Event.  In addition to all
other  rights of the  holders of  Preferred  Shares  contained  herein,  after a
Triggering Event (as defined below),  each holder of Preferred Shares shall have
the right,  at such holder's  option,  to require the Company to redeem all or a
portion of such holder's  Preferred  Shares at a price per Preferred Share equal
to the greater of (i) $1,250 and (ii) the product of (A) the Conversion  Rate at
such time and (B) the Closing Bid Price  calculated  as of the date  immediately
preceding  such  Triggering  Event on which the  exchange or market on which the
Common  Stock is  traded  is open  ("Triggering  Event  Redemption  Price"  and,
collectively with "Major Transaction Redemption Price," the "Redemption Price").

            (c) "Major  Transaction".  A "Major  Transaction" shall be deemed to
have  occurred  at such  time as any of the  following  events  occur  with  the
recommendation and approval of the Company's Board of Directors:

                  (i) the consolidation,  merger, reorganization,  restructuring
or similar  transaction  of the Company with or into another  Person (other than
pursuant to a migratory  merger  effected solely for the purpose of changing the
jurisdiction of incorporation  of the Company or any such transaction  where the
Company is the survivor); or

                  (ii) the sale or transfer of  substantially  all of the assets
of the Company or all of its material subsidiaries or any similar transaction or
related transactions which effectively results in a sale of all or substantially
all of the assets of the Company and/or its subsidiaries (other than a public or
private  offering of Viral  Technologies,  Inc.  ("VTI") if the Company  owns at
least 50% of the voting  control and 50% of the  economic  interest in VTI after
such offering).

            (d) "Triggering Event". A "Triggering Event" shall be deemed to have
occurred at such time as any of the following events:

                  (i) the  Company's  notice to any holder of Preferred  Shares,
including by way of public  announcement,  at any time,  of its intention not to
comply with proper  requests for conversion of any Preferred  Shares into shares
of Common  Stock,  including due to any of the reasons set forth in Section 4(a)
below;

                  (ii) the Company, with the approval of its Board of Directors,
fails to continue to own,  directly or  indirectly,  all of the capital stock of
all of its material subsidiaries (other than due to a merger or consolidation of
any subsidiary  into the Company or a wholly-owned  subsidiary of the Company or
in the case of a public or private  offering  of VTI where the  Company  owns at
least  50% of the  voting  control  and  50% of  the  economic  interest  in VTI
following such Offering);

                  (iii) if for any  reason,  the  Company  fails to  perform  or
observe any, agreement or other provision  contained herein or in the Securities
Purchase Agreement or the Registration Rights Agreement, and such failure is not
cured within ten (10)  business  days after the Company has been notified of the
occurrence thereof, and such failure

<PAGE>

has had, or could  reasonably be expected to have, a material  adverse effect on
(A)  the  financial  condition,   operating  results,  business,  properties  or
operation  of the  Company  and its  subsidiaries  taken  as a whole  or (B) the
Preferred Shares; or

                  (iv)  any   representation   or  warranty   contained  in  the
Securities  Purchase Agreement or the Registration  Rights Agreement is false or
misleading  on or as of the date made and  which  either  reflects  or has had a
material  adverse  effect on (A) the  financial  condition,  operating  results,
business,  properties or operations of the Company and its subsidiaries taken as
a whole or (B) the Preferred Shares.

            (e)   Mechanics  of   Redemption  at  Option  of  Buyer  Upon  Major
Transaction.  No  sooner  than 15 days  nor  later  than  10 days  prior  to the
consummation of a Major Transaction, but not prior to the public announcement of
such Major  Transaction,  the Company shall deliver  written  notice thereof via
facsimile and overnight  courier ("Notice of Major  Transaction") to each holder
of Preferred Shares. At any time after receipt of a Notice of Major Transaction,
the  holders  of  at  least  two-thirds  (2/3)  of  the  Preferred  Shares  then
outstanding  may  require the  Company to redeem all of the  holder's  Preferred
Shares then  outstanding by delivering  written notice thereof via facsimile and
overnight  courier  ("Notice  of  Redemption  at  Option  of  Buyer  Upon  Major
Transaction") to the Company, which Notice of Redemption at Option of Buyer Upon
Major  Transaction  shall indicate (i) the number of Preferred  Shares that such
holders  are  voting  in favor of  redemption  and  (ii)  the  applicable  Major
Transaction Redemption Price, as calculated pursuant to Section 3(a) above.

            (f)  Mechanics  of  Redemption  at Option of Buyer  Upon  Triggering
Event.  Within  three (3)  business  days after the  occurrence  of a Triggering
Event,  the Company  shall  deliver  written  notice  thereof via  facsimile and
overnight  courier  ("Notice of  Triggering  Event") to each holder of Preferred
Shares.  At any time after receipt of a Notice of Triggering  Event, the holders
of at least  two-thirds  (2/3) of the  Preferred  Shares  then  outstanding  may
require the Company to redeem all of the Preferred Shares by delivering  written
notice  thereof via facsimile and  overnight  courier  ("Notice of Redemption at
Option  of Buyer  Upon  Triggering  Event")  to the  Company,  which  Notice  of
Redemption  at Option of Buyer Upon  Triggering  Event  shall  indicate  (i) the
number of Preferred  Shares that such holders are voting in favor of  redemption
and (ii)  the  applicable  Triggering  Event  Redemption  Price,  as  calculated
pursuant to Section 3(b) above.

            (g) Payment of Redemption  Price.  Upon the  Company's  receipt of a
Notice(s) of Redemption at Option of Buyer Upon Major Transaction or a Notice(s)
of Redemption at Option of Buyer Upon Triggering Event, as the case may be, from
the  holders  of  at  least  two-thirds  (2/3)  of  the  Preferred  Shares  then
outstanding,  the Company shall  immediately  notify each holder by facsimile of
the Company's receipt of such requisite notices necessary to affect a redemption
and each holder of Preferred Shares shall thereafter promptly send such holder's
Preferred  Stock  Certificates  to be redeemed  to the  Company or its  Transfer
Agent. The Company shall deliver the applicable  Redemption Price to such holder
within 30 days after the Company's  receipt of the requisite notices required to
affect a redemption; provided that a holder's Preferred Stock Certificates shall
have been so delivered to the Company or its Transfer  Agent;  provided  further
that if the Company is unable to redeem all of the Preferred Shares, the Company
shall  redeem an amount  from each  holder  of  Preferred  Shares  equal to such
holder's  pro-rata amount (based on the number of Preferred  Shares held by such
holder relative to the number of Preferred Shares  outstanding) of all Preferred
Shares being redeemed.

<PAGE>

If the Company  shall fail to redeem all of the Preferred  Shares  submitted for
redemption (other than pursuant to a dispute as to the arithmetic calculation of
the Redemption Price), in addition to any remedy such holder of Preferred Shares
may have under this  Certificate of  Designations  and the  Securities  Purchase
Agreement, the applicable Redemption Price payable in respect of such unredeemed
Preferred  Shares shall bear  interest at the rate of 1.75% per month  (prorated
for partial months) until paid in full or until voided as provided herein. Until
the Company pays such unpaid applicable Redemption Price in full to each holder,
holders of at least two-thirds  (2/3) of the Preferred Shares then  outstanding,
including shares of Preferred  Shares submitted for redemption  pursuant to this
Section 3 and for which the applicable Redemption Price has not been paid, shall
have  the  option  (the  "Void  Optional  Redemption  Option")  to,  in  lieu of
redemption,  require the  Company to  promptly  return to each holder all of the
Preferred  Shares that were  submitted for  redemption by such holder under this
Section 3 and for which the  applicable  Redemption  Price has not been paid, by
sending  written notice thereof to the Company via facsimile (the "Void Optional
Redemption Notice"). Upon the Company's receipt of such Void Optional Redemption
Notice(s) and prior to payment of the full applicable  Redemption  Price to each
holder, (i) the Notice(s) of Redemption at Option of Buyer Upon Triggering Event
or the Notice(s) of Redemption at Option of Buyer Upon Major Transaction, as the
case may be,  shall be null and void  with  respect  to those  Preferred  Shares
submitted for redemption and for which the applicable  Redemption  Price has not
been paid,  (ii) the  Company  shall  immediately  return any  Preferred  Shares
submitted to the Company by each holder for  redemption  under this Section 3(i)
and for which the applicable  Redemption  Price has not been paid, and (iii) the
Fixed  Conversion  Price of such returned  Preferred Shares shall be adjusted to
the lesser of (A) the Fixed  Conversion  Price as in effect on the date on which
the Void  Optional  Redemption  Notice(s is delivered to the Company and (B) the
lowest  Closing Bid Price  during the period  beginning on the date on which the
Notice(s)  of  Redemption  of  Option of Buyer  Upon  Major  Transaction  or the
Notice(s) of Redemption at Option of Buyer Upon  Triggering  event,  as the case
may be, is  delivered  to the  Company  and ending on the date on which the Void
Optional  Redemption  Notice(s) is delivered  to the Company;  provided  that no
adjustment  shall be made if such adjustment  would result in an increase of the
Fixed Conversion  Price then in effect.  Notwithstanding  the foregoing,  in the
event of a  dispute  as to the  determination  of the  Closing  Bid Price or the
arithmetic  calculation of the Redemption  Price, such dispute shall be resolved
pursuant to Section  2(c)(iii)  above with the term  "Closing  Bid Price"  being
substituted for the term "Average Market Price" and the term "Redemption  Price"
being substituted for the term "Conversion  Rate." Payments provided for in this
Section 3 shall have  priority to payments to other  stockholders  in connection
with a Major Transaction.

            (4)   Inability to Fully Convert.

                  (a) Holder's Option if Company Cannot Fully Convert.  If, upon
the Company's receipt of a Conversion  Notice,  the Company can not issue shares
of Common Stock registered for resale under the  Registration  Statement for any
reason, including,  without limitation,  because the Company (x) does not have a
sufficient  number of shares of Common Stock  authorized and  available,  (y) is
otherwise  prohibited by applicable  law or by the rules or  regulations  of any
stock  exchange,   interdealer   quotation   system  or  other   self-regulatory
organization  with  jurisdiction  over the Company or its Securities,  including
without  limitation the Common Share Limit, from issuing all of the Common Stock
which is to be issued to a holder of Preferred  Shares  pursuant to a Conversion
Notice or (z)  fails to have a  sufficient  number  of  shares  of Common  Stock
registered for resale under the Registration  Statement,  then the Company shall
issue as many shares of Common Stock as it is able to issue in  accordance  with
such  holder's  Conversion  Notice and pursuant to Section 2(e) above and,  with
respect to the unconverted Preferred Shares, the holder, solely at such holder's
option, can elect to:

                        (i)   require  the  Company to redeem  from such
holder  those  Preferred  Shares for which the Company is unable to issue Common
Stock  in  accordance   with  such  holder's   Conversion   Notice   ("Mandatory
Redemption") at a price per Preferred Share (the "Mandatory  Redemption  Price")
equal to the Redemption Price as of such Conversion Date;


<PAGE>

                        (ii)  if  the   Company's   inability  to  fully
convert  Preferred  Shares is pursuant  to Section  4(a)(z)  above,  require the
Company  to issue  restricted  shares of Common  Stock in  accordance  with such
holder's Conversion Notice and pursuant to Section 2(e) above;

                        (iii) void its  Conversion  Notice and retain or
have returned,  as the case may be, the nonconverted  Preferred Shares that were
to be converted pursuant to such holder's Conversion Notice.

                  (b) Mechanics of  Fulfilling  Holder's  Election.  The Company
shall  immediately  send via  facsimile  to a holder of Preferred  Shares,  upon
receipt of a facsimile copy of a Conversion Notice from such holder which cannot
be fully satisfied as described in Section 4(a) above, a notice of the Company's
inability to fully satisfy such holder's  Conversion  Notice (the  "Inability to
Fully Convert  Notice").  Such  Inability to Fully Convert Notice shall indicate
(i) the  reason  why the  Company  is  unable  to fully  satisfy  such  holder's
Conversion Notice, (ii) the number of Preferred Shares which cannot be converted
and (iii) the applicable  Mandatory  Redemption  Price.  Such holder must within
five (5)  business  days of receipt of such  Inability to Fully  Convert  Notice
deliver  written  notice via  facsimile  to the Company  ("Notice in Response to
Inability to Convert") of its election pursuant to Section 4(a) above.

                  (c) Payment of Redemption Price. If such holder shall elect to
have its shares redeemed  pursuant to Section  4(a)(i) above,  the Company shall
pay the  Mandatory  Redemption  Price in cash to such holder  within thirty (30)
days of the Company's receipt of the holder's Notice in Response to Inability to
Convert.  If the Company shall fail to pay the applicable  Mandatory  Redemption
Price to such holder on a timely  basis as described in this Section 4(c) (other
than pursuant to a dispute as to the determination of the arithmetic calculation
of the  Redemption  Price),  in addition to any remedy such holder of  Preferred
Shares  may have under  this  Certificate  of  Designations  and the  Securities
Purchase Agreement,  such unpaid amount shall bear interest at the rate of 1.75%
per month  (prorated  for  partial  months)  until paid in full.  Until the full
Mandatory  Redemption Price is paid in full to such holder, such holder may void
the Mandatory  Redemption with respect to those  Preferred  Shares for which the
full  Mandatory  Redemption  Price  has not been  paid  and  receive  back  such
Preferred Shares. Notwithstanding the foregoing, if the Company fails to pay the
applicable  Mandatory  Redemption Price within such thirty (30) days time period
due to a dispute as to the  determination  of the arithmetic  calculation of the
Redemption  Price,  such dispute shall be resolved pursuant to Section 2(e)(iii)
above  with  the  term  "Redemption   Price"  being  substituted  for  the  term
"Conversion Rate".

                  (d)  Pro-rata  Conversion  and  Redemption.  In the  event the
Company  receives a  Conversion  Notice  from more than one holder of  Preferred
Shares on the same day and the Company can convert and redeem some, but not all,
of the  Preferred  Shares  pursuant to this Section 4, the Company shall convert
and redeem  from each holder of  Preferred  Shares  electing  to have  Preferred
Shares  converted  and  redeemed at such time an amount  equal to such  holder's
pro-rata  amount  (based on the number of  Preferred  Shares held by such holder
relative to the number of Preferred Shares  outstanding) of all Preferred Shares
being converted and redeemed at such time.

            (5)  Reissuance  of  Certificates.  In the event of a conversion  or
redemption  pursuant to this Certificate of Designations of less than all of the
Preferred Shares represented by a particular  Preferred Stock  Certificate,  the
Company  shall  promptly  cause to be issued and delivered to the holder of such
Preferred  Shares a  preferred  stock  certificate  representing  the  remaining
Preferred Shares which have not been so converted or redeemed.


<PAGE>

            (6) Reservation of Shares.  The Company shall, so long as any of the
Preferred  Shares  are  outstanding,  reserve  and  keep  available  out  of its
authorized  and unissued  Common Stock,  solely for the purpose of effecting the
conversion  of the  Preferred  Shares,  such number of shares of Common Stock as
shall from time to time be  sufficient  to effect the  conversion  of all of the
Preferred Shares then outstanding;  provided that the number of shares of Common
Stock so reserved  shall at no time be less than 200% of the number of shares of
Common  Stock  for  which  the  Preferred  Shares  are at any time  convertible;
provided further that such shares of Common Stock so reserved shall be allocated
for issuance upon  conversion of Preferred  Shares pro rata among the holders of
Preferred  Shares  based on the number of  Preferred  Shares held by such holder
relative to the total number of then outstanding Preferred Shares.

            (7) Voting Rights.  Holders of Preferred Shares shall have no voting
rights,  except as  required  by law,  including  but not limited to the General
Corporation  Law of the State of  Colorado,  and as  expressly  provided in this
Certificate of Designations.

            (8)  Liquidation,  Dissolution,  Winding-Up.  In  the  event  of any
voluntary or involuntary liquidation,  dissolution or winding up of the Company,
the holders of the Preferred  Shares shall be entitled to receive in cash out of
the assets of the Company,  whether from capital or from earnings  available for
distribution  to its  stockholders  (the "Preferred  Funds"),  before any amount
shall be paid to the holders of any of the  capital  stock of the Company of any
class junior in rank to the Preferred Shares in respect of the preferences as to
the distributions and payments on the liquidation, dissolution and winding up of
the Company,  an amount per Preferred Share equal to the sum of $1,000 (such sum
being referred to as the "Liquidation  Value");  provided that, if the Preferred
Funds are  insufficient  to pay the full amount due to the holders of  Preferred
Shares and holders of shares of other  classes or series of  preferred  stock of
the Company that are of equal rank with the  Preferred  Shares as to payments of
Preferred Funds (the "Pari Passu Shares"),  then each holder of Preferred Shares
and Pari Passu Shares shall receive a percentage of the Preferred Funds equal to
the full  amount of  Preferred  Funds  payable to such  holder as a  liquidation
preference,  in accordance with their  respective  Certificate of  Designations,
Preferences  and Rights,  as a percentage of the full amount of Preferred  Funds
payable to all holders of Preferred  Shares and Pari Passu Shares.  The purchase
or redemption by the Company of stock of any class,  in any manner  permitted by
law,  shall  not,  for  the  purposes  hereof,  be  regarded  as a  liquidation,
dissolution or winding up of the Company. Neither the consolidation or merger of
the  Company  with or into any other  Person,  nor the sale or  transfer  by the
Company of less than  substantially  all of its assets,  shall, for the purposes
hereof, be deemed to be a liquidation, dissolution or winding up of the Company.
No holder of  Preferred  Shares  shall be entitled  to receive any amounts  with
respect thereto upon any  liquidation,  dissolution or winding up of the Company
other than the amounts provided for herein.

            (9)  Preferred  Rank.  All shares of Common Stock shall be of junior
rank to all Preferred  Shares in respect to the preferences as to  distributions
and payments upon the  liquidation,  dissolution  and winding up of the Company.
The rights of the shares of Common Stock shall be subject to the preferences and
relative  rights of the  Preferred  Shares.  Without the prior  express  written
consent of the holders of not less than two-thirds (2/3) of the then outstanding
Preferred Shares, the Company shall not hereafter  authorize or issue additional
or other capital  stock that is of senior or equal rank to the Preferred  Shares
in  respect  of the  preferences  as to  distributions  and  payments  upon  the
liquidation,  dissolution  and  winding  up of the  Company.  Without  the prior
express written consent of the holders of not less than two-thirds  (2/3) of the
then outstanding  Preferred Shares, the Company shall not hereafter authorize or
make any amendment to the Company's  Certificate of Incorporation or bylaws,  or
file any  resolution  of the board of directors of the Company with the Delaware
Secretary of State  containing any provisions,  which would adversely  affect or
otherwise impair the rights or relative priority of the holders of the Preferred
Shares  relative to the holders of the Common  Stock or the holders of any other
class of  capital  stock.  In the event of the  merger or  consolidation  of the
Company with or into another  corporation,  the Preferred  Shares shall maintain
their relative powers,  designations and preferences  provided for herein and no
merger shall result inconsistent therewith.

            (10)  Restriction  on Redemption  and Cash Dividends with respect to
Other Capital  Stock.  Until all of the Preferred  Shares have been converted or
redeemed as provided  herein,  the Company  shall not,  directly or  indirectly,
redeem, or declare or pay any cash dividend or distribution on, its Common Stock
without  the prior  express  written  consent  of the  holders  of not less than
two-thirds (2/3) of the then outstanding Preferred Shares.

            (11)  Limitation on Number of Conversion  Shares.  The Company shall
not be obligated  to issue,  in the  aggregate,  more than  2,243,782  shares of
Common Stock (such amount to be proportionately and equitably adjusted from time
to time in the event of stock splits,  stock  dividends,  combinations,  reverse
stock  splits,  reclassification,  capital  reorganizations  and similar  events
relating to the Common Stock) (the "Common Share Limit") upon  conversion of the
Preferred Shares, if issuance of a larger number of shares of Common Stock would
constitute a breach of the Company's  obligations under the rules or regulations
of The American Stock  Exchange or any other  principal  securities  exchange or
market upon which the Common Stock becomes traded.  The Common Share Limit shall
be allocated  among the holders of Preferred  Shares pro rata based on the total
number of Preferred Shares issued on the Closing Date. The remaining  portion of
the Common Share Limit  attributable to any holder of Preferred  Shares,  all of
whose Preferred Shares has been converted or redeemed,  shall be allocated among
the  remaining  holders  of  Preferred  Shares  pro rata  based on the number of
Preferred Shares then outstanding.

            (12) Vote to Change the Terms of Preferred  Shares.  The affirmative
vote at a meeting duly called for such purpose or the written  consent without a
meeting,  of  the  holders  of not  less  than  two-thirds  (2/3)  of  the  then
outstanding  Preferred  Shares,  shall  be  required  for  any  change  to  this
Certificate of Designations or the Company's  Certificate of Incorporation which
would  amend,  alter,  change  or  repeal  any  of  the  powers,   designations,
preferences and rights of the Preferred Shares.

            (13) Lost or Stolen  Certificates.  Upon  receipt by the  Company of
evidence  satisfactory  to  the  Company  of the  loss,  theft,  destruction  or
mutilation  of any  Preferred  Stock  Certificates  representing  the  Preferred
Shares,  and, in the case of loss, theft or destruction,  of any indemnification
undertaking  by the holder to the Company and, in the case of  mutilation,  upon
surrender and  cancellation of the Preferred Stock  Certificate(s),  the Company
shall execute and deliver new preferred stock  certificate(s)  of like tenor and
date;  provided,  however,  the  Company  shall  not be  obligated  to  re-issue
preferred  stock  certificates  if the  holder  contemporaneously  requests  the
Company to convert such Preferred Shares into Common Stock.

      IN  WITNESS   WHEREOF,   the  Company  has  caused  this   Certificate  of
Designations to be signed by Geert Kersten,  its Chief Executive Officer,  as of
the 22nd day of December 1997.

ISSUER

                              By:
                               Name: Geert Kersten
                              Its:  Chief Executive Officer

<PAGE>





                               EXHIBIT I

                                 ISSUER
                           CONVERSION NOTICE

Reference is made to the Certificate of Designations,  Preferences and Rights of
Cel-Sci Corporation (the "Certificate of Designations").  In accordance with and
pursuant to the Certificate of  Designations,  the undersigned  hereby elects to
convert the number of shares of Series D Preferred  Stock,  par value $1,000 per
share (the "Preferred Shares"),  of Cel-Sci Corporation,  a Colorado corporation
(the  "Company"),  indicated below into shares of Common Stock,  par value $0.01
per  share  (the  "Common  Stock"),  of the  Company,  by  tendering  the  stock
certificate(s)  representing the share(s) of Preferred Shares specified below as
of the date specified below.

Date of Conversion:

Number of Preferred Shares to be converted:

Stock certificate no(s). of Preferred Shares to be converted:

Please confirm the following information:

Conversion Price:

Number of shares of Common Stock to be issued:

Please issue the Common Stock and, if applicable,  any check drawn on an account
of the  Company  into  which the  Preferred  Shares are being  converted  in the
following name and to the following address:

Issue to:



Facsimile Number:

Authorization:
                  By:
                  Title:

Dated:

[ADD INFORMATION RE: DTC / DWAC PROCEDURES]




NEITHER THIS WARRANT NOR ANY SHARES OF COMMON STOCK  ISSUABLE  UPON THE EXERCISE
OF THIS  WARRANT  HAVE BEEN  REGISTERED  UNDER THE  SECURITIES  ACT OF 1933,  AS
AMENDED, AND THE RULES AND REGULATIONS  PROMULGATED  THEREUNDER (THE "SECURITIES
ACT").  THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT
MAY  NOT  BE  OFFERED,   SOLD,  OR  OTHERWISE  TRANSFERRED  IN  THE  ABSENCE  OF
REGISTRATION  UNDER THE SECURITIES ACT OR UNLESS SUCH OFFER, SALE OR TRANSFER IS
EXEMPT FROM SUCH REGISTRATION.

               COMMON STOCK PURCHASE WARRANT CERTIFICATE

                        Dated: December 22, 1997

  to Purchase [NO SHARES] Shares of Common Stock, par value $0.01 per
                               Share, of

                          CEL-SCI CORPORATION

      CEL-SCI  CORPORATION,  a  Colorado  corporation  (the  "Company"),  hereby
certifies  that  [INVESTOR  NAME],  its  permissible   transferees,   designees,
successors and assigns  (collectively,  the "Holder"),  for value  received,  is
entitled to purchase  from the Company at any time  commencing  on December  22,
1997, and terminating on December 22, 2001  ("Termination  Date") up to [WARRANT
SHARE NO] (#) shares  (each a "Share"  and  collectively  the  "Shares")  of the
Company's  common  stock par value $0.01 per Share (the "Common  Stock"),  at an
exercise price of [$8.625][$9.315]  per Share (the "Exercise Price"). The number
of Shares purchasable hereunder and the Exercise Price are subject to adjustment
as provided in Section 4 hereof.

      1.    Exercise of Warrants.

            (a)  This  Common  Stock  Purchase  Warrant  Certificate   ("Warrant
Certificate" or "Certificate")  may be exercised by delivering (via facsimile or
otherwise)  a completed  Election to  Purchase  in the form  attached  hereto as
Exhibit A (the "Election to Purchase")  duly  executed,  to the Company at their
principal  office,  currently  located  at 66 Canal  Center  Plaza,  Suite  510,
Alexandria,  VA 22314, Attn: Geert R. Kersten, Chief Executive Officer, (or such
other  office or agency of the Company  within the United  States as the Company
may designate to the Holder).  The date of such  delivery  shall be the "Warrant
Exercise Date". The Holder must also surrender to a common carrier for overnight
delivery to the principal  office of the Company this original  Certificate  and
the original Election to Purchase form,  together with a certified check payable
to, or wire  transfer  to,  the  Company  in the  amount of the  Exercise  Price
multiplied by the number of Shares being purchased. The Company or the Company's
Transfer  Agent, as the case may be, shall within three (3) business days of the
Warrant   Exercise  Date  send  to  the  Holder  hereof  by  overnight   courier
certificates  of  fully  paid  and  non-assessable  Common  Stock  which  in the
aggregate  represent the number of Shares being  purchased;  provided,  however,
that the Holder may elect to utilize the cashless exercise  provisions set forth
below in lieu of tendering the Exercise  Price in cash,  which  election must be
agreed to by the Company in writing.  The  certificates so delivered shall be in
such  denominations as may be requested by the Holder and shall be registered in
the name of the Holder or such other name as shall be  designated by the Holder.
Notwithstanding  the  foregoing,  the  Company  shall not be required to deliver
shares of Common Stock unless and until this  original  Warrant  Certificate  is
surrendered to the Company.  All or less than all of the Warrants represented by
this Certificate may be exercised and, in case of the exercise of less than all,
the Company, upon surrender hereof, will at the Company's expense deliver to the
Holder a new Warrant  Certificate  or  Certificates  of like tenor and dated the
date hereof  entitling said holder to purchase the number of Shares  represented
by this  Certificate  which have not been exercised and to receive  Registration
Rights with respect to such Shares.

            (b)  Cashless  Exercise.  Notwithstanding  the  foregoing  provision
regarding  payment of the  Exercise  Price in cash,  the  Holder may  request in
writing and provided the Company agrees in writing, to

<PAGE>

receive a reduced  number of Shares in lieu of tendering  the Exercise  Price in
cash. In the case of cashless  exercise the number of Shares to be issued to the
Holder shall be computed using the following formula:

                        X = Y(A-B)
                              A

where:      X = the number of Shares to be issued to the Holder;
            Y = the number of Shares to be exercised  under this Warrant
Certificate;
            A = the Market Value  (defined  below) of one share of Common Stock;
and
            B = the Exercise Price.

As used in this Section 1(b),  "Market Value" refers to the closing bid price of
the Common Stock as currently  shown by the ticker  symbol HIV.A (as reported by
Bloomberg,  L.P.) on the day before the date that  Election to Purchase and this
Warrant  Certificate  are duly  surrendered to the Company for a full or partial
exercise hereof.  Notwithstanding the foregoing definition,  if the Common Stock
is not listed on a national  securities  exchange or quoted in the Nasdaq System
at the time said  Election  to  Purchase  is  submitted  to the  Company  in the
foregoing manner,  the Market Value of the Common Stock shall be the fair market
value  thereof,  as  determined in good faith by the Holders of the Warrants and
the Board of Directors of the Company,  unless the Company shall become  subject
to a merger,  acquisition,  or other consolidation pursuant to which the Company
is not the surviving  entity, in which case the Market Value of the Common Stock
shall be deemed to be the value  received by the Company's  common  stockholders
pursuant to such merger, acquisition or other consolidation.


      2.  Exchange,  Transfer  and  Replacement.  (a) At any  time  prior to the
exercise  hereof,  this  Certificate  may be  exchanged  upon  presentation  and
surrender  to the  Company,  alone or with other  Certificates  of like tenor of
different  denominations  registered in the name of the same Holder, for another
Certificate or Certificates of like tenor in the name of such Holder exercisable
for  the  aggregate   number  of  Shares  as  the  Certificate  or  Certificates
surrendered.

            (b)  Replacement  of Warrant  Certificate.  Upon receipt of evidence
reasonably  satisfactory  to the  Company of the loss,  theft,  destruction,  or
mutilation of this Warrant Certificate and, in the case of any such loss, theft,
or destruction,  upon delivery of an indemnity agreement reasonably satisfactory
in form and amount to the Company, or, in the case of any such mutilation,  upon
surrender and  cancellation  of this Warrant  Certificate,  the Company,  at its
expense,  will execute and deliver in lieu thereof, a new Warrant Certificate of
like tenor.

            (c)  Cancellation;  Payment of Expenses.  Upon the surrender of this
Warrant Certificate in connection with any transfer,  exchange or replacement as
provided in this Section 2, this Warrant  Certificate shall be promptly canceled
by the Company.  The Company shall pay all taxes (other than securities transfer
taxes) and all other expenses  (other than legal expenses,  if any,  incurred by
the  Holder  or  transferees)   and  charges  payable  in  connection  with  the
preparation,  execution  and delivery of Warrant  Certificates  pursuant to this
Section 2.

            (d) Warrant Register.  The Company shall maintain,  at its principal
executive  offices  (or at the  offices of the  transfer  agent for the  Warrant
Certificate or such other office or agency of the Company as it may designate by
notice to the holder  hereof),  a register  for this  Warrant  Certificate  (the
"Warrant  Register"),  in which the Company shall record the name and address of
the person in whose name this Warrant  Certificate  has been issued,  as well as
the name and address of each  transferee  and each prior  owner of this  Warrant
Certificate.

      3. Rights and  Obligations of Holders of this  Certificate.  The Holder of
this  Certificate  shall not, by virtue  hereof,  be entitled to any rights of a
stockholder in the Company, either at law or in equity;

<PAGE>

provided,  however,  that in the event any  certificate  representing  shares of
Common Stock or other securities is issued to the holder hereof upon exercise of
some or all of the Warrants,  such holder shall, for all purposes,  be deemed to
have become the holder of record of such Common  Stock on the date on which this
Certificate, together with a duly executed Election to Purchase, was surrendered
and payment of the aggregate  Exercise Price was made,  irrespective of the date
of delivery of such Common Stock certificate.

      4.    Adjustments.

            (a) Stock Dividends, Reclassifications,  Recapitalizations,  Etc. In
the  event  the  Company:  (i)  pays a  dividend  in  Common  Stock  or  makes a
distribution in Common Stock, (ii) subdivides its outstanding  Common Stock into
a greater number of shares,  (iii) combines its outstanding  Common Stock into a
smaller  number of shares or (iv) increases or decreases the number of shares of
Common Stock  outstanding by  reclassification  of its Common Stock (including a
recapitalization  in  connection  with a  consolidation  or  merger in which the
Company  is the  continuing  corporation),  then (1) the  Exercise  Price on the
record  date of such  division or  distribution  or the  effective  date of such
action shall be adjusted by multiplying  such Exercise Price by a fraction,  the
numerator  of  which  is the  number  of  shares  of  Common  Stock  outstanding
immediately  before  such  event and the  denominator  of which is the number of
shares of Common Stock  outstanding  immediately  after such event,  and (2) the
number of shares of Common  Stock  for which  this  Warrant  Certificate  may be
exercised  immediately  before such event shall be adjusted by multiplying  such
number by a fraction,  the numerator of which is the Exercise Price  immediately
before such event and the denominator of which is the Exercise Price immediately
after such event.

            (b) Cash Dividends and Other Distributions. In the event that at any
time or from time to time the Company shall  distribute to all holders of Common
Stock  (i)  any  dividend  or  other  distribution  of  cash,  evidences  of its
indebtedness,  shares of its capital stock or any other properties or securities
or (ii) any options,  warrants or other rights to subscribe  for or purchase any
of the foregoing  (other than in each case, (w) the issuance of any rights under
a shareholder rights plan, (x) any dividend or distribution described in Section
4(a), (y) any rights, options,  warrants or securities described in Section 4(c)
and (z) any cash dividends or other cash  distributions from current or retained
earnings),  then the number of shares of Common Stock issuable upon the exercise
of each  Warrant  Certificate  shall  be  increased  to a number  determined  by
multiplying  the number of shares of Common Stock  issuable upon the exercise of
such  Warrant  Certificate  immediately  prior to the  record  date for any such
dividend or  distribution  by a fraction,  the  numerator of which shall be such
Current Market Value (as  hereinafter  defined) per share of Common Stock on the
record date for such  dividend or  distribution,  and the  denominator  of which
shall be such Current  Market Value per share of Common Stock on the record date
for such  dividend or  distribution  less the sum of (x) the amount of cash,  if
any, distributed per share of Common Stock and (y) the fair value (as determined
in good faith by the Board of  Directors  of the  Company,  whose  determination
shall be  evidenced by a board  resolution,  a copy of which will be sent to the
Holders upon request) of the portion, if any, of the distribution  applicable to
one share of Common Stock  consisting  of evidences of  indebtedness,  shares of
stock, securities, other property, warrants, options or subscription or purchase
rights;  and the  Exercise  Price shall be adjusted  to a number  determined  by
dividing the Exercise Price  immediately  prior to such record date by the above
fraction.  Such adjustments  shall be made whenever any distribution is made and
shall become effective as of the date of distribution, retroactive to the record
date for any such  distribution.  No  adjustment  shall be made pursuant to this
Section 4(b) which shall have the effect of  decreasing  the number of shares of
Common Stock  issuable upon exercise of each Warrant  Certificate  or increasing
the Exercise Price.

            (c) Rights Issue. In the event that at any time or from time to time
the  Company  shall issue  rights,  options or  warrants  entitling  the holders
thereof to subscribe for shares of Common Stock, or securities  convertible into
or  exchangeable  or exercisable for Common Stock (other than in connection with
the adoption of a  shareholder  rights plan by the Company)  (collectively,  the
"Rights") where the consideration received by the Company for such Rights (equal
to the sum of the lowest amounts of consideration, if any, received or

<PAGE>

receivable by the Company with respect to any one share of Common Stock upon the
granting or sale of the Rights or upon  exercise or  conversion  of the Rights),
entitling such holders to subscribe for or purchase  shares of Common Stock at a
price per share that as of the record  date for such  issuance  is less than the
then  Current  Market Value per share of Common  Stock,  the number of shares of
Common Stock  issuable  upon the exercise of each Warrant  Certificate  shall be
increased to a number  determined by multiplying  the number of shares of Common
Stock  theretofore  issuable  upon  exercise of each  Warrant  Certificate  by a
fraction,  the  numerator of which shall be the number of shares of Common Stock
outstanding  on the  date  of  issuance  of such  rights,  options,  warrant  or
securities  plus the number of  additional  shares of Common  Stock  offered for
subscription  or purchase or into or for which such  securities  that are issued
are convertible, exchangeable or exercisable, and the denominator of which shall
be the number of shares of Common Stock  outstanding  on the date of issuance of
such rights,  option,  warrants or securities plus the total number of shares of
Common  Stock  which the  aggregate  consideration  received  or  expected to be
received by the Company (assuming the exercise or conversion of all such rights,
options, warrants or securities) would purchase at the then Current Market Value
per share of Common  Stock.  In the event of any such  adjustment,  the Exercise
Price shall be adjusted to a number  determined  by dividing the Exercise  Price
immediately prior to such date of issuance by the aforementioned  fraction. Such
adjustment  shall be  immediately  after such  rights,  options or warrants  are
issued  and shall  become  effective  (retroactive  to the  record  date for the
determination of stockholders entitled to receive such rights, options, warrants
or  securities,  if  applicable).  No adjustment  shall be made pursuant to this
Section 4(c) which shall have the effect of  decreasing  the number of shares of
Common  Stock  purchasable  upon  exercise  or each  Warrant  Certificate  or of
increasing  the  Exercise  Price.  In the event any such Rights  expire  without
exercise,  the Exercise  Price shall be  readjusted to remove the effect of such
Rights.

            (d)  Combination:  Liquidation.  (i) Except as  provided  in Section
4(d)(ii) below,  in the event of a Combination  (as defined below),  each Holder
shall have the right to receive upon  exercise of the Warrant  Certificates  the
kind and amount of shares of capital stock or other securities or property which
such  Holder  would have been  entitled  to receive  upon or as a result of such
Combination had such Warrant  Certificate  been exercised  immediately  prior to
such event (subject to further  adjustment in accordance with the terms hereof).
Unless paragraph (ii) is applicable to a Combination,  the Company shall provide
that the  surviving  or  acquiring  Person  (the  "Successor  Company")  in such
Combination will assume by written instrument the obligations under this Section
4 and the obligations to deliver to the Holder such shares of stock,  securities
or assets as, in  accordance  with the foregoing  provisions,  the Holder may be
entitled to acquire.  The  provisions of this Section  4(d)(i)  shall  similarly
apply to successive Combinations involving any Successor Company.  "Combination"
means an event in which the Company  consolidates with, mergers with or into, or
sells all or substantially  all of its assets to another Person,  where "Person"
means any individual, corporation, partnership, joint venture, limited liability
company,  association,  joint-stock company, trust, unincorporated organization,
government or any agency or political subdivision thereof or any other entity.

            (ii) In the event of (x) a Combination  where  consideration  to the
holders of Common Stock in exchange  for their shares is payable  solely in cash
or (y) the  dissolution,  liquidation or winding-up of the Company,  the Holders
shall be entitled to receive,  upon  surrender  of their  Warrant  Certificates,
distributions  on an equal  basis  with the  holders  of  Common  Stock or other
securities issuable upon exercise of the Warrant Certificates, as if the Warrant
Certificates  had  been  exercised  immediately  prior to such  event,  less the
Exercise Price. In case of any Combination  described in this Section  4(d)(ii),
the  surviving  or  acquiring  Person  and,  in the  event  of any  dissolution,
liquidation or winding-up of the Company,  the Company,  shall deposit  promptly
with an agent or trustee  for the  benefit  of the  Holders  the funds,  if any,
necessary  to pay to the  Holders  the  amounts  to which they are  entitled  as
described above. After such funds and the surrendered  Warrant  Certificates are
received,  the  Company  is  required  to  deliver a check in such  amount as is
appropriate  (or,  in the case or  consideration  other  than  cash,  such other
consideration as is appropriate) to such Person or Persons as it may be directed
in writing by the Holders surrendering such Warrant Certificates.

            (e) Change in Option Price or Conversion Rate. If the purchase price
provided for in any option,  the additional  consideration (if any) payable upon
the issue,  conversion  or exchange of any  convertible  security or the rate at
which any convertible security is

<PAGE>

convertible  into or  exchangeable  for Common  Stock  changes at any time,  the
Exercise  Price  in  effect  at the  time  of  such  change  shall  be  adjusted
immediately  to the Exercise  Price which would have been in effect at such time
had such option or  convertible  security  originally  provided for such changed
purchase price, additional consideration or conversion rate, as the case may be,
at the time  initially  granted,  issued or sold.  If the terms of any option or
convertible  security which was outstanding as of the date hereof are changed in
the manner described in the immediately preceding sentence,  then such option or
convertible  security  and the  Common  Stock  deemed  issuable  upon  exercise,
conversion  or  exchange  thereof  shall be deemed to have been issued as of the
date of such  change;  provided  that no such change shall at any time cause the
Exercise  Price  hereunder to be  increased,  except that, in the event any such
options or convertible securities expire, the Exercise Price shall be readjusted
to remove the effect of such options or convertible securities.

            (f) Notice of Adjustment.  Whenever the Exercise Price or the number
of shares of Common Stock and other property,  if any, issuable upon exercise of
the Warrant  Certificates  is adjusted,  as herein  provided,  the Company shall
deliver to the holders of the Warrant Certificates in accordance with Section 10
a  certificate  of the Company's  Chief  Financial  Officer  setting  forth,  in
reasonable  detail,  the event  requiring the adjustment and the method by which
such  adjustment was  calculated  (including a description of the basis on which
(i) the  Board of  Directors  determined  the fair  value  of any  evidences  of
indebtedness,  other  securities  or  property  or  warrants,  options  or other
subscription  or purchase rights and (ii) the Current Market Value of the common
Stock was  determined,  if either of such  determinations  were  required),  and
specifying the Exercise Price and number of shares of Common Stock issuable upon
exercise of Warrant Certificates after giving effect to such adjustment.

            (g) Notice of Certain  Transactions.  In the event that the  Company
shall propose (a) to pay any dividend  payable in securities of any class to the
holders  of  its  Common  Stock  or to  make  any  other  non-cash  dividend  or
distribution to the holders of its Common Stock, (b) to offer the holders of its
Common Stock rights to subscribe for or to purchase any  securities  convertible
into  shares  of  Common  Stock or  shares  of stock of any  class or any  other
securities,  rights  or  options,  (c) to  effect  any  capital  reorganization,
reclassification,  consolidation  or merger affecting the class of Common Stock,
as a  whole,  or  (d)  to  effect  the  voluntary  or  involuntary  dissolution,
liquidation  or winding-up of the Company,  the Company  shall,  within the time
limits specified below,  send to each Holder a notice of such proposed action or
offer.  Such notice  shall be mailed to the Holders at their  addresses  as they
appear in the Warrant Register (as defined in Section 2(d)), which shall specify
the record date for the purposes of such dividend,  distribution  or rights,  or
the date such  issuance or event is to take place and the date of  participation
therein by the  holders of Common  Stock,  if any such date is to be fixed,  and
shall briefly  indicate the effect of such action on the Common Stock and on the
number and kind of any other shares of stock and on other property,  if any, and
the number of shares of Common Stock and other property,  if any,  issuable upon
exercise of each Warrant  Certificate and the Exercise Price after giving effect
to any  adjustment  pursuant  to Section 4 which will be required as a result of
such  action.  Such notice shall be given as promptly as possible and (x) in the
case of any action covered by clause (a) or (b) above, at least 10 days prior to
the record date for determining holders of the Common Stock for purposes of such
action or (y) in the case of any other  such  action,  at least 20 days prior to
the date of the  taking of such  proposed  action  or the date of  participation
therein by the holders of Common Stock, whichever shall be the earlier.

            (h) Current Market Value. As used in this Section 4, "Current Market
Value" per share of Common Stock or any other  security at any date means (i) if
the security is not  registered  under the  Securities  Exchange Act of 1934, as
amended (the  "Exchange  Act"),  the value of the  security,  determined in good
faith by the Holders of the  Warrants  and the Board of Directors of the Company
and certified in a board resolution, or (ii) if the security is registered under
the Exchange Act, the average of the daily closing bid prices (or the equivalent
in an over-the-counter  market) for each day on which the Common Stock is traded
for any period on the principal  securities  exchange or other securities market
on which the common Stock is being  traded  (each,  a "Trading  Day") during the
period commencing ten (10)

<PAGE>

Trading Days before such date and ending on the date one day prior to such date,
or if the security has been registered  under the Exchange Act for less than ten
(10) consecutive Trading Days before such date, the average of the daily closing
bid prices (or such equivalent) for all of the Trading Days before such date for
which daily closing bid prices are  available;  provided,  however,  that if the
closing bid price is not determinable for at least five (5) Trading Days in such
period, the "Current Market Value" of the security shall be determined as if the
security were not registered under the Exchange Act.

            (i) Other Adjustments.  If the event of any other transaction of the
type  contemplated  by this  Section 4, but not  expressly  provided  for by the
provisions  hereof,  the Board of Directors of the Company will make appropriate
adjustment  in the Exercise  Price so as to equitably  protect the rights of the
Holder.

            (j) No  Impairment  of Holder's  Rights.  The  Company  will not, by
amendment  of  its  certificate  of  incorporation  or  bylaws  or  through  any
reorganization, transfer of assets, consolidation, merger, dissolution, issue or
sale of securities  or any other  voluntary  action,  avoid or seek to avoid the
observance or performance of any of the terms of this Warrant  Certificate,  but
will at all times in good faith assist in the carrying out of all such terms and
in the  taking of all  action as may be  necessary  or  appropriate  in order to
protect the rights of the Holder against dilution or other impairment.

      5.    Company's Representations.

            (a) The Company covenants and agrees that all shares of Common Stock
issuable upon exercise of this Warrant Certificate will, upon delivery,  be duly
and validly  authorized and issued,  fully-paid and non-assessable and free from
all taxes, liens, claims and encumbrances.

            (b) The  Company  covenants  and  agrees  that it will at all  times
reserve and keep  available an  authorized  number of shares of its Common Stock
and other applicable securities sufficient to permit the exercise in full of all
outstanding options, warrants and rights, including this Warrant Certificate.

            (c) The Company shall promptly secure the listing of the Shares upon
each national  securities  exchange or automated  quotation system, if any, upon
which  shares of Common  Stock are then  listed  or become  listed  (subject  to
official notice of issuance upon exercise of this Warrant Certificate) and shall
maintain,  so long as any other shares of Common Stock shall be so listed,  such
listing  of all  shares of Common  Stock  from  time to time  issuable  upon the
exercise of this  Warrant  Certificate;  and the  Company  shall so list on each
national  securities exchange or automated quotation system, as the case may be,
and shall  maintain  such listing of, any other  shares of capital  stock of the
company issuable upon the exercise of this Warrant Certificate if and so long as
any  shares  of the same  class  shall be  listed  on such  national  securities
exchange or automated quotation system.

            (d) The Company has taken all necessary  action and  proceedings  as
required and  permitted  by  applicable  law,  rule and  regulation,  including,
without limitation, the notification of the principal market on which the Common
Stock is traded, for the legal and valid issuance of this Warrant Certificate to
the Holder under this Warrant Certificate.

            (e) The Shares,  when issued in  accordance  with the terms  hereof,
will be duly  authorized  and,  when paid for or issued in  accordance  with the
terms  hereof,  shall be  validly  issued,  fully paid and  non-assessable.  The
Company has authorized and reserved for issuance to Warrant Holder the requisite
number of shares of Common Stock to be issued pursuant to this Warrant.

            (f) With a view to making  available  to Holder the benefits of Rule
144 promulgated under the Act and any other rule or regulation of the Securities
and  Exchange  Commission  ("SEC")  that may at any time  permit  Holder to sell
securities of the Company to the public without registration, the Company agrees
to use its reasonable best efforts to:

                  (i) make and keep public information available, as those terms
are understood and defined in Rule 144, at all times;

                  (ii) file with the SEC in a timely manner all

<PAGE>

reports  and  other  documents  required  of the  Company  under the Act and the
Securities Exchange Act of 1934, as amended (the "Exchange Act"); and

                  (iii) furnish to any Holder  forthwith  upon request a written
statement by the Company that it has complied with the reporting requirements of
Rule 144 and of the Act and the Exchange  Act, a copy of the most recent  annual
or quarterly  report of the  Company,  and such other  reports and  documents so
filed by the Company as may be reasonably requested to permit any such Holder to
take  advantage of any rule or regulation of the SEC  permitting  the selling of
any such securities without registration.

      6.  Registration  Rights.  The Holder is  entitled  to the benefit of such
registration  rights  in  respect  of  the  Shares  as  are  set  forth  in  the
Registration  Rights  Agreement dated as of December 22, 1997 by and between the
Company and the Holder.

      7.  Fractional  Shares;  Legends.  (a) In lieu of issuance of a fractional
share upon any exercise  hereunder,  the Company will pay the cash value of that
fractional  share,  calculated on the basis of the Exercise Price.  (b) Prior to
registration of the shares of Common Stock underlying this Warrant  Certificate,
all such  certificates  shall bear a  restrictive  legend to the effect that the
Shares  represented by such  certificate have not been registered under the 1933
Act, and that the Shares may not be sold or  transferred  in the absence of such
registration or an exemption  therefrom,  such legend to be substantially in the
form of the  bold-face  language  appearing at the top of Page 1 of this Warrant
Certificate.

      8.  Disposition  of  Warrants  or  Shares.  The  Holder  of  this  Warrant
Certificate, each transferee hereof and any holder and transferee of any Shares,
by his or its acceptance thereof, agrees that no public distribution of Warrants
or  Shares  will  be  made in  violation  of the  provisions  of the  1933  Act.
Furthermore,  it shall be a condition to the  transfer of the Warrants  that any
transferee thereof deliver to the Company his or its written agreement to accept
and be  bound by all of the  terms  and  conditions  contained  in this  Warrant
Certificate.

      9. Merger or Consolidation. The Company will not merge or consolidate with
or into any other  corporation,  or sell or  otherwise  transfer  its  property,
assets and business substantially as an entirety to another corporation,  unless
the  corporation  resulting  from  such  merger  or  consolidation  (if  not the
Company),  or such transferee  corporation,  as the case may be, shall expressly
assume, by supplemental agreement reasonably  satisfactory in form and substance
to the Holder, the due and punctual performance and observance of each and every
covenant and condition of this Warrant  Certificate to be performed and observed
by the Company.

      10. Notices.  Except as otherwise  specified  herein to the contrary,  all
notices,  requests,  demands and other communications  required or desired to be
given  hereunder  shall only be  effective  if given in writing by  certified or
registered  U.S.  mail with return  receipt  requested and postage  prepaid;  by
private  overnight  delivery  service  (e.g.  Federal  Express);   by  facsimile
transmission  (if no  original  documents  or  instruments  must  accompany  the
notice);  or by personal delivery.  Any such notice shall be deemed to have been
given (a) on the second business day immediately  following the mailing thereof,
if mailed by certified or registered  U.S. mail as specified  above;  (b) on the
business day immediately  following  deposit with a private  overnight  delivery
service  if  sent  by  said  service;   (c)  upon  receipt  of  confirmation  of
transmission if sent by facsimile transmission; or (d) upon personal delivery of
the notice.  All such notices  shall be sent to the  following  addresses (or to
such other  address or  addresses  as a party may have  advised the other in the
manner provided in this Section 9):

            If to the Company:

            Cel-Sci Corporation
            66 Canal Center Plaza, Suite 510
            Alexandria, VA 22314
            Attention:  Mr. Geert R. Kersten
            Telephone: (703) 549-5293
            Facsimile: (703) 549-6269


<PAGE>

            If to the Holder:

            [INVESTOR]
            [INVESTOR ADDRESS]
            Attention:
            Telephone:
            Facsimile:


            With a copy to:

            Shoreline Pacific Institutional Finance
            3 Harbor Drive, Suite 211
            Sausalito, CA  94965
            Attention:  General Counsel
            Fax:  (415) 332-7808
            Tel:  (415) 332-7800

Notwithstanding  the time of effectiveness of notices set forth in this Section,
an Election to Purchase shall not be deemed  effectively given until it has been
duly completed and submitted to the Company  together with the original  Warrant
Certificate  to be exercised  and payment of the Exercise  Price in a manner set
forth in this Section.

11.  Governing  Law:  Jurisdiction.  This  Certificate  shall be governed by and
construed in  accordance  with the laws of the State of New York  applicable  to
contracts  made and to be performed in the State of New York. The parties hereto
irrevocably  consent to the jurisdiction of the United States federal courts and
state  courts  located in the County of New York in the State of New York in any
suit  or  proceeding   based  on  or  arising  under  this  Certificate  or  the
transactions  contemplated  hereby  and  irrevocably  agree  that all  claims in
respect of such suit or proceeding may be determined in such courts. The Company
and each Purchaser  irrevocably  waives the defense of an inconvenient  forum to
the  maintenance of such suit or proceeding in such forum.  The Company and each
Purchaser  further  agrees  that  service  of process  upon the  Company or such
Purchaser,  as  applicable,  mailed by the first class mail in  accordance  with
Section 10 shall be deemed in every  respect  effective  service of process upon
the  Company or such  Purchaser  in any suit or  proceeding  arising  hereunder.
Nothing  herein shall  affect  Purchaser's  right to serve  process in any other
manner  permitted by law. The parties  hereto agree that a final  non-appealable
judgment in any such suit or proceeding  shall be conclusive and may be enforced
in other  jurisdictions  by suit on such judgment or in any other lawful manner.
The parties hereto irrevocably waive the right to trial by jury under applicable
law.

      12. Successors and Assigns. This Warrant Certificate shall be binding upon
and shall  inure to the  benefit  of the  parties  hereto  and their  respective
successors and assigns.

      13. Headings. The headings of various sections of this Warrant Certificate
have been  inserted  for  reference  only and shall not  affect  the  meaning or
construction of any of the provisions hereof.

      14. Severability.  If any provision of this Warrant Certificate is held to
be  unenforceable  under  applicable  law, such provision shall be excluded from
this Warrant Certificate, and the balance hereof shall be interpreted as if such
provision were so excluded.


<PAGE>

      15.  Modification and Waiver.  This Warrant  Certificate and any provision
hereof may be amended, waived, discharged or terminated only by an instrument in
writing signed by the Company and the Holder.

      16.  Limitation  on  Exercise.  Notwithstanding  anything to the  contrary
contained herein, this Warrant Certificate may not be exercised by the Holder to
the extent that, after giving effect to Certificate Shares to be issued pursuant
to an Election to  Purchase,  the total  number of shares of Common Stock deemed
beneficially  owned by such Holder  (other than by virtue of  ownership  of this
Warrant Certificate,  or ownership of other securities that have restrictions on
the Holder's rights to convert or exercise  similar to the limitations set forth
herein),  together with all shares of Common Stock deemed  beneficially owned by
the  Holder's  "affiliates"  (as  defined  in Rule 144 of the Act) that would be
aggregated  for purposes of  determining  whether a group under Section 13(d) of
the  Securities  Exchange  Act of 1934  exists,  would  exceed 4.9% of the total
issued and outstanding shares of the Common Stock;  provided that the Holder may
waive the limitation of this Section 16 (i) upon 61 days prior written notice or
(ii) immediately  upon a merger in which the Company does not survive,  the sale
of all  or  substantially  all  of the  Company's  assets,  the  failure  of the
Company's current stockholders to any longer hold more than 50% of the Company's
voting securities, or any similar change in control transaction. The delivery of
an Election to Purchase by the Holder shall be deemed a  representation  by such
Holder  that  it  is  in  compliance  with  this  paragraph.  The  term  "deemed
beneficially  owned" as used in this Warrant  Certificate  shall exclude  shares
that might otherwise be deemed  beneficially  owned by reason of the exercise of
this Warrant Certificate.

      17. Specific Enforcement. The Company and the Holder acknowledge and agree
that  irreparable  damage would occur in the event that any of the provisions of
this Warrant  Certificate  were not performed in accordance  with their specific
terms or were  otherwise  breached.  It is  accordingly  agreed that the parties
shall be entitled to an injunction or injunctions to prevent or cure breaches of
the provisions of this Warrant Certificate and to enforce specifically the terms
and  provisions  hereof,  this being in  addition  to any other  remedy to which
either of them may be entitled by law or equity.

      18. Assignment.  This Warrant  Certificate may be transferred or assigned,
in whole or in part,  at any time and from  time to time by the then  Holder  by
submitting this Warrant to the Company together with a duly executed  Assignment
in  substantially  the  form  and  substance  of the  Form of  Assignment  which
accompanies this Warrant Certificate and, upon the Company's receipt hereof, and
in any event, within three (3) business days thereafter, the Company shall issue
a Warrant  Certificate  to the Holder to evidence  that  portion of this Warrant
Certificate, if any as shall not have been so transferred or assigned.

            IN WITNESS WHEREOF,  the Company has caused this Warrant Certificate
to be duly executed,  manually or by facsimile, by one of its officers thereunto
duly authorized.
                                    CEL-SCI CORPORATION


Date:_________________              By:_________________________________
                                          Geert R. Kersten
                                          Chief Executive Officer


<PAGE>


                          ELECTION TO PURCHASE

                      To Be Executed by the Holder
                 in Order to Exercise the Common Stock
                      Purchase Warrant Certificate

      The undersigned  Holder hereby elects to exercise  _______ of the Warrants
represented by the attached Common Stock Purchase  Warrant  Certificate,  and to
purchase the shares of Common Stock issuable upon the exercise of such Warrants,
and requests that certificates for securities be issued in the name of:

            ----------------------------------------------------------
                        (Please type or print name and address)
            ==========================================================
            ----------------------------------------------------------
                         (Social Security or Tax Identification Number)
and delivered
to:______________________________________________________________
- -----------------------------------------------------------------------------
 .
            (Please  type or print name and  address if  different  from
above)

If such number of Warrants being exercised  hereby shall not be all the Warrants
evidenced  by the attached  Common Stock  Purchase  Warrant  Certificate,  a new
Common Stock Purchase Warrant Certificate for the balance of such Warrants shall
be  registered  in the name of, and  delivered to, the Holder at the address set
forth below.

      [In full  payment  of the  purchase  price with  respect  to the  Warrants
exercised and transfer taxes, if any, the undersigned  hereby tenders payment of
$__________ by certified  check,  money order or wire transfer payable in United
States currency to the order of Cel-Sci Corporation.] or [The undersigned elects
cashless  exercise in accordance  with Section 1(b) of the Common Stock Purchase
Warrant Certificate and such election has been agreed to by the Company.]

                                     HOLDER:



Dated:___________________
By:_____________________________________
                                      Name:
                                     Title:
                                    Address:




<PAGE>


                           FORM OF ASSIGNMENT
               (To be signed only on transfer of Warrant)



For value received,  the undersigned hereby sells,  assigns,  and transfers unto
_____________  the right  represented by the within  Warrant to purchase  ______
shares of Common Stock of Cel-Sci Corporation, a Colorado corporation,  to which
the within  Warrant  relates,  and  appoints  ____________________  Attorney  to
transfer such right on the books of Cel-Sci Corporation, a Colorado Corporation,
with full power of substitution of premises.




Dated:                                      By:
                                                       Name:
                                                       Title:
                                      (signature must conform to name  of holder
                                       as specified on the fact of the Warrant)

                                          Address:




Signed in the presence of :





                          REGISTRATION RIGHTS AGREEMENT


      This REGISTRATION  RIGHTS  AGREEMENT,  dated as of December 22, 1997, (the
"Agreement"),   is  made  by  and  between  CEL-SCI   CORPORATION,   a  Colorado
corporation,  66 Canal Center Plaza, Suite 510, Alexandria,  Virginia 22314 (the
"Company"), and the undersigned investors (the "Initial Investors").


                               W I T N E S S E T H :

      WHEREAS,  in  connection  with the  Securities  Purchase  Agreement  dated
December 22, 1997 among the Initial  Investors  and the Company  (the  "Purchase
Agreement"),  the  Company  has  agreed,  upon  the  terms  and  subject  to the
conditions  of said  Purchase  Agreement,  to  issue  and  sell  to the  Initial
Investors Ten Thousand  (10,000) shares of Series D Convertible  Preferred Stock
(the "Preferred Shares") of the Company, convertible into shares of common stock
of the Company par value $0.01 per share (the  "Common  Stock"),  together  with
Warrants to purchase  additional  shares of Common  Stock.  The shares of Common
Stock into which the Preferred  Shares are  convertible and the shares of Common
Stock into which the  Warrants  are  exercisable  are  collectively  referred to
herein  as  the  "Registrable  Shares."  In  connection  with  the  sale  of the
Registrable  Shares to the  Initial  Investors  (the  "Offering"),  each of such
investors  will  be  entitled  to  registration  rights  as set  forth  in  this
Agreement.

      WHEREAS,  to induce the  Initial  Investors  to execute  and  deliver  the
Purchase  Agreement,  the  Company  has agreed to provide  certain  registration
rights  under  the  Securities  Act of  1933,  as  amended,  and the  rules  and
regulations  thereunder,  or any similar  successor statute  (collectively,  the
"Securities  Act"),  and applicable  state  securities  laws with respect to the
Registrable Shares;

      NOW, THEREFORE,  in consideration of the premises and the mutual covenants
contained  herein and other good and  valuable  consideration,  the  receipt and
sufficiency  of which are  hereby  acknowledged,  the  Company  and the  Initial
Investors hereby agree as follows:

      1.  Definitions.  Capitalized  terms used herein and not otherwise defined
herein shall have the respective  meanings set forth in the Purchase  Agreement.
As used in  this  Agreement,  the  following  terms  shall  have  the  following
meanings:

            (a)  "Holders"  are  stockholders  of the Company  who, by virtue of
agreements with the Company, are entitled to include their securities in certain
Registration Statements filed by the Company.

            (b)  "Investors"  means the Initial  Investors and any transferee or
assignee of the Initial Investors who agree to become bound by the provisions of
this Agreement in accordance with Section 9 hereof.

            (c) "Registrable  Securities" means the Registrable Shares, together
with any  shares of Common  Stock or other  securities  which may be issued as a
dividend or other  distribution  or in exchange for  Registrable  Shares and any
additional shares of Common Stock or other securities which may be issued due to
anti-dilution  adjustments  with respect to the  Registrable  Shares,  which are
required to be included in a  Registration  Statement  pursuant to Section  2(a)
below.

            (d) "Registration  Period" means the period between the date of this
Agreement  and the  earlier  of (i) the  date on  which  all of the  Registrable
Securities  (including  all shares of Common  Stock into which the  Warrants are
exercisable) have been sold in transactions  where the transferee is not subject
to securities  law resale  restrictions  (or is subject to securities law resale
restrictions  solely  because  it is an  "affiliate"  of the  Company  under the
Securities Act and the Rules promulgated thereunder),  or (ii) the date on which
the  Registrable  Securities  (in the  opinion  of  Investors'  counsel)  may be
immediately sold without registration and free of restrictions on transfer under
Rule 144k or otherwise.


<PAGE>

            (e) "Registration  Statement" means a registration  statement of the
Company filed with the Securities and Exchange  Commission (the "SEC") under the
Securities Act.

            (f) The terms "register,"  "registered," and "registration" refer to
a  registration  effected by preparing  and filing a  Registration  Statement in
compliance  with  the  Securities  Act  and  applicable  rules  and  regulations
thereunder  and  pursuant  to  Rule  415  under  the  Securities  Act,  and  the
declaration or ordering of effectiveness of such  Registration  Statement by the
SEC.

            (g) "AMEX Limit" means 2,243,782 shares of Common Stock,  unless the
Company has obtained  shareholder  approval to issue a greater  number of common
shares or has  otherwise  received  a waiver  from AMEX to such  effect.  If the
Company has obtained such shareholder  approval or waiver,  then the limit shall
not apply.

      2.    Registration.

            (a)  Mandatory  Registration.  The Company  will  prepare and file a
Registration  Statement  on  Form  S-3  with  the  SEC,  registering  all of the
Registrable Securities for resale promptly following the closing of the purchase
of the Preferred  Shares and the Warrants (the "Closing Date") and in any event,
not later than  twenty  five (25) days  after the  Closing  Date.  To the extent
allowable  under the Securities Act and the Rules  promulgated  thereunder,  the
Registration  Statement  shall  include  the  Registrable  Securities  and  such
indeterminate number of additional shares of Common Stock as may become issuable
upon  conversion  of the  Preferred  Shares and  exercise of the Warrants (i) to
prevent  dilution  resulting  from  stock  splits,  stock  dividends  or similar
transactions, or (ii) by reason of changes in the exercise price of the Warrants
in accordance  with the terms thereof or the  conversion  price of the Preferred
Shares.  The  number  of  shares  of Common  Stock  initially  included  in such
Registration  Statement  shall  include  no  less  than  125% of the  number  of
Registrable  Securities  that are issued on the Closing Date and  issuable  upon
exercise of the Warrants as of the Closing Date. The Registration Statement (and
each  amendment or supplement  thereto) shall be provided to, and subject to the
reasonable  approval of, the Initial  Investors and their  counsel.  The Company
shall use its best efforts to cause such  Registration  Statement to be declared
effective  by the SEC as soon as  practicable  after  filing and in any event no
later than sixty (60) days after the Closing Date or, if the Company is notified
by the SEC that the Registration  Statement will be reviewed, one hundred twenty
(120)  days  after the  Closing  Date  (either  such date,  as  applicable,  the
"Required Effective Date"). Such best efforts shall include,  but not be limited
to,  promptly  responding  to all comments  received  from the staff of the SEC.
Should  the  Company  receive  notification  from the SEC that the  Registration
Statement  will receive no action or no review from the SEC,  the Company  shall
cause such  Registration  Statement to become effective within five (5) business
days of such SEC notification.  Once declared  effective by the SEC, the Company
shall cause such  Registration  Statement  to remain  effective  throughout  the
Registration Period.

            (b) Piggyback Registrations. If, at any time prior to the expiration
of  the  Registration  Period,  the  Company  decides  to  register  any  of its
securities  for  its  own  account  or for  the  account  of  others  (excluding
registrations  relating to equity  securities  to be issued solely in connection
with an acquisition of any entity or business or in connection with stock option
or other employee  benefit plans),  the Company will promptly give the Investors
written  notice  thereof,  and will  use its best  efforts  to  include  in such
registration all or any part of the Registrable  Securities so requested by such
Investors  (excluding  any  Registrable  Securities  previously  included  in  a
Registration Statement).  Each Investor's request for registration must be given
to the Company in writing  within ten (10) days after receipt of the notice from
the Company.  If the registration for which the Company gives notice is a public
offering involving an underwriting,  the Company will so advise the Investors as
part of the  above-described  written  notice.  In such event,  if the  managing
underwriter(s)  of the  public  offering  impose a  limitation  on the number of
shares of Common  Stock  which may be  included  in the  Registration  Statement
because, in such underwriter(s)' judgment, such limitation would be necessary to
effect an orderly  public  distribution,  then the Company  will be obligated to
include only such limited  portion,  if any, of the Registrable  Securities with
respect  to  which  such  Investors  have  requested  inclusion  hereunder.  Any
exclusion of Registrable  Securities shall be made pro-rata among all Holders of
the Company's securities seeking to include shares of Common Stock in proportion
to the number of shares of Common Stock  sought to be included by such  Holders;
provided,  however, that the Company will not exclude any Registrable Securities
unless the Company has first excluded all outstanding  securities the Holders of
which are not entitled by right to inclusion of securities in such  Registration
Statement.

<PAGE>

No right to registration of Registrable Securities under this Section 2(b) shall
be construed to limit in any way the  registration  required  under Section 2(a)
above.  The  obligations of the Company under this Section 2(b) will expire upon
the  earlier  of: (i) the  effectiveness  of the  Registration  Statement  filed
pursuant  to  Section  2(a)  above;  (ii) after the  Company  has  afforded  the
opportunity for the Investors to exercise registration rights under this Section
2(b) for two registrations;  provided, however, that any Investor who shall have
had any  Registrable  Securities  excluded  from any  Registration  Statement in
accordance with this Section 2(b) shall be entitled to include in any additional
Registration  Statement  filed by the  Company  the  Registrable  Securities  so
excluded;  or (iii) when all of the Registrable  Securities held by any Investor
may be sold by such  Investor  under Rule 144 under the 1933 Act  without  being
subject to any volume restrictions.

            (c)  Late  Registration  Payments.  If  the  Registration  Statement
required  pursuant to Section 2(a) above has not been declared  effective by the
Required  Effective  Date,  or if  after  the  Registration  Statement  has been
declared  effective by the SEC sales cannot be made pursuant to the Registration
Statement  (whether  because of  failure to keep  effective,  to  disclose  such
information  as is necessary for sales to be made  pursuant to the  Registration
Statement,  to  register  sufficient  shares,  subject  to the  AMEX  limit,  or
otherwise)  the  Company  will make cash  payments  to the  Investor  as partial
compensation  for  such  delay  (the  "Late  Registration  Payments").  The Late
Registration  Payments  will be equal to one percent (1%) of the purchase  price
paid for the Common Shares for the first month following the Required  Effective
Date,  two percent (2%) of the purchase price paid for the Common Shares for the
second  month,  and three  percent  (3%) of said  purchase  price for each month
thereafter,  continuing through the date the Registration  Statement is declared
effective by the SEC. The Late Registration Payments will be prorated on a daily
basis for  partial  months  and will be paid to the  Initial  Investors  in cash
within  five (5)  business  days  following  the earlier of: (i) the end of each
month  following the Required  Effective Date, or (ii) the effective date of the
Registration  Statement.  Nothing  herein  shall limit the  Investor's  right to
pursue actual damages for the Company's failure to file a Registration Statement
or to  have  it  declared  effective  by the  SEC on or  prior  to the  Required
Effective Date in accordance with the terms of this Agreement.

            (d)  Eligibility  for Form S-3. The Company  represents and warrants
that it meets the  requirements  for the use of Form S-3 for registration of the
sale by the Initial  Investors of the  Registrable  Securities,  and the Company
shall file all reports  required  to be filed by the  Company  with the SEC in a
timely manner so as to maintain such eligibility for the use of Form S-3.

      3.  Additional   Obligations  of  the  Company.  In  connection  with  the
registration of the Registrable Securities, the Company shall have the following
additional obligations:

            (a) The Company shall keep the  Registration  Statement  required by
Section 2(a) hereof  effective  pursuant to Rule 415 under the Securities Act at
all times during the Registration Period as defined in Section 1(d) above.

            (b)  The  Registration   Statement   (including  any  amendments  or
supplements  thereto and  prospectuses  contained  therein) filed by the Company
shall not contain  any untrue  statement  of a material  fact or omit to state a
material fact required to be stated therein, or necessary to make the statements
therein,  in light of the circumstances in which they were made, not misleading.
The  Company  shall  prepare  and file with the SEC such  amendments  (including
post-effective amendments) and supplements to the Registration Statement and the
prospectus  used  in  connection  with  the  Registration  Statement  as  may be
necessary to keep the Registration  Statement  effective at all times during the
Registration  Period, and, during such period,  shall comply with the provisions
of the  Securities  Act  with  respect  to the  disposition  of all  Registrable
Securities of the Company covered by the Registration  Statement until such time
as all of such  Registrable  Securities have been disposed of in accordance with
the intended  methods of disposition by the sellers  thereof as set forth in the
Registration  Statement.  In the  event the  number  of  shares of Common  Stock
included  in a  Registration  Statement  filed  pursuant  to this  Agreement  is
insufficient  to cover all of the  Registrable  Securities,  the  Company  shall
amend, if permissible, the Registration Statement and/or file a new Registration
Statement  so as  to  cover  all  of  the  Registrable  Securities  as  soon  as
practicable,  but in no event  more than  twenty  (20)  business  days after the
Company  first  determines  (or  reasonably  should  have  determined)  the need
therefor.  The Company shall use its best efforts to cause such amendment and/or
new Registration  Statement to become effective as soon as practicable following
the filing thereof.  The Late  Registration  Payment  provisions of Section 2(c)
above shall become applicable with respect to the effectiveness

<PAGE>

of such amendment  and/or new Registration  Statement,  only with respect to the
shares to be included in such amendment and/or  Registration  Statement and only
to the extent of the AMEX Limit, on the thirtieth  (30th) day following the date
the Company first determines (or reasonably should have determined) the need for
the amendment and/or new Registration Statement.

            (c) The Company  shall furnish to each  Investor  whose  Registrable
Securities  are included in the  Registration  Statement (i) promptly  after the
same is prepared and publicly distributed, filed with the SEC or received by the
Company, one copy of the Registration  Statement and any amendment thereto; each
preliminary  prospectus  and final  prospectus  and each amendment or supplement
thereto;  and, in the case of the Registration  Statement required under Section
2(a) above,  each  letter  written by or on behalf of the Company to the SEC and
each  item of  correspondence  from  the  SEC,  in each  case  relating  to such
Registration  Statement  (other  than  any  portion  of any item  thereof  which
contains  information for which the Company has sought confidential  treatment);
and (ii)  such  number  of  copies  of a  prospectus,  including  a  preliminary
prospectus, and all amendments and supplements thereto, and such other documents
as such Investor may reasonably  request in order to facilitate the  disposition
of the Registrable Securities owned by such Investor.

            (d) The  Company  shall use its best  efforts  to (i)  register  and
qualify the Registrable  Securities covered by the Registration  Statement under
such other  securities or blue sky laws of such  jurisdictions  as the Investors
reasonably request, (ii) prepare and file in those jurisdictions such amendments
(including  post-effective  amendments) and supplements to such registrations as
may be necessary to maintain the  effectiveness  thereof during the Registration
Period,  (iii) take such other  actions as may be  necessary  to  maintain  such
registrations and  qualifications in effect at all times during the Registration
Period,  and (iv) take all other  actions  reasonably  necessary or advisable to
qualify   the   Registrable   Securities   for   sale  in  such   jurisdictions.
Notwithstanding  the foregoing  provision,  the Company shall not be required in
connection  therewith or as a condition thereto to (i) qualify to do business in
any  jurisdiction  where it would not  otherwise  be required to qualify but for
this  Section  3(d),  (ii)  subject  itself  to  general  taxation  in any  such
jurisdiction,  (iii)  file a general  consent  to service of process in any such
jurisdiction, (iv) provide any undertakings that cause more than nominal expense
or burden to the Company, or (v) make any change in its charter or bylaws, which
in each case the Board of Directors of the Company  determines to be contrary to
the best interests of the Company and its stockholders.

            (e) In the event  Investors  who hold a majority  in interest of the
Registrable Securities being offered in an offering select underwriters for such
offering,  the Company  shall enter into and  perform its  obligations  under an
underwriting   agreement  in  usual  and  customary  form   including,   without
limitation,  customary  indemnification and contribution  obligations,  with the
managing underwriter of such offering.  The Investors  participating in any such
underwriting  shall be responsible for payment of the fees of such  underwriters
and the  attorney  fees and  costs  incurred  by one law firm  selected  by such
Investors to represent their interests in the underwritten offering. No Investor
shall be obligated to  participate  in any such  underwriting.  In the event the
Investors  select  underwriters  for the  Offering,  the  Company  shall  not be
responsible for any delays in the filing or  effectiveness  of the  Registration
Statement caused by such underwriters (including the payment of any amounts with
respect to such late filing or effectiveness).

            (f) The Company  shall notify each  Investor  who holds  Registrable
Securities  being sold pursuant to a Registration  Statement of the happening of
any event of which the Company has knowledge as a result of which the prospectus
included  in the  Registration  Statement  as then in effect  includes an untrue
statement of a material  fact or omits to state a material  fact  required to be
stated  therein or necessary  to make the  statements  therein,  in light of the
circumstances under which they were made, not misleading (a "Suspension Event").
The Company shall make such  notification  as promptly as practicable  after the
Company  becomes aware of such  Suspension  Event,  shall  promptly,  but in all
events  within  five (5)  business  days,  use its best  efforts  to  prepare  a
supplement  or  amendment to the  Registration  Statement to correct such untrue
statement or omission,  and shall deliver a number of copies of such  supplement
or  amendment  to  each  Investor  as  such  Investor  may  reasonably  request.
Notwithstanding  the foregoing  provision,  the Company shall not be required to
maintain  the  effectiveness  of  the  Registration  Statement  or to  amend  or
supplement the Registration  Statement for a period (a "Delay Period")  expiring
upon the earlier to occur of (i) the date on which such material  information is
disclosed  to the  public or ceases to be  material,  (ii) the date on which the
Company is able to comply with its disclosure  obligations and SEC  requirements
related  thereto,  or  (iii)  thirty  (30)  days  after  the  occurrence  of the
Suspension Event; provided, however,

<PAGE>

that there  shall not be more than two Delay  Periods  in any twelve  (12) month
period.  In the event that the aggregate  number of days in all Delay  Period(s)
taken together within a twelve-month  period exceeds forty-five (45) days, or in
the event that there are more than two Delay Periods in any twelve-month period,
regardless  of duration,  the Company  shall  compensate  the Investors for such
delay by making monthly cash payments,  prorated on a daily basis,  to each such
Investor  of one percent  (1%) of the  purchase  price paid for the  Registrable
Shares  still  held by such  Investor  at such  time  for the  first  month of a
Suspension  Event,  two  percent  (2%)  of  the  purchase  price  paid  for  the
Registrable Shares held by such Investor for the second month, and three percent
(3%) of said purchase price for each month  thereafter,  continuing  through the
date the Delay Period ceases (the "Delay Compensation").  The Delay Compensation
will begin to accrue on the  thirty-first  (31st) day falling within one or more
Suspension  Events in any twelve-month  period (or on the first day of any Delay
Period in excess of the first two Delay Periods) and will be payable thirty days
from that date and each thirty days thereafter until the Registration  Statement
is brought effective.  Notwithstanding the foregoing, no Delay Compensation will
be due if any Delay Period is a result of actions taken or information  provided
by an Investor or the review of any Registration  Statement or prospectus by any
attorneys or inspectors representing an Investor.

            (g) The Company  shall use its best  efforts to prevent the issuance
of any  stop  order or  other  suspension  of  effectiveness  of a  Registration
Statement and, if such an order is issued,  shall use its best efforts to obtain
the  withdrawal  of such order at the earliest  possible time and to notify each
Investor  who holds  Registrable  Securities  being sold (or, in the event of an
underwritten  offering, the managing underwriters) of the issuance of such order
and the resolution thereof.

            (h) The Company shall permit a single firm of counsel  designated by
the  Investors  who hold a majority in interest  of the  Registrable  Securities
being sold pursuant to such  registration to review the  Registration  Statement
and  all  amendments  and  supplements  thereto  (as  well as all  requests  for
acceleration  or  effectiveness  thereof) a  reasonable  period of time prior to
their  filing with the SEC,  and shall not file any  document in a form to which
such counsel reasonably objects.  The Investors shall be responsible for payment
of the fees of such counsel.

            (i) The  Company  shall make  generally  available  to its  security
Holders  as soon as  practical,  but not later than  ninety  (90) days after the
close of the period covered thereby,  an earnings statement (in a form complying
with  the  provisions  of  Rule  158  under  the  Securities   Act)  covering  a
twelve-month  period  beginning  not later  than the first day of the  Company's
fiscal quarter following the effective date of the Registration Statement.

            (j) At the request of any Investor who holds Registrable  Securities
being sold pursuant to such registration,  the Company shall furnish on the date
that  Registrable  Securities  are  delivered  to an  underwriter  for  sale  in
connection with the Registration  Statement (i) a letter,  dated such date, from
the Company's  independent certified public accountants in form and substance as
is customarily given by independent certified public accountants to underwriters
in an  underwritten  public  offering,  addressed to the Investors;  and (ii) an
opinion,  dated such date, from counsel representing the Company for purposes of
such Registration Statement, in form and substance as is customarily given in an
underwritten public offering, addressed to the underwriters and Investors.

            (k) The Company shall make  available for inspection by any Investor
whose Registrable  Securities are being sold pursuant to such registration,  any
underwriter  participating  in any  disposition  pursuant  to  the  Registration
Statement,  and any  attorney,  accountant  or other agent  retained by any such
Investor  or  underwriter  (collectively,   the  "Inspectors"),   all  pertinent
financial and other records, pertinent corporate documents and properties of the
Company  (collectively,  the  "Records"),  as shall be  reasonably  necessary to
enable each  Inspector to exercise its due diligence  responsibility,  and cause
the Company's officers,  directors and employees to supply all information which
any  Inspector  may  reasonably  request  for  purposes  of such due  diligence;
provided,  however,  that each Inspector  shall hold in confidence and shall not
make any disclosure  (except to an Investor) of any Record or other  information
which the  Company  determines  in good faith to be  confidential,  and of which
determination the Inspectors are so notified,  unless (i) the disclosure of such
Records is  necessary  to avoid or correct a  misstatement  or  omission  in any
Registration Statement,  (ii) the release of such Records is ordered pursuant to
a  subpoena  or  other  order  from a court  or  government  body  of  competent
jurisdiction,  or such  release  is  reasonably  necessary  in  connection  with
litigation or other legal process or (iii) the  information  in such Records has
been  made  generally  available  to the  public  other  than by  disclosure  in
violation of this or any other  agreement.  The Company shall not be required to
disclose any confidential information in such Records to any Inspector until and

<PAGE>

unless such  Inspector  shall have entered into  confidentiality  agreements (in
form and  substance  satisfactory  to the Company) with the Company with respect
thereto,  substantially  in the form of this Section 3(k).  Each Investor agrees
that it shall,  upon learning that disclosure of such Records is sought in or by
a court or governmental  body of competent  jurisdiction or through other means,
give  prompt  notice to the  Company  and allow the  Company,  at the  Company's
expense, to undertake  appropriate action to prevent disclosure of, or to obtain
a protective order for, the Records deemed confidential. Nothing herein shall be
deemed to limit the  Investor's  ability  to sell  Registrable  Securities  in a
manner which is otherwise consistent with applicable laws and regulations.

            (l) The  Company  shall  hold in  confidence  and shall not make any
disclosure  of  information  concerning  an  Investor  provided  to the  Company
pursuant hereto unless (i) disclosure of such information is necessary to comply
with federal or state  securities  laws, (ii) the disclosure of such information
is necessary to avoid or correct a misstatement or omission in any  Registration
Statement,  (iii) the  release  of such  information  is ordered  pursuant  to a
subpoena  or  other  order  from a  court  or  governmental  body  of  competent
jurisdiction,  or such  release  is  reasonably  necessary  in  connection  with
litigation  or other  legal  process  or (iv)  such  information  has been  made
generally  available to the public other than by disclosure in violation of this
or any other  agreement.  The Company  agrees that it shall,  upon learning that
disclosure of such information concerning an Investor is sought in or by a court
or  governmental  body of competent  jurisdiction  or through other means,  give
prompt  notice to such  Investor and allow such  Investor,  at its  expense,  to
undertake appropriate action to prevent disclosure of, or to obtain a protective
order for, such information.

            (m) The Company  shall use its best efforts  either to (i) cause all
the Registrable Securities covered by the Registration Statement, subject to the
AMEX  Limit to be  listed  on  NASDAQ,  the AMEX or NYSE and on each  additional
national  securities  exchange on which similar securities issued by the Company
are then listed,  if any, if the listing of such Registrable  Securities is then
permitted  under the rules of such exchange,  or (ii) secure  designation of all
the Registrable Securities covered by the Registration Statement, subject to the
AMEX Limit, as a National Association of Securities Dealers Automated Quotations
System  ("Nasdaq")  "national market system security" within the meaning of Rule
11Aa2-1 of the SEC under the  Securities  Exchange Act of 1934,  as amended (the
"Exchange  Act")  or a Nasdaq  Small  Cap  security,  and the  quotation  of the
Registrable Securities on such Nasdaq system.

            (n) The Company shall provide a transfer agent and registrar,  which
may be a single  entity,  for the  Registrable  Securities  not  later  than the
effective date of the Registration Statement.

            (o)  The  Company  shall  cooperate  with  the  Investors  who  hold
Registrable  Securities being sold and the managing underwriter or underwriters,
if any, to facilitate the timely  preparation and delivery of certificates  (not
bearing any restrictive legends) representing  Registrable Securities to be sold
pursuant to the  Registration  Statement and enable such  certificates  to be in
such  denominations  or amounts as the case may be, and registered in such names
as the  managing  underwriter  or  underwriters,  if any, or the  Investors  may
reasonably  request;  and,  within three (3) business days after a  Registration
Statement which includes Registrable Securities is ordered effective by the SEC,
the Company shall deliver, and shall cause legal counsel selected by the Company
to deliver, to the transfer agent for the Registrable Securities (with copies to
the Investors  whose  Registrable  Securities are included in such  Registration
Statement)  instructions  to the transfer agent to issue new stock  certificates
without a legend and an opinion of such counsel that the Registrable Shares have
been registered.

            (p) The Company shall take all other reasonable actions necessary to
expedite  and  facilitate   disposition  by  the  Investor  of  the  Registrable
Securities pursuant to the Registration Statement.

            (q) At the  request of any  Investor,  the  Company  shall  promptly
prepare  and  file  with  the  SEC  such  amendments  (including  post-effective
amendments) and supplements to a Registration  Statement and the prospectus used
in connection  with the  Registration  Statement as may be necessary in order to
change the plan of  distribution  set forth in such  Registration  Statement  to
conform to written information supplied to the Company by such Investor for such
purpose.


<PAGE>

            (r) The Company shall comply with all  applicable  laws related to a
Registration  Statement and offering and sale of securities  and all  applicable
rules and regulations of governmental authorities in connection therewith.

            (s) From and after the date of this  Agreement,  the  Company  shall
not, and shall not agree to, allow the holders of any  securities of the Company
(other than the holders of the  Registrable  Securities) to include any of their
securities in any Registration  Statement or any amendment or supplement thereto
under  Section 2 hereof  without the consent of the holders of a majority of the
Registrable Securities. The execution of this Agreement by the Initial Investors
shall  constitute the consent of such holders to the inclusion of  approximately
Two Hundred Thousand (200,000) shares in the Registration  Statement to be filed
pursuant to Section 2(a) hereof.

                  4.....Obligations of the Investors.  In connection  with the
registration  of the  Registrable  Securities,  the  Investors  shall have the
following obligations:

            (a) It shall be a  condition  precedent  to the  obligations  of the
Company to take any  action  pursuant  to this  Agreement  with  respect to each
Investor  that such  Investor  shall  furnish to the  Company  such  information
regarding  itself,  the  number  of  Registrable  Securities  held by it and the
intended method of disposition of the Registrable Securities held by it as shall
be  reasonably  required by rules of the SEC to effect the  registration  of the
Registrable  Securities  (the  "Requested  Information").   The  information  so
provided by the Investor shall be included  without  material  alteration in the
Registration Statement and shall not be modified without such Investor's written
consent.  At least ten (10) business days prior to the first anticipated  filing
date of the Registration Statement,  the Company shall notify each Investor that
it must deliver the Requested Information if such Investor elects to have any of
such Investor's Registrable  Securities included in the Registration  Statement.
The  Closing  of the  Offering  is  deemed  to be  notice  with  respect  to the
information  regarding  each  Investor  required  by the Company to enable it to
comply with Section 2(a) of this Agreement.  If within five (5) business days of
such notice the Company  has not  received  the  Requested  Information  from an
Investor  (a  "Non-Responsive   Investor"),   then  the  Company  may  file  the
Registration   Statement  without  including  Registrable   Securities  of  such
Non-Responsive Investor.

            (b) Each Investor,  by such Investor's acceptance of the Registrable
Securities,  agrees to cooperate with the Company as reasonably requested by the
Company  in  connection  with the  preparation  and  filing of the  Registration
Statement hereunder, unless such Investor has notified the Company in writing of
such  Investor's  election  to  exclude  all  of  such  Investor's   Registrable
Securities from the Registration Statement.

            (c) In the event  Investors  holding a majority  in  interest of the
Registrable  Securities being registered  determine to engage the services of an
underwriter,  each  Investor  agrees to enter into and perform  such  Investor's
obligations  under an  underwriting  agreement,  in usual  and  customary  form,
including,  without  limitation,   customary  indemnification  and  contribution
obligations,  with the managing underwriter of such offering and take such other
actions as are  reasonably  required  in order to  expedite  or  facilitate  the
disposition of the Registrable Securities, unless such Investor has notified the
Company in writing of such Investor's election to exclude all of such Investor's
Registrable Securities from the applicable  Registration  Statement. No Investor
shall be obligated to participate in any such underwriting.

            (d) Each Investor  agrees that,  upon receipt of any notice from the
Company of the  happening of any event of the kind  described in Section 3(f) or
3(g),  such Investor will  immediately  discontinue  disposition  of Registrable
Securities  pursuant to the  Registration  Statement  covering such  Registrable
Securities  until such Investor's  receipt of the copies of the  supplemented or
amended  prospectus  contemplated by Section 3(f) or 3(g) and, if so directed by
the Company,  such Investor  shall deliver to the Company (at the expense of the
Company) or destroy (and deliver to the Company a  certificate  of  destruction)
all  copies,  other than file  copies,  in such  Investor's  possession,  of the
prospectus  covering such Registrable  Securities current at the time of receipt
of such notice.

            (e) No Investor may  participate  in any  underwritten  registration
hereunder  unless such Investor (i) agrees to sell such  Investor's  Registrable
Securities on the basis provided in any  underwriting  arrangements  approved by
the Investors entitled  hereunder to approve such  arrangements,  (ii) completes
and executes all questionnaires, powers of

<PAGE>

attorney,  indemnities,  underwriting  agreements and other documents reasonably
required under the terms of such underwriting arrangements,  and (iii) agrees to
pay its pro rata share of all  underwriting  discounts and commissions and other
fees and  expenses  of  investment  bankers  and any manager or managers of such
underwriting  and legal expenses of the  underwriter  applicable with respect to
its  Registrable  Securities,  in each case to the  extent  not  payable  by the
Company pursuant to the terms of this Agreement.

      5.  Expenses  of  Registration.  All  expenses,  other  than  underwriting
discounts and commissions incurred in connection with registrations,  filings or
qualifications  pursuant to Sections 2 and 3 or the fees of counsel  pursuant to
Section  3(e) hereof,  but  including,  without  limitation,  all  registration,
listing and  qualifications  fees,  printers and  accounting  fees, the fees and
disbursements of counsel for the Company, shall be borne by the Company.

      6. Indemnification.  In the event any Registrable  Securities are included
in a Registration Statement under this Agreement:

            (a) To the extent  permitted by law, the Company will  indemnify and
hold  harmless  each  Investor  who  holds  such  Registrable  Securities,   the
directors,  officers,  employees,  representatives  or agents,  if any,  of such
Investor,  each person,  if any, who controls any Investor within the meaning of
the  Securities  Act or the  Exchange  Act, any  underwriter  (as defined in the
Securities Act) for the Investors,  the directors,  if any, of such  underwriter
and the  officers,  if any, of such  underwriter,  and each person,  if any, who
controls any such  underwriter  within the meaning of the  Securities Act or the
Exchange  Act (each,  an  "Indemnified  Person"),  against any  losses,  claims,
damages, settlements, fines, penalties, judgments, expenses (including attorneys
fees) or liabilities (joint or several) (collectively  "Claims") to which any of
them become  subject  under the  Securities  Act, the Exchange Act or otherwise,
insofar  as such  Claims  (or  actions  or  proceedings,  whether  commenced  or
threatened,  in  respect  thereof)  arise  out of or are  based  upon any of the
following statements,  omissions or violations in the Registration Statement, or
any post-effective  amendment thereof, or any prospectus  included therein:  (i)
any untrue statement or alleged untrue statement of a material fact contained in
the Registration  Statement or any  post-effective  amendment  thereof or in any
filings made in  connection  with the  qualification  of the Offering  under the
securities  or "blue  sky" laws of any  jurisdiction  in which  the  Registrable
Securities  are offered or the omission or alleged  omission to state  therein a
material fact required to be stated  therein or necessary to make the statements
therein not misleading, (ii) any untrue statement or alleged untrue statement of
a material  fact  contained in any  preliminary  prospectus if used prior to the
effective  date  of such  Registration  Statement,  or  contained  in the  final
prospectus  (as  amended or  supplemented,  if the Company  files any  amendment
thereof or supplement  thereto with the SEC) or the omission or alleged omission
to state  therein  any  material  fact  necessary  to make the  statements  made
therein,  in light of the circumstances  under which the statements therein were
made, not misleading, or (iii) any violation or alleged violation by the Company
of the Securities Act, the Exchange Act or any state  securities law or any rule
or  regulation  (the matters in the  foregoing  clauses (i) through (iii) being,
collectively,  "Violations").  Subject to the  restrictions set forth in Section
6(c) with respect to the number of legal  counsel,  the Company shall  reimburse
the Investors and each such underwriter or controlling person,  promptly as such
expenses  are  incurred  and are due and  payable,  for any legal  fees or other
reasonable  expenses  incurred  by  them in  connection  with  investigating  or
defending  any such Claim.  Notwithstanding  anything to the contrary  contained
herein, the indemnification  agreement contained in this Section 6(a): (A) shall
not apply to a Claim  arising out of or based upon a Violation  which  occurs in
reliance upon and in  conformity  with  information  furnished in writing to the
Company by any  Indemnified  Person or underwriter for such  Indemnified  Person
expressly  for  use in  connection  with  the  preparation  of the  Registration
Statement  or  any  such  amendment  thereof  or  supplement  thereto,  if  such
prospectus  was timely made  available  by the Company  pursuant to Section 3(c)
hereof;  (B) with respect to any preliminary  prospectus  shall not inure to the
benefit  of any such  person  from  whom the  person  asserting  any such  Claim
purchased the  Registrable  Securities  that are the subject  thereof (or to the
benefit of any person  controlling  such  person)  if the  untrue  statement  or
omission of material fact contained in the preliminary  prospectus was corrected
in the prospectus,  as then amended or supplemented,  if a prospectus was timely
made available by the Company pursuant to Section 3(c) hereof; and (C) shall not
apply to amounts paid in settlement of any Claim if such  settlement is effected
without the prior  written  consent of the Company,  which  consent shall not be
unreasonably  withheld.  Such  indemnity  shall  remain in full force and effect
regardless of any investigation made by or on behalf of the Indemnified  Persons
and shall  survive the transfer of the  Registrable  Securities by the Investors
pursuant to Section 9.

            (b) In  connection  with  any  Registration  Statement  in  which an
Investor is participating, each such Investor, severally and not jointly,

<PAGE>

agrees to indemnify and hold harmless, to the same extent and in the same manner
set forth in Section  6(a),  the  Company,  each of its  directors,  each of its
officers who signs the Registration Statement, each person, if any, who controls
the Company  within the meaning of the  Securities  Act or the Exchange Act, any
underwriter  and  any  other  stockholder  selling  securities  pursuant  to the
Registration  Statement  or any of its  directors  or officers or any person who
controls such  stockholder or  underwriter  within the meaning of the Securities
Act or the Exchange Act (collectively  and together with an Indemnified  Person,
an  "Indemnified  Party"),  against  any Claim to which  any of them may  become
subject,  under the  Securities  Act, the Exchange Act or otherwise,  insofar as
such Claim  arises out of or is based  upon any  Violation,  in each case to the
extent (and only to the extent) that such Violation  occurs in reliance upon and
in conformity with written information furnished to the Company by such Investor
expressly  for use in  connection  with such  Registration  Statement,  and such
Investor will promptly reimburse any legal or other expenses reasonably incurred
by them in connection with investigating or defending any such Claim;  provided,
however,  that the indemnity  agreement contained in this Section 6(b) shall not
apply to amounts paid in settlement of any Claim if such  settlement is effected
without the prior written  consent of such Investor,  which consent shall not be
unreasonably  withheld;  provided further,  however,  that the Investor shall be
liable  under  this  Section  6(b) for only  that  amount of a Claim as does not
exceed the net proceeds to such Investor as a result of the sale of  Registrable
Securities pursuant to such Registration Statement.  Such indemnity shall remain
in full force and effect regardless of any investigation made by or on behalf of
such  Indemnified  Party and  shall  survive  the  transfer  of the  Registrable
Securities by the Investors pursuant to Section 9.  Notwithstanding  anything to
the contrary contained herein, the  indemnification  agreement contained in this
Section 6(b) with respect to any preliminary  prospectus  shall not inure to the
benefit of any Indemnified Party if the untrue statement or omission of material
fact contained in the preliminary  prospectus was corrected on a timely basis in
the prospectus, as then amended or supplemented.

            (c) Promptly after receipt by an  Indemnified  Person or Indemnified
Party  under  this  Section  6 of  notice  of the  commencement  of  any  action
(including any  governmental  action),  such  Indemnified  Person or Indemnified
Party shall, if a Claim in respect  thereof is to made against any  indemnifying
party under this Section 6, deliver to the  indemnifying  party a written notice
of the commencement  thereof and this indemnifying party shall have the right to
participate in, and, to the extent the  indemnifying  party so desires,  jointly
with any other indemnifying  party similarly  noticed,  to assume control of the
defense thereof with counsel mutually  satisfactory to the indemnifying parties;
provided,  however,  that an Indemnified  Person or Indemnified Party shall have
the right to retain its own  counsel,  with the fees and  expenses to be paid by
the indemnifying party, if, in the reasonable opinion of counsel retained by the
indemnifying party, the representation by such counsel of the Indemnified Person
or Indemnified  Party and the indemnifying  party would be inappropriate  due to
actual or  potential  differing  interests  between such  Indemnified  Person or
Indemnified   Party  and  other  party  represented  by  such  counsel  in  such
proceeding.  The Company  shall pay for only one separate  legal counsel for the
Investors;  such legal  counsel  shall be  selected by the  Investors  holding a
majority  in  interest  of the  Registrable  Securities.  The failure to deliver
written  notice  to the  indemnifying  party  within  a  reasonable  time of the
commencement of any such action shall not relieve such indemnifying party of any
liability to the Indemnified  Person or Indemnified  Party under this Section 6,
except to the extent that the indemnifying party is prejudiced in its ability to
defend such action. The indemnification required by this Section 6 shall be made
by  periodic   payments  of  the  amount   thereof  during  the  course  of  the
investigation or defense, as such expense, loss, damage or liability is incurred
and is due and  payable.  The  provisions  of this  Section 6 shall  survive the
termination of this Agreement.

      7. Contribution.  If the indemnification  provided for in Section 6 herein
is  unavailable  to the  Indemnified  Parties in respect of any losses,  claims,
damages  or  liabilities  referred  to  herein  (other  than  by  reason  of the
exceptions  provided  therein),  then each such  Indemnifying  Party, in lieu of
indemnifying  such  Indemnified  Party,  shall  contribute to the amount paid or
payable by such Indemnified Party as a result of such losses, claims, damages or
liabilities  as  between  the  Company on the one hand and any  Investor  on the
other, in such proportion as is appropriate to reflect the relative fault of the
Company and of such  Investor in  connection  with the  statements  or omissions
which resulted in such losses,  claims,  damages or liabilities,  as well as any
other relevant  equitable  considerations.  The relative fault of the Company on
the one hand and of any Investor on the other shall be  determined  by reference
to,  among other  things,  whether the untrue or alleged  untrue  statement of a
material  fact or omission or alleged  omission to state a material fact relates
to information supplied by the Company or by such Investor.


<PAGE>

      In no event shall the obligation of any  Indemnifying  Party to contribute
under this Section 7 exceed the amount that such  Indemnifying  Party would have
been obligated to pay by way of indemnification if the indemnification  provided
for  under   Section  6(a)  or  6(b)  hereof  had  been   available   under  the
circumstances.

      The  Company  and the  Investors  agree  that  it  would  not be just  and
equitable if contribution pursuant to this Section 7 were determined by pro rata
allocation (even if the Investors or the underwriters were treated as one entity
for such  purpose)  or by any other  method of  allocation  which  does not take
account of the equitable considerations referred to in the immediately preceding
paragraphs.  The amount paid or payable by an  Indemnified  Party as a result of
the losses,  claims,  damages  and  liabilities  referred to in the  immediately
preceding paragraphs shall be deemed to include,  subject to the limitations set
forth above, any legal or other expenses reasonably incurred by such Indemnified
Party in connection  with  investigating  or defending any such action or claim.
Notwithstanding the provisions of this section, no Investor or underwriter shall
be required to contribute any amount in excess of the amount by which (i) in the
case of any Investor,  the net proceeds  received by such Investor from the sale
of Registrable Securities or (ii) in the case of an underwriter, the total price
at which the  Registrable  Securities  purchased  by it and  distributed  to the
public were offered to the public  exceeds,  in any such case, the amount of any
damages that such Investor or underwriter  has otherwise been required to pay by
reason of such  untrue or  alleged  untrue  statement  or  omission  or  alleged
omission. No person guilty of fraudulent  misrepresentation  (within the meaning
of Section 11(f) of the Securities Act ) shall be entitled to contribution  from
any person who was not guilty of such fraudulent misrepresentation.

      8. With a view to making  available to the  Investors the benefits of Rule
144 promulgated under the Securities Act or any other similar rule or regulation
of the SEC that may at any time permit the  Investors to sell  securities of the
Company to the public without registration ("Rule 144"), the Company agrees to:

            (a) File with the SEC in a timely manner and make and keep available
all reports and other  documents  required of the Company under the Exchange Act
so long as the Company remains subject to such  requirements  and the filing and
availability  of such reports and other documents is required for the applicable
provisions of Rule 144; and

            (b)  Furnish  to  each  Investor  so long  as  such  Investor  holds
Registrable  Securities,  promptly upon request,  (i) a written statement by the
Company that it has complied with the reporting requirements of Rule 144 and the
Exchange Act,  (ii) a copy of the most recent annual or quarterly  report of the
Company and such other reports and documents so filed by the Company,  and (iii)
such other information as may be reasonably requested to permit the Investors to
sell such securities pursuant to Rule 144 without registration.

      9.  Assignment  of  Registration  Rights.  The rights to have the  Company
register   Registrable   Securities   pursuant  to  this   Agreement   shall  be
automatically  assigned by the Investors to  transferees  or assignees of all or
any  portion  of  such  securities  or  Warrants  exercisable  into  Registrable
Securities  only if (i) the Investor  agrees in writing with the  transferee  or
assignee to assign such rights, and a copy of such agreement is furnished to the
Company  within a reasonable  time after such  assignment,  (ii) the Company is,
within a  reasonable  time after such  transfer or  assignment,  furnished  with
written  notice of the name and address of such  transferee  or assignee and the
securities with respect to which such registration  rights are being transferred
or assigned, (iii) following such transfer or assignment the further disposition
of such  securities  by the  transferee  or  assignee  is  restricted  under the
Securities Act and applicable  state securities laws, (iv) at or before the time
the Company  received  the written  notice  contemplated  by clause (ii) of this
sentence,  the  transferee or assignee  agrees in writing with the Company to be
bound by all of the provisions  contained  herein,  (v) such transfer shall have
been  made in  accordance  with  the  applicable  requirements  of the  Purchase
Agreement,  and (vi) such transferee  shall be an "accredited  investor" as that
term is defined in Rule 501 of  Regulation D  promulgated  under the  Securities
Act.

      10. Amendment of Registration Rights.  Provisions of this Agreement may be
amended and the  observance  thereof  may be waived  (either  generally  or in a
particular  instance and either  retroactively or  prospectively)  only with the
written  consent of the  Company  and each  Investor.  Any  amendment  or waiver
effected in accordance  with this Section 10 shall be binding upon each Investor
and the Company.


<PAGE>

      11.  Third  Party  Beneficiary.  The  parties  acknowledge  and agree that
Shoreline Pacific Institutional Finance, the Institutional Division of Financial
West  Group  ("Shoreline"),  shall be deemed a third  party  beneficiary  of the
Company's  agreements and  representations  set forth in this Agreement,  and to
indemnification  for any  damages  resulting  to  Shoreline  from any  actual or
threatened breach thereof by the Company,  both in Shoreline's personal capacity
and,  should  Shoreline so elect,  and provided that  Shoreline has obtained the
prior written consent of the Investor, on behalf of the Investor.

      12.   Miscellaneous.

            (a) Conflicting  Instructions.  A person or entity is deemed to be a
holder of Registrable  Securities  whenever such person or entity owns of record
such Registrable Securities.  If the Company receives conflicting  instructions,
notices or elections  from two or more  persons or entities  with respect to the
same  Registrable   Securities,   the  Company  shall  act  upon  the  basis  of
instructions,  notice or election  received  from the  registered  owner of such
Registrable Securities.

            (b) Notices. Any notices required or permitted to be given under the
terms of this  Agreement  shall be sent by  certified or  registered  mail (with
return  receipt  requested) or delivered  personally or by courier  (including a
nationally recognized overnight delivery service) or by facsimile  transmission.
Any  notice  so given  shall be  deemed  effective  upon  receipt  if  delivered
personally,  by U.S. Mail or by courier or facsimile transmission,  in each case
addressed to a party at the following address or such other address as each such
party furnishes to the other in accordance with this Section 12(b), and:

            If to the Company:

            Cel-Sci Corporation
            66 Canal Center Plaza, Suite 510
            Alexandria, VA 22314
            Facsimile: (703) 549-6269
            Attention: Mr. Geert R. Kersten

            with copy to:

            Hart & Trinen
            1624 Washington Street
            Denver, CO 80203
            Facsimile: (303) 839-5414
            Attention: Mr. Bill Hart, Esq.

            If to Nelson Partners:

            Nelson Partners
            c/o Leeds Management Services
            129 Front Street, 5th Floor
            Hamilton HM 12
            Bermuda
            Telecopy: (441) 292-2239
            Attention:  Ms. Anne Dupuy

            with a copy to:

            Citadel Investment Group, LLC
            225 West Washington Street
            9th Floor
            Chicago, IL  60606
            Telecopy: (312) 368-1347
            Attention:  Mr. Michael J. Hughes and Mr. Kenneth C. Griffin


<PAGE>

            and with a copy to:

            Katten, Muchin, & Zavis
            525 West Monroe Street
            Suite 1700
            Chicago, IL  60661-3693
            Telecopy:  (312) 902-1061
            Attention:  Mr. Steven G. Martin, Esq.

            If to Olympus Securities, Ltd.:

            Olympus Securities, Ltd.
            c/o Leeds Management Services
            129 Front Street, 5th Floor
            Hamilton HM 12
            Bermuda
            Telecopy: (441) 292-2239
            Attention:  Ms. Anne Dupuy

            with a copy to:

            Citadel Investment Group, LLC
            225 West Washington Street
            9th Floor
            Chicago, IL  60606
            Telecopy: (312) 368-1347
            Attention:  Mr. Michael J. Hughes and Mr. Kenneth C. Griffin

            and with a copy to:

            Katten, Muchin, & Zavis
            525 West Monroe Street
            Suite 1700
            Chicago, IL  60661-3693
            Telecopy:  (312) 902-1061
            Attention:  Mr. Steven G. Martin, Esq.

            If to KA Investments LDC:

            KA Investments LDC
            c/o Tarmachan Capital
            1712 Hopkins Crossroads
            Minnetonka, MN  55305
            Telecopy: (612) 542-4253
            Attention:  Ms. Ivana Bozjack

            with a copy to:

            Robinson Silverman Pearce Aronsohn Berman LLP
            1150 Avenue Of The Americas
            @ 51st Street
            New York, NY 10104
            Telecopy: (212) 541-1432
            Attention: Mr. Eric Louis Cohen, Esq.


<PAGE>

            If to the following Purchasers:

            Leonardo, L.P.
            c/o Angelo, Gordon & Co., L.P.
            245 Park Avenue, 26th Floor
            New York, NY  10167
            Telecopy:  (212) 692-6395
            Attention:  Mr. Gary Wolf

            GAM Arbitrage Investments, Inc.
            11 Athol Street
            Douglas, Isle of Man
            British Isles, British Virgin Islands
            Attention:  Mr. Michael L. Gordon

            AG Super Fund International Partners, L.P.
            Abbott Building
            PO Box 3186
            Road Town, Tortola
            British Virgin Islands
            Attention:  Mr. Michael L. Gordon

            Raphael, L.P.
            c/o Raphael Capital Management Limited
            Abott Building
            PO Box 3186 Main Street
            Road Town, Tortola
            British Virgin Islands
            Attention:  Mr. Michael L. Gordon

            Ramius Fund, Ltd.:
            c/o Bank of Bermuda Building
            6 Front Street
            PO Box HM 1020
            Hamilton, Bermuda HMDX
            Attention:  Michael L. Gordon

            Baldwin Enterprises, Inc.
            529 East South Temple
            Salt Lake City, Utah 84102
            Attention:  Michael L. Gordon

            and a copy to:

            Angelo, Gordon & Co., L.P.
            245 Park Avenue, 26th Floor
            New York, NY  10167
            Telecopy:  (212) 867-6395
            Attention:  Mr. Gary Wolf


<PAGE>

            in each case with a copy to:

            Shoreline Pacific Institutional Finance
            3 Harbor Drive, Suite 211
            Sausalito, CA  94965
            Attention:  General Counsel
            Telephone: (415) 332-7800
            Facsimile:  (415) 332-7808

            (c)  Waiver.  Failure of any party to  exercise  any right or remedy
under this Agreement or otherwise,  or delay by a party in exercising such right
or remedy, shall not operate as a waiver thereof.

            (d) Governing Law. This Agreement shall be governed by and construed
in  accordance  with the laws of the State of New York  applicable  to contracts
made  and to be  performed  in  the  State  of  New  York.  The  parties  hereto
irrevocably  consent to the jurisdiction of the United States federal courts and
state  courts  located in the County of New York in the State of New York in any
suit or proceeding  based on or arising under this Agreement or the transactions
contemplated  hereby  and  irrevocably  agree that all claims in respect of such
suit or  proceeding  may be  determined  in such  courts.  The  Company and each
Investor  irrevocably  waives  the  defense  of an  inconvenient  forum  to  the
maintenance  of such suit or  proceeding  in such  forum.  The  Company and each
Investor  further  agrees  that  service  of  process  upon the  Company or such
Investor,  as  applicable,  in accordance  with Section 12(b) shall be deemed in
every respect  effective service of process upon the Company or such Investor in
any suit or proceeding arising hereunder.  Nothing herein contained shall affect
Investor's  right to serve  process in any other  manner  permitted  by law. The
parties  hereto agree that a final  non-appealable  judgment in any such suit or
proceeding  shall be conclusive  and may be enforced in other  jurisdictions  by
suit on such judgment or in any other lawful manner.

The Company and each Investor hereby waive any and all rights to a jury trial of
any claim or cause of action  based upon  arising out of this  Agreement  or the
other related  agreements  and documents or any dealings  among them relating to
the subject matter hereof and the relationship  that is being  established.  The
scope of this waiver is intended to encompass  any and all disputes  that may be
filed in any court  and that  relate to the  subject  matter of this  Agreement,
including  without  limitation,  contract  claims,  tort claims,  breach of duty
claims, and all other common law and statutory claims.  The parties  acknowledge
that this waiver is a material inducement to enter into a business relationship,
that each has already  relied on the waiver and that each will  continue to rely
on the waiver in their related  future  dealings.  The Company and each Investor
hereby  warrants and represents  that it has reviewed this waiver with its legal
counsel,  and that it  knowingly  and  voluntarily  waives its jury trial rights
following  consultation with legal counsel. This waiver is irrevocable,  meaning
that it shall  apply to any  subsequent  amendments,  renewals,  supplements  or
modifications to this Agreement or to any other related documents or agreements.
In the event of litigation,  this Agreement may be filed as a written consent to
a trial by the court.

            (e) Severability.  In the event that any provision of this Agreement
is invalid or  unenforceable  under any applicable  statute or rule of law, then
such  provision  shall be deemed  inoperative to the extent that it may conflict
therewith  and shall be deemed  modified to conform with such statute or rule of
law. Any provision hereof which may prove invalid or unenforceable under any law
shall not affect the validity or enforceability of any other provision hereof.

            (f) Entire  Agreement.  This  Agreement  and the Purchase  Agreement
(including all schedules and exhibits  thereto)  constitute the entire agreement
among the parties hereto with respect to the subject matter hereof. There are no
restrictions,  promises, warranties or undertakings,  other than those set forth
or referred to herein or therein. This Agreement supersedes all prior agreements
and  understandings  among the parties hereto with respect to the subject matter
hereof.

            (g) Successors and Assigns. Subject to the requirements of Section 9
hereof,  this  Agreement  shall inure to the benefit of and be binding  upon the
successors and assigns of each of the parties hereto.

            (h) Use of Pronouns.  All pronouns and any variations  thereof refer
to the  masculine,  feminine or neuter,  singular or plural,  as the context may
require.


<PAGE>

            (i) Headings.  The headings and subheadings in the Agreement are for
convenience  of  reference  only and  shall not limit or  otherwise  affect  the
meaning hereof.

            (j)  Counterparts.  This  Agreement  may be  executed in two or more
counterparts,  each of which shall be deemed an original  but all of which shall
constitute one and the same agreement. This Agreement, once executed by a party,
may be  delivered  to the other  party  hereto by  facsimile  transmission,  and
facsimile signatures shall be binding on the parties hereto.

            (k) Further  Acts.  Each party shall do and perform,  or cause to be
done and  performed,  all such  further acts and things,  and shall  execute and
deliver all such other agreements,  certificates,  instruments and documents, as
the other  party may  reasonably  request  in order to carry out the  intent and
accomplish  the  purposes  of  this  Agreement  and  the   consummation  of  the
transactions contemplated hereby.

            (l)  Remedies.  No provision  of this  Agreement  providing  for any
remedy to a Investor  shall limit any remedy which would  otherwise be available
to such Investor at law or in equity.  Nothing in this Agreement shall limit any
rights a Investor may have with any applicable  federal or state securities laws
with respect to the investment  contemplated  hereby.  The Company  acknowledges
that a breach by it of its obligations  hereunder will cause irreparable harm to
a Investor.  Accordingly,  the Company acknowledges that the remedy at law for a
breach of its obligations under this Agreement will be inadequate and agrees, in
the event of a breach or threatened  breach by the Company of the  provisions of
this  Agreement,  that a Investor  shall be  entitled,  in addition to all other
available  remedies,  to an  injunction  restraining  any breach  and  requiring
immediate compliance, without the necessity of showing economic loss and without
any bond or other security being required.

            (m) Consents. Except as otherwise set forth herein, all consents and
other  determinations  to be made by the  Investors  pursuant to this  Agreement
shall  be made by  Investors  holding  66  2/3% of the  Registrable  Securities,
determined  as  if  all  Warrants  then   outstanding  had  been  exercised  for
Registrable Securities.

      IN WITNESS  WHEREOF,  the parties  have caused  this  Registration  Rights
Agreement to be duly executed as of the date first above written.

COMPANY:

CEL-SCI CORPORATION:


By:
   Geert R. Kersten
   Chief Executive Officer



NELSON PARTNERS



By:
      Name:  Anne Dupuy
      Title:  Officer




<PAGE>

OLYMPUS SECURITIES, LTD.



By:
      Name:  Anne Dupuy
      Title:  Officer



KA INVESTMENTS LDC.



By:
      Name:
      Title: Secretary


LEONARDO, L.P.

By:  Angelo, Gordon & Co., L.P.
        General Partner


By:
      Name: Michael L. Gordon
      Title:      Chief Operating Officer


GAM ARBITRAGE INVESTMENTS, INC.

By:  Angelo, Gordon & Co., L.P.
        Investment Advisor


By:
      Name: Michael L. Gordon
      Title:      Chief Operating Officer

AG SUPER FUND INTERNATIONAL PARTNERS, L.P.

By:  Angelo, Gordon & Co., L.P.
        General Partner


By:
      Name: Michael L. Gordon
      Title:      Chief Operating Officer




<PAGE>

RAPHAEL, L.P.



By:
      Name: Michael L. Gordon
      Title:      Chief Operating Officer



RAMIUS FUND, LTD.

By:  AG Ramius Partners, L.L.C.
        Investment Advisor


By:
      Name: Michael L. Gordon
      Title:      Managing Officer


BALDWIN ENTERPRISES, INC.

By:  AG Ramius Partners, L.L.C.
        Investment Advisor


By:
      Name: Michael L. Gordon
      Title:      Managing Officer


AGR HALIFAX FUND, LTD




By:
      Name:  Morgan Stark
      Title:        Managing Officer, AG Ramius Partners LLC







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission